Coating stent materials with polyhedral oligomeric silsesquioxane-poly(carbonateurea)urethane nanocomposites by Bakhshi, R.
 
 
Coating stent materials with 
polyhedral oligomeric 
silsesquioxane-poly(carbonate-
urea)urethane nanocomposites 
 
 
 
 
A thesis submitted in the partial fulfilment of the 
requirements for the degree of  
 
Doctor of Philosophy (Ph.D.)  
 
September 2009 
 
 
 
by 
 
 
R R R Raheleh Bakhshi  aheleh Bakhshi  aheleh Bakhshi  aheleh Bakhshi        
 
 
 
 
 
University College London 
 
 
   1 
ABBREVIATIONS 
 
AB …………….. Alamar Blue 
APTT…………...Activated partial theomboplastin time 
γ-APS ………….3-aminopropyltriethoxysilane 
ATR-FTIR …….. Attenuated total internal reflection Fourier transforms infrared spectroscopy analyser 
AFM …………... Atomic force microscopic 
BMS……………..Bare metal stent 
CABG …………. Coronary artery bypass grafting 
CAD …………… Coronary artery disease 
CE ……………... Cholesterol esterase 
COF…………….Chronic outward force 
CTB …………… CellTiter-Blue 
DES …………… Drug eluting stents 
DMAC ………… N,N’-dimethylacetamide 
DMEM ………… Dulbecco’s modified Eagle medium 
DSC …………… Differential scanning calorimetry 
EC……………….Endothelial cell 
ECM …………... Extra cellular matrix 
EDX …………… Energy dispersive X-Ray 
EHDA …………. Electrohydrodynamic spraying 
EPs …………….. Endothelial progenitor cells 
FDA …………….Food and Drug Administration 
GPC …………… Gel permeation chromatography 
HUVECs ………. Human umbilical cord vein endothelial cells 
ICP-MS ……….. Inductively coupled plasma mass spectroscopy 
ISR …………….. In-stent restenosis 
IVUS …………... Intravascular ultrasound 
LMWH………….Low molecular weight heparin 
LST ……………. Late stage thrombosis 
MDI …………….4,4’-methylenebis(phenyl isocyanate) 
MI ……………... Myocardial infarction 
MRI ……………. Magnetic resonance imaging   2 
NIH ……………. Neointimal hyperplasia 
NiTi ……………. Nickel titanium alloy 
PBS ……………. Phosphate buffered solution 
PCI …………….. Percutaneous coronary intervention 
PCU ……………. Polycarbonate urea-urethane 
PEG ……………..Polyethyleneglycol 
PEG ……………..Polyethyleneglycol 
PET ……………..Polyethylene terephthalate 
PLA ……………..Phospholipase A2 
PLLA …………... Poly-L-lactide 
PGA ……………. Poly glycolic acid 
POSS …………... Polyhedral oligomeric silsesquioxane 
PTCA …………... Percutaneous transluminal coronary angioplasty 
PU………………..Polyurethane 
PZC ……………...Points of zero charge 
RRF ……………. Radial resistive force 
SEM …………….Scanning electron microscope 
SMC ………….....Smooth muscle cells 
SQS ……………. Silsesquioxanes 
TCP…………….. Tissue culture plastic 
TVR …………… Target vessel revascularisation 
vWF…………….. von Willebrand Factor 
XPS ……………. X-ray photoelectron spectroscopy 
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TERMINOLOGY 
 
Angioplasty. Angioplasty is the technique of mechanically widening a narrowed or 
obstructed blood vessel.  
Stent. Stent is a man-made tube inserted into a natural vessel /conduit in the body to 
prevent, or counteract, a disease-induced, localized flow constriction. 
Restenosis literally means the reoccurrence of stenosis, a narrowing of a blood vessel, 
leading to restricted blood flow. Restenosis usually pertains to an artery/large blood 
vessel that has become narrowed, received treatment to clear the blockage and 
subsequently become renarrowed. 
Intimal hyperplasia. Intimal hyperplasia is the universal response of a vessel to 
injury. It is the thickening of the layer of a blood vessel as a complication of a 
reconstruction procedure. 
Magnetic Resonance Imaging. Magnetic Resonance Imaging is primarily a medical 
imaging technique most commonly used in radiology to visualize detailed internal 
structure and limited function of the body. 
Haemostasis. Haemostasis is a complex process which causes the bleeding process to 
stop. It refers to the process of keeping blood within a damaged blood vessel 
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ABSTRACT 
 
The  long-term  efficacy  of  coronary  or  peripheral  stenting  is  limited  by  in-stent 
restenosis (ISR), which occurs in 15 to 30% of patients and is attributed primarily to 
neointimal hyperplasia. By adding a drug-eluting coating, this rate has been reduced 
to about 5% or less. However, recently longer-term follow-up data has highlighted 
problems  with  drug-coated  stents,  including  late  stage  thrombosis.  A  bio-stable 
poly(carbonate-urea)urethane  has  been  used  for  stent  coating  and  the  surface 
properties  of  the  polymer  have  been  optimised  by  incorporating  the  polyhedral 
oligomeric silsesquioxane molecule. These POSS polymers improve the adhesion and 
the  growth  of  endothelial  cells.  The  work  described  in  this  thesis,  presents  an 
innovative approach in self-expanding/balloon expandable coronary stent design that 
incorporates  a  NiTi/stainless  steel  alloy  scaffold  with  a  polyhedral  oligomeric 
silsesquioxane- poly (carbonate-urea) urethane nanocomposite polymer (POSS-PCU) 
coating.  Electrohydrodynamic  spraying  and  ultrasonic  atomization  spraying  of  the 
non-biodegradable  nanocomposite  polyhedral  oligomeric  silsesquioxane  (POSS) 
polymer  have  been  investigated  in  detail  for  coating  metallic  stent  materials  and 
compared with dip coating. Because of the tight geometry of coronary stents, these 
new coating techniques have been shown to offer advantages over traditional coating 
techniques. These advantages include, reduced polymer consumption, precise coating 
thickness as low as 10  m and a highly controllable spray which leads to consistent 
reproducible results. However, poor adhesion, or bond deterioration over the lifespan/ 
deployment of the device could reduces the efficiency and could impart even more 
complexity to the implant including formation of debris which can induce thrombus 
formation. Changing the surface physical property/chemical composition through the 
proposed protocol has been shown to increase the bonding strength by up to three 
times. This study has identified a new process and conditions which can be used in 
stent coating research. 
 
   10 
PUBLICATIONS AND PRESENTATIONS 
 
1.  R.  Bakhshi,  M.J.  Edirisinghe,  A.  Darbyshire,  Z.  Ahmad,  A.  M.  Seifalian; 
Electrohydrodynamic  jetting  behaviour  of  polyhedral  oligomeric 
silsesquioxane nanocomposites. Journal of Biomaterials Applications, 2009; 
23(4):293-309. 
  
2.  R.  Bakhshi,  J.Eaton-Evans,  M.Edirisinghe,  A.Darbyshire,  Z.You, 
A.M.Seifalian,  G.Hamilton;  A  novel  nanocomposite  polymer  for  the 
development of a new aortic stent graft. British Journal of Surgery (Abstract), 
2009; 96(s1):5. 
 
3.  R.  Bakhshi,  M.J.Edirisinghe,  J.Eaton  Evans,  A.  Darbyshire,  Z.You,  J.  Lu, 
A.M.Seifalian; Polymeric coating of surface modified nitinol stent with POSS-
nanocomposite polymer using electrohydrodynamic spraying. Submitted to the 
Journal of The Royal Society Interface. 
 
4.  R. Bakhshi, M.J. Edirisinghe, A.Darbyshire, AM. Seifalian; Surface properties 
and biological behaviour of Polyhedral Oligomeric Silsesquioxane/poly(urea-
urethane) carbonate hybrid nanocomposite. Final version is being finalized for 
submission to Biomaterials.  
 
5.  R.Bakhshi,  A.Darbyshire,  M.J.  Edirisinghe,  G.  Hamilton,  A.M.Seifalian; 
Novel  nanocomposite  polymer  for  cardiovascular  devices.  Nanoparticles 
2008, Bradford (UK), February 2008. 
 
6.  R.Bakhshi,  J.Eaton-Evans,  M.J.  Edirisinghe;  Development  of  Abdominal 
Aortic  Aneurysm  stent  graft  with  bioactive  nanocomposite  polymer.  8th 
World Biomaterial Conference, Amsterdam (Netherlands), May 2008. 
 
7.  R.Bakhshi,  M.Edirisinghe,  J.Eaton-Evans,  A.  Darbyshire,  H.Salasinski, 
R.Kannan, A.Seifalian; Surface compatibility of a new origami based AAA   11 
and  coronary  stents  integrated  with  a  nanocomposite  polyurethane  graft. 
British Cardiovascular meeting, Bournemouth (UK), November 2008. 
 
8.  R.Bakhshi,  J.Eaton-Evans,  M.Edirisinghe,  A.Darbyshire,  Z.You,  A.M. 
Seifalian, G.Hamilton. Novel nanocomposite polymer for the development of 
a  new  aortic  stent  graft.  Pearce  Gould  Visiting,  UCL,  London  (UK), 
November 2008. 
  
  
 
 
 
 
 
 
 
 
 
 
 
   12 
ACKNOWLEDGEMENTS 
 
I am forever grateful to Professor Mohan Edirisinghe for believing in my 
abilities and inspiring me to achieve my full potential. Thank you for 
giving  me  the  opportunity  to  carry  out  this  project  and  providing 
immense supervision and support. 
 
I  wish  to  express  my  deepest  gratitude  to  Professor  Alexander  M 
Seifalian,  whose  unending  supervision,  help  and  patience  have  been 
invaluable.  Thank  you  for  giving  me  the  opportunity  to  work  on  this 
project and for the constant support. 
 
There are so many others in the Department of Mechanical engineering 
and  Department  of  Surgery  who  have  given  me  constant  support  and 
encouragement.  My  sincerest thanks  to Dr.  Zeeshan  Ahmed,  Dr.  Bala 
Ramesh,  and  most  particularly  to  Mr.  Arnold  Darbyshire.  This  thesis 
would have not been possible without all his help and advice. 
 
I  am  very  grateful  to  all  staff  and  my  colleagues  at  Department  of 
Mechanical  engineering  and  Department  of  Surgery  for  their  constant 
support and most of all for their friendship. 
 
I would also like to thank EPSRC for the financial support. 
 
And lastly but most importantly my thanks go to my dearest parents for 
their  sacrifice,  love  and  support  in  numerous  ways  on  my  personal 
development. I would like to thank my dearest brother, Hamid Reza, who 
has always believed in me and whose support is an immense source of 
strength.   13 
LIST OF TABLES 
 
Table 2.1. Commercially coated stents (Wieneke et al. 2002). 
Table 2.2. Overview of drug delivery vehicle (Regar, Sianos, & Serruys 2001). 
Table 2.3. Drug eluting stents (Vaina & Serruys 2006). 
Table 3.1. Distribution of selected plasma proteins in the PEG fraction (Hao 1979). 
Table 4.1. Selected properties of POSS-PCU hybrid nanocomposites compared with 
control PCU based on GPC result. 
Table 4.2. DSC melting temperatures and glass transition temperatures of POSS-PCU 
hybrid nanocomposites compared with control PCU 
Table 4.3.  Point of zero charge (PZC) as a function of POSS content as derived from 
ζ- potential measurements. 
Table 4.4. Surface tensions of four probe liquids. 
Table 4.5. Advancing (θa) and receding (θr) contact angles, and hysteresis of POSS-
PCU compared with control PCU. 
Table 4.6. Surface Tension of POSS-PCU against PCU.  
Table 4.7. Stress-strain behaviour of polymers. 
Table 4.8. Selected properties of polymers based on GPC results. 
Table 5.1. Physical properties of POSS-PCU2 nanocomposite polymer solution, the 
values are average of three reading; DMAC: N, N-dimethylacetamide. 
Table 5.2. Taguchi orthogonal array method for parameter testing. 
Table5. 3. Droplet sizes of 12 samples sprayed with POSS-PCU2 with different 
parameters. 
Table 5.4. Set of parameters used for films preparation for tensile testing and 
ICP/MS.   14 
Table 6.1. Orthogonal arrays for parameter testing. 
Table 6.2. Composition of the Si compositions (in wt.%) measured by EDX for 
different silane modification scenarios. A) 2%, 15min, pH=4; B) 2%, 1hour, pH=8; C) 
5%, 1hour, pH=4; D) 5%, 15min, pH=8; 
Table 6.3. Surface composition obtained from the quantification of the XPS survey 
spectra. 
Table 6.4. Effect of aging solution on POSS-PCU2 coating surface. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   15 
LIST OF FIGURES 
 
 
Figure 2.1. Balloon angioplasty. (A) a guide wire with a deflated balloon is passed 
through the catheter in the narrowed artery; (B) the balloon is then inflated to push the 
plaque against the artery wall; (C) the balloon is then removed. 
Figure 2.2. Coronary artery bypass grafting. 
Figure 2.3. Stenting procedure. After removal of the balloon the stent is left in place 
to keep the artery open. 
Figure 2.4. (A) Palmaz stent made from stainless steel; and (B) Symphony stent made 
from Nitinol. 
Figure 2.5. Schematic stress-strain diagram for Nitinol and stainless steel.
 
Figure 2.6. Stress-strain curves comparing with biomaterials. 
Figure 2.7. Delivery pattern of a super-elastic stent. A stent is manufactured in the 
open configuration (state B), and deformed to a close position (Satate A). 
Figure  2.8.  (A)  Photograph  of  self-expanding  biostable  polymeric  polyethylene 
terephthalate  (PET)  stent;  (B)  the  Igaki-Tamai  stent  is  a  premounted,  balloon 
expandable PLLA stent that also has the ability of self-expansion. 
Figure 2.9. A) Chemical structure of rapamycin; (B) chemical structure of paclitaxel. 
Figure  2.10.  Critical  length  scale  for  different  materials  (Lichtenhan  &  Hibrid 
Plastics 2003) 
Figure 2.11. Types of synthesized nanocomposites.  
Figure  2.12.  Three-dimensional  structure  of  polyhedral  oligomeric  silsesquioxane 
molecule. 
Figure 2.13. Different structures of silsesquioxanes. (A) ladder structure; (B) Partial 
cage structure; (C) cage structure.  
Figure 2.14. Different modes observed in electrohydrodynamic spray deposition. 
Figure 2.15. Forces acting on a Taylor cone (Hartman et al. 1999).  
Figure 2.16. Schematic diagram of the ultrasonic atomizer: (1) electrical connection 
to  the  broadband  ultrasonic  generator  connection  of  oscillator;  (2)  connection  for 
nitrogen;  (3)  connection  for  liquid  solution;  (4)  protecting  cap;  (5)  Titanium 
amplifying section; (6) Piezoceramic element; (7) Nozzle; (8) Atomizing surface; (9) 
atomizer jet.   16 
Figure 2.17. Different nozzle design for ultrasonic atomization spraying. 
Figure 3.1. Tensile testing of NiTi strip arrangement using tensometer. 
Figure 3.2. Simplified reaction scheme of nanocomposite synthesis. 
Figure 3.3. Arrangement of apparatus for electrohydrodynamic spray deposition. 
Figure 3.4. Arrangement of apparatus for ultrasonic atomization spraying. 
Figure  3.5.  Electrochemical  anodisation  of  NiTi  alloy  using  sodium  nitrate  in 
methanol solution. 
Figure 3.6. Molecular structure of 3-aminopropyltriethoxysilane used in this study. 
NH2 is the functional group that chemically reacts with the isocyanate. 
Figure  3.7.  Reaction  stages  of  organotrialkoxysilane.  (A)  Hydrolysis;  (B) 
Condensation; (C) Hydrogen bonding; (D) Crosslinking. 
 Figure 3.8. Peel test arrangement. Arrows show the moving directions of the grips. 
Figure  4.1.  Molecular  weight  distribution  of  control  PCU  and  POSS-PCU 
nanocomposites. 
Figure 4.2. Stress–strain curves of POSS-based polyurethane nanocomposites: (A) 
PCU; (B) POSS-PU2; (C) POSS-PU4; (D) POSS-PU8. 
Figure  4.3.  Heating  DSC  scans  in  nitrogen  (10°C/min)  overlay  of  (A)  PCU  as 
compared to (B) POSS-PCU2, (C) POSS-PCU4 and (D) POSS-PCU8.  
Figure  4.4.  The  viscosity  of  control  PCU  and  POSS-PCU  nanocomposites  as  a 
function of shear rate. 
Figure  4.5.  AFM  phase  contrast  micrographs  of  (A)  PCU;  (B)  POSS-PCU2;  (C) 
POSS-PCU4; and (D) POSS-PCU8.  
Figure  4.6.  ζ-potentials  of  control  PCU  and  POSS-PCU  nanocomposites  in 
dependence of pH value of electrolyte solution.  
Figure 4.7. Water contact angle images on the surface of: (A) PCU; (B) POSS-PCU2; 
(C) POSS-PCU4; and (D) POSS-PCU8.  
Figure 4.8. FT-IR spectra of: (A) PCU; (B) POSS-PU2; (C) POSS-PU4; and (D) 
POSS-PU8.  
Figure 4.9. AFM topography images of (A) PCU; (B) POSS-PCU2; (C) POSS-PCU4 
(D) POSS-PCU8. 
Figure  4.10.    (A)  Schematic  representation  of  bulk  versus  surface  distribution  of 
POSS nano-particles in POSS-PCU nanocomposite. (B) Preferential segregation of 
POSS moieties towards the film-air surface.     17 
Figure 4.11. CellTiter Blue standard calibration curve for HUVECs. 
Figure 4.12. Cell viability test using CellTiter-Blue assay for HUVECs exposed to 
POSS-PCU nanocomposites and control PCU for 48 h. 
Figure 4.13. Morphological evolution of ECs seeded on TCP (A1–3); PCU (B1-3); 
POSS-PCU2 (C1-3); POSS-PCU4 (D1-3); and POSS-PCU8 (E1-3) by optical phase 
contrast microscopy. EPCs at 7 days (A-E1), 14 days (A-E2) and 21 days (A-E3). 
TCP were used as a control.  
Figure  4.14.  Cytoskeleton  visualization  (A)  and  cell  phenotype  characterization 
vWF
+ (B) by confocal microscopy after 48 hours of culture on POSS-PCU2. 
Figure  4.15.  Initial  observation  of  POSS-PCU2  following  70  days  immersion  in 
different degradative solutions. 
Figure 4.16. Ultimate tensile strength of POSS-PCU2 following 70 days immersion 
in different media.  
Figure  4.17.  Molecular  weight  distribution  of  POSS-PCU2  nanocomposites 
following 70 days immersion in different media: (A) hydrolytic solutions; (B) plasma 
fractions; and (C) oxidative/peroxidative solutions. 
Figure 5.1. The electrohydrodynamic spraying set up for stainless steel coating. 
The rotating centre is 8 mm away from the jet.  
Figure  5.2.  Electrohydrodynamic  spraying  modes  obtained  from  10  wt%  polymer 
solution at a flow rate of 8 µl/s; (A) dripping mode at 4 kV; (B) unstable cone-jet 
mode at 5.6 kV; (C) stable cone-jet mode at 6.1 kV; (D) rim emission at 5.8 kV; (E) 
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Figure 5.3. Mode Selection map for: (a) 10wt%; (b) 15 wt%; and (c) 20 wt% polymer 
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Figure 5.4. Morphology of the electrosprayed films after (a, d) 1 hour, (b, e) 2 hours, 
(c, f) 3 hours. 
Figure 5.5. Film thickness as a function of electrospraying time. 
Figure 5.6. SEM images of polymer films. Each sample is displayed at ×160 (left) 
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defined in Table 5.2.    18 
Figure 5.7. Graph showing the relationship between spraying temperature and mean 
polymer droplet diameter. 
Figure 5.8. Tensile strength of cast films. 
Figure  5.9.  Comparison  of  tensile  stress  between  films  prepared  by 
electrohydrodynamic spraying with different thicknesses. 
Figure 5.10.  Comparison of tensile stress between films with different thicknesses. 
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Figure  5.12.  Alamar  Blue  viability  assay  on  HUVECs  exposed  to  POSS-PCU2 
nanocomposite for 8 and 72 h. 
Figure  5.13.  Scanning  microscopy  images  of  nanocomposite  surface  prepared  by 
ultrasonic atomization (A). HUVECs adhered to nanocomposite after 24 hours on film 
surface prepared by casting (B);  and ultrasonic atomization spraying (C).  
Figure 6.1. Mechanical response of NiTi strip. 
Figure  6.2.  Scanning  electron  micrographs  showing  the  cross-sections  of  oxide 
coating on NiTi: (A) before anodisation; (B) after anodisation followed by; (C) heat 
treatment at 600 °C for 1 h. (H) schematic view of the NiTi strip.  
Figure 6.3. Topography of anodized NiTi samples: (A) before heat treatment; (B) 
after heat treatment at 600°C.  
Figure  6.4.  Energy  dispersive  X-ray  spectra  of  the  treated  NiTi:  (A)  as  supplied 
before treatment; (B) after anodisation; and (C) after silanisation. 
Figure 6.5. XPS survey spectra of the surface of NiTi : (A) NiTi alloy as received; 
(B)anodized NiTi; (C) heat treated at 600°C; and (D) Silanised NiTi. 
Figure 6.6. Schematic illustration of the bonding mechanism between activated silane 
solution and NiTi. 
Figure 6.7. Scanning electron micrographs showing cross-sections of treated, coated 
NiTi  strip:  (A)  casting;  (B)  electrosprayed;  100   m  thick  polymer  coating;  (C) 
electrosprayed, 50  m thick polymer coating. 
Figure 6.8. Peel strength test results for untreated and treated NiTi strip: (◊) 100  m 
electrosprayed coating on treated NiTi; (×) 50  m electrosprayed coating on treated 
NiTi; (♦) casting on treated NiTi; (●) Untreated NiTi.  
Figure 6.9. Typical scanning  electron micrographs of post-incubated POSS-PCU2 
nanocomposite  polymer  coating  on  NiTi  in:  (A)  distilled  water;  (B)  Cholesterol   19 
Esterase; (C) Phospholipase A2; (D) Plasma fraction II; (E) Plasma fraction III; (F) 
H2O2 ; and G) t-butyl peroxide after 70 days.  
Figure 6.10. Peel strength test of coated NiTi strip following 70 days immersion in 
different  media.  A)  hydrolytic  solutions,  B)  plasma  fractions  and  C) 
oxidative/peroxidative solutions. 
Figure 6.11. Ni release profiles from NiTi strips obtained from mass spectroscopy. 
Strips were incubated in DMEM.  
Figure 6.12. Ni release profiles from NiTi strips obtained from sass spectroscopy. 
Strips were incubated in plasma fraction I. 
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CHAPTER 1. Introduction 
 
 
Since the introduction of stents to clinical cardiology, several researchers have shown 
the  superiority  of  coronary  stent  implantation  as  compared  to  conventional 
angioplasty. However, restenosis still remains a major drawback of this technique. 
Basic research in animal models has identified stent-related factors including stent-
material and stent-design as major determinants of intimal proliferation. The concept 
of  stent  coating  has  been  developed  to  allow  the  combination  of  favourable 
biomaterial characteristics from different materials. 
 
In this thesis a novel nanocomposite polymer for the stent coating application is being 
introduced. The properties of the nanocomposite for the application at the vascular 
interface are investigated. The application of new methodologies to coat bare metal 
stents including stainless steel and NiTi are investigated.  
 
1.1. Contents of this thesis 
In  this  thesis,  a  critical  literature  review  on  the  conventional  treatments  for 
cardiovascular  diseases  is  presented  in  Chapter  2.  After  a  brief  description  of 
cardiovascular disease, conventional treatments of the disease are introduced. This 
chapter also discusses stents technology in more detail. The current development of 
stent  technology  is  investigated.  Then  the  problems  with  current  stents  either  in 
clinical  studies  or  research  are  discussed.  It  also  discusses  the  possible  role  of 
nanotechnology in the development of stents,  and finally it  reviewes the different   21 
coating  methods  in  more  detail,  as  stent  materials  coating  is  one  of  the  main 
objectives behind this thesis research.  
 
Chapter 3 gives a detailed description of the experimental procedures. This chapter 
discusses  the  materials  and  techniques  used  for  the  research  carried  out  in 
experimental  chapters  4,  5  and  6.  The  polymer  characterization  techniques  and 
procedures  are  described.  The  equipment  used  for  the  electrohydrodynamic 
processing and ultrasonic atomization spraying is discribed in detail. A protocol for 
surface treatment of Nitinol (NiTi) is also described. 
 
Chapter 4 discusses the characterisation of the developed nanocomposite introduced 
in  this  thesis.  The  bulk  and  surface  properties  of  POSS-based  nanocomposite  are 
discussed  in  depth  and  compared  to  a  carbonate  based-polyurethane.  The  surface 
properties of the nanocomposite are of greatest importance as the application of the 
nanocomposite is investigated at the vascular interface. 
 
Chapter  5  discusses  the  application  of  two  methodologies,  electrohydrodynamic 
spraying  and  ultrasonic  atomization  spraying  techniques  to  coat  bare  metal  stents 
including  stainless  steel  and  NiTi.  The  techniques  have  been  optimised  for  both 
methodologies  using  POSS-PCU  nanocomposites  and  best  processing  parameters  
selected.  
 
Chapter 6 describes a new surface modification technique, developed to coat NiTi 
alloy. This alloy has been developed in development of stents. The morphological and 
topographical  changes  at  the  surface  of  the  NiTi  are  also  assessed  upon  surface   22 
modification.  The  bond  strength  between  the  nanocomposite  and  the  NiTi  after 
surface treatment was also investigated and compared with un-modified NiTi.  
 
In  each  experimental  chapter,  an  extensive  discussion  has  been  carried  out  and  a 
summary of the conclusions outlined in Chapter 7. Chapter 7 also set out the future 
plan of actions in order to further exploit the research development for biologically 
assessment of nanocomposite for stent application.   
 
1.2. Hypothesis 
Silsesquioxane-polyurethane  nanocomposites  possess  the  optimal  characteristics  as 
coating for cardiovascular stents, as they are biocompatible, biostable, strong, and 
have  the  surface  characteristics  with  the  potential  of  anti-thrombogenecity  and 
endothelialisation properties. 
 
1.3. Aims and objectives of the research 
The primary aim of this study was to introduce a nanocomposite polymer for stents 
coating.  For  this  reason,  a  range  of  silsesquioxane  based-polyurethane 
nanocomposites were studied in order to select the most suitable polymer for further 
investigations.  The  selected  nanocomposite  should  have  good  biostability  and 
elasticity  in  the  first  step.  Second,  nanocomposites  were  studied  to  optimise  the 
surface properties for blood-polymer interactions. 
  
The  secondary  aim  was  to  understand  the  fundamental  of  electrohydrodynamic 
processing and ultrasonic atomization spraying to use these techniques nanocomposite 
solutions.  By  understanding  process  parameters,  optimum  conditions  for   23 
electrohydrodynamic/ultrasonic atomization spraying for coating stents materials with 
nanocomposite is the one of the main objectives of this thesis. 
 
Failure of the coating of the stents in vivo, reduces the efficiency and imparts even 
more  complexity  to  the  implant  including  formation  of  debris  which  can  induce 
thrombus formation. Therefore, the other aim of this work is to increase the longevity 
of the coating of the stent materials by introducing a protocol for effective bonding of 
the nanocomposite polymer to NiTi.  
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CHAPTER 2. Literature Review 
 
2.1. Cardiovascular disease 
Cardiovascular disease broadly covers a range of conditions affecting both the heart 
and the blood vessels. It is the leading cause of death in the aged western population 
(Hooi et al. 2004). In America alone, almost 2,400 deaths occur each day as a result of 
the disease, an average rate of one death every 37 seconds (Rosamond et al. 2008). 
When atherosclerosis which is described as the hardening and loss of elasticity of 
arteries  occurs  in  the  coronary  arteries  it  is  refered  to  as  coronary  artery  disease 
(CAD).  This causes about 2100 deaths annually  per million of the population in 
England and Wales (about 110,000 deaths in total). The disease is typically caused by 
the deposition of atherosclerotic plaques (inflamed fatty deposits) on the inner wall of 
arteries  (Mayer  et  al.  2007),  which  narrows  the  vessel  lumen  and  obstructs  the 
coronary arteries. This narrowing is commonly referred to as a stenosis and leads to a 
consequential restriction of the blood supply to the muscle cells surrounding the heart. 
Coronary artery stenosis may be asymptomatic or may lead to shortness of breath and 
angina, a chest pain. A critical reduction of the blood supply to the heart may result in 
myocardial infarction (MI) or death.  
 
The atherosclerotic lesions that form may also become fragile and rupture, resulting in 
thrombus  formation  and  a  further  restriction  of  blood  flow.  The  symptoms  and 
treatment  depend  on  which  set  of  arteries  are  affected.  Peripheral  artery  disease 
mainly  relates  to  vessels  of  the  lower  limbs  (Kirkpatrick  1999).  However,  the 
symptomatic prevalence is mainly in vessels smaller than 6 mm internal diameter.    25 
2.2. Vessel structure and function 
Oxygenated blood is distributed to the heart via the coronary arteries which are on the 
surface of the heart. The two primary coronary arteries are the left and right main 
coronary  arteries.  These  originate  near  the  cusps  of  the  aortic  valve.  Additional 
arteries branch off the two main coronary arteries to supply the heart muscle with 
blood. Since coronary arteries deliver blood to the heart muscle, any coronary artery 
disorder or disease can have serious implications by reducing the flow of oxygen and 
nutrients to the heart, which may lead to myocardial infarction and possibly death. 
The vascular system is composed of arteries, capillaries and veins. Differentiation of 
arteries and veins results in their anatomic layers. 
 
The wall of an artery consists of three layers. The innermost layer, which is in direct 
contact  with  the  flow  of  blood,  is  the  tunica  intima.  This  layer  is  lined  with 
endothelial cells (ECs) which form flat pavement-like patterns on the inside of the 
vessels and are surrounded by a connective tissue basement membrane. The basement 
membrane separates endothelium from the underlying layers. ECs act as protective 
barrier  and  control  the  exchange  of  nutrients  and  fluid  between  blood  and  tissue, 
which  is  the  basis  for  the  maintenance  of  the  stability  of  the  physiological 
environment essential to cell survival. The middle layer is the tunica media and it is 
usually  the  thickest  layer.  It  is  composed  of  smooth  muscle  cells  (SMC)  and 
extracellular  matrix  (ECM).  It  not  only  provides  support  for  the  vessel  but  also 
changes the vessel diameter to regulate blood flow and blood pressure. The outermost 
layer, which attaches the vessel to the surrounding tissue, is the tunica adventitia. It is 
composed  of  connective  tissue  and  contains  primarily  fibroblasts,  elastic  and   26 
collagenous  fibers.  These  fibres  allow  the  vessel  to  stretch  whilst  preventing 
overexpansion due to the pressure that is exerted on the walls by blood flow.  
 
Blood passes through capillaries into venules, it then flows into progressively larger 
veins until it reaches the heart. The walls of the veins have the same three layers as 
the arteries, but develop thinner walls. The tunica media (smooth muscle) and tunica 
externa (connective tissue) are much reduced and have the media composed primarily 
of SMC with relatively low amounts of elastic tissue. 
 
2.3. Conventional treatments of cardiovascular disease 
The symptoms and health risks that are associated with a stenosed (narrowed) artery 
may be treated medically by modification of risk factors and/or by drug treatment. If 
these medical treatments fail or are inappropriate, two invasive therapies are available 
for improving the blood flow in occluded vessels. The first is called percutaneous 
transluminal coronary  angioplasty (PTCA) - or simple balloon angioplasty- and it  
involves  a  non-surgical  widening  from  within  the  artery  using  a  balloon  catheter 
(Gruentzig et al. 1979). The first clinical application of coronary angioplasty using a 
balloon  catheter  was  performed  more  than  20  years  ago  by  Gruentzig  (Gruentzig 
1978). In PTCA a balloon-tipped catheter is inserted into the body, typically via the 
femoral artery located in the groin and negotiated to the site of occlusion. Balloon 
inflation within the stenosed section compresses the plaque against the vessel wall, 
increasing the internal diameter of the lumen and hence, increasing blood flow. The 
balloon is subsequently deflated and the catheter removed (Figure 2.1).  
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The second therapeutic option left is coronary artery bypass grafting (CABG) (Cook 
et al. 2007) and it involves major cardiac surgery. In coronary artery bypass surgery, 
the affected artery is bypassed by grafting another blood vessel (usually saphenus vein 
(Kunlin  J.  1949)  from  the  leg)  to  carry  blood  around  the  obstruction,  thereby 
improving myocardial blood supply (Figure 2.2). In the 1970's and 1980's, an artery 
from the inside of the chest wall, the internal thoracic artery was used as an alternative 
to vein for the bypass grafts (Berroeta et al. 2006).  Bypass grafting typically requires 
open-chest  surgery  and  the  use  of  a  heart-lung  bypass  machine  to  circulate  and 
exygenate the blood. The patient may need to stay in the hospital for a few days after 
open-chest bypass surgery, and possible complications may develop from the surgery. 
 
Bypass surgery is usually performed for heart attack only when other treatments, such 
as medicine and angioplasty, are unlikely to be effective because of the location or 
extent of the blockage. Bypass may be a better option for people with diabetes or with 
two or more blocked coronary arteries. Generally, the greater the extent of coronary 
atherosclerosis, the greater the benefits of bypass surgery over angioplasty (Smith, et 
al. 2006). CABG is offered when there is a blockage of 50% or more in the left main 
coronary artery, alone, or 70% or more in all three other major coronary arteries. For 
patients who do not have suitable vein or are not able to tolerate general anaesthesia, 
CABG is not usually practible.  
 
Although  PTCA  is  of  lower  cost  and  is  far  less  invasive  than  CABG  surgery, 
restenosis of the artery is an associated problem (Dorros et al. 1983). Restenosis is a 
narrowing at the site of balloon dilatation (Waller et al. 1991). It develops rapidly 
following  the  procedure.  The  precise  mechanisms  for  restenosis  probably  vary   28 
between  patients,  but  a  combination  of  artery  wall  remodelling  and  intimal 
hyperplasia is likely involved (Austin et al. 1985). Restenosis has three main causes 
(Lafont et al. 1995; Schwartz et al. 1998). The first, recoil of the artery, happens when 
the balloon is deflated. It usually occurs immediately or after 24 hours of completion 
of  the  procedure,  and  may  require  emergency  CABG.  The  subsequent  problem  -
negative remodelling- mostly arises during the first six months and is a contraction of 
the adventitia secondary to an injury reaction (3-6 months). In the case of negative 
remodeling, this contraction is non-uniform, leading to areas of sagging or bulging 
within the vessel, resulting in a restenosis of the vessel lumen. The third subsequent 
problem that can result from the mechanical process of balloon inflation within the 
target vessel is vascular injury, initiating an inflammatory response that stimulates the 
migration of smooth muscle cells to the site of trauma (4-6 months) (Hou et al. 2000). 
This  migration  of  cells  is  coupled  with  rapid  proliferation,  resulting  in  the 
uncontrolled  build  up  of  cellular  (scar)  material.  This  process  of  rapid  cell 
proliferation is commonly termed neointimal hyperplasia (NIH). The elastic nature of 
an artery means that expansion during balloon inflation is followed by a subsequent 
contraction  as  the  balloon  is  deflated.  As  a  consequence  of  these  physiological 
responses to balloon induced arterial injury, PTCA has associated with it a 30 to 50% 
restenosis rate (failure rate) within a year of the procedure (Serruys et al. 2002). A 
repeat  procedure  is  required  consequently  in  approximately  20%  of  patients  with 
simple lesions. The rate of re-intervention is much higher (up to 50%) for arteries of 
small calibre (≤3mm), long lesions, total occlusion and in people with diabetes. 
 
Interventional cardiologists have employed a number of approaches in order to reduce 
the rates of restenosis following vascular interventions.  In the mid-1990s, balloon   29 
angioplasty  with  a  procedure  known  as  stenting,  revolutionized  the  treatment  of 
coronary artery disease. The main advantage is that it is carried out as an outpatient 
procedure, reducing costs and recovery time significantly. With a success rate of 70-
75% in terms of vessel patency, it is replaced by bypass surgery except for multiple 
blockage cases (van Domburg et al. 1999).  
 
2.4. Stents 
Since 1996, implantation of stents in blood vessels has been performed in humans 
after  angioplasty  to  prevent  occlusion  and  restenosis  of  coronary  arteries  (van 
Domburg et al. 1999). A stent constitutes the most effective way to treat stenosis since 
they act as permanent prosthetic linings to keep the artery inflated and maintain its 
patency. 
 
Coronary stents are small cylindrical wire mesh tubes, range from 8 to 38 mm in 
length and from 2.5 to 4 mm in diameter (Vaina & Serruys 2006). Stents differ in 
inetrunit connections, flexibility, radiopacity, surface area coverage and composition. 
Because of the mechanical strength required to properly support vessel walls, stents 
are typically made of metallic materials including stainless steel, cobalt and tantalum 
alloys (Kang et al. 2007; Liu et al. 2006; Mani et al. 2007). Stents are deployed in 
conjunction with balloon angioplasty, whereby the stent is crimped over the deflated 
balloon  located  at  the  end  of  the  catheter  and  expanded  in  situ  as  the  balloon  is 
inflated (Figure 2.3).  
 
The stent device is not attempting to remove the obstruction, but instead, to create a 
larger  lumen  within  the  lesion.  Thus  the  ideal  stent  should  capitalize  on  the   30 
development  of  a  purposeful,  localized  dissection  and  plaque  disruption.  An  ideal 
stent should expand the artery stenosis mechanically and propagate pulsatile blood 
flow.  Second,  the  material  itself  needs  to  be  biocompatible,  corrosion  resistant, 
resistant to thrombus, stenosis and external compression, visible using standard x-ray 
and magnetic resonance imaging (MRI) methodology. The material also needs to be 
fatigue resistant because, the device is subjected to continuous cyclic loading induced 
by  systole/diastole  blood  pressure  after  the  implantation  (Poncin  &  Proft  2003; 
Whittaker & Fillinger 2006). Selection of a specific stent for a patient is generally 
made based on the operator’s experience with that stent, lesion characteristics (i.e. 
ease  of  stent  deliverability,  need  for  side-branch  access,  size  of  the  target  vessel, 
lesion length) and the stent delivery system. 
 
Currently  there  are  two  broad  categories  of  stents:  balloon-expandable  and  self- 
expanding. 316L stainless steel, an alloy of iron, chromium, and nickel is frequently 
used for the balloon expandable stents. Examples of balloon expandable stents are the 
Palmaz stent (Cordis Corp., Warren NJ) made from stainless steel and the Strecker 
stent (Medi-Tech, Watertown MA) made from tantalum (Figure 2.4A).  If the stent is 
to  be  balloon  expanded,  it  must  exhibit  plastic  deformation  in  the  strain  range 
corresponding to the balloon expansion to avoid recoil.  
 
Although  nickel-titanium  alloy  (Nitinol/NiTi)  was  first  developed  for  aerospace 
technology  (Nickel  Titanium  Naval  Ordinance  Laboratory)  (Whittaker  &  Fillinger 
2006), it is being utilized in medical applications. The use of NiTi in medical devices 
ranges from orthodontic dental arch wires, medical guide wires for diagnostic and 
more  recently  in  self-expanding  endovascular  stents  (Tan,  Dodd,  &  Crone  2003).   31 
Nitinol exhibits a combination of properties  (which will bw discussed  later in thi 
section)  which  makes  these  alloys  particularly  suitable  for  self  expanding  stent. 
Examples of the self-expanding stents are the Wallstent (Schneider and Minneapolis 
MN, USA) made from Ni-Co-Ti-Steel, the Gianturco Z-stent (Cook, Bloomington IN) 
made  from  stainless  steel  and  the  Symphony  stent  (Boston  Scientific/Vascular, 
Natick, MA) made from Nitinol (Figure 2.4B). If the stent is to be self-expanded, it 
needs a shape memory effect (see section 2.4.1.2) at body temperature. 
 
2.4.1. Application of NiTi in biomedical application 
The  growth  of  NiTi  in  the  medical  industries  has  exploded  in  the  last  20  years. 
Currently available stent metals like stainless steel and tantalum have limitations such 
as suboptimal radiopacity and mechanical properties which may complicate insertion 
and positioning of the stent at the site of obstruction. In contrast, NiTi alloy (with 
nearly  equiatomic  nickel  and  titanium  distribution)  has  attracted  considerable 
attention for such an application. This is because of its several advantages, including 
optimal  radiopacity,  superelasticity  and  shape  memory  characteristics  and  good 
biocompatibility (Poncin & Proft 2003; Stoeckel et al. 2004; Whittaker & Fillinger 
2006). In this section, after a brief explanation of the fundamental mechanisms of 
shape memory and superelasticity is followed by a describtion of how they relate to 
the characteristic performance of self-expanding stents.  
 
2.4.1.1. Superelastic properties 
Superelasticity  refers  to  the  ability  of  certain  metals  to  undergo  large  elastic 
deformation.  Conventional  stent  materials,  such  as  stainless  steel  or  cobalt-based 
alloys,  exhibit  different  elastic  deformation  behaviour  from  that  of  the  structural   32 
material of the living body. The elastic deformation of conventional stent materials is 
limited approximately to 1% strain, and elongation typically increases and decreases 
proportionally with the applied force. In contrast to this material, Nitinol alloys can be 
elastically deformed. 
 
A stress-induced phase transformation is accompanied by strains in excess of 8% that 
can  be  fully  recovered  through  a  reverse  phase  transformation  if  the  material  is 
unloaded (Figure 2.5). The loading and unloading show plateaus, along which large 
deflections (strains) can be stored during loading or recovered during unloading with 
small changes in loads (stress). After an initial linear increase in stress with strain, a 
large strain can be obtained with only a small further stress increase. This is called the 
loading  plateau.  The  end  of  this  plateau  is  reached  at  approximately  8%  strain. 
Unloading from the end of the plateau region causes the stress to decrease rapidly 
until a lower plateau (unloading plateau) is reached. Strain is recovered in this region 
with only a small decrease in stress. The last portion of the deforming strain is finally 
recovered  in  a  linear  fashion.  Because  more  than  8%  deformation  is  elastically 
recovered, this behaviour is called superelasticity.  
 
Stainless steel, titanium and other metals are very stiff relative to biological materials, 
yielding  little  in  response  to  pressures  from  surrounding  tissue.  The  extraordinary 
compliance of NiTi clearly makes it the metal most mechanically similar to biological 
materials (Figure 2.6).  
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2.4.1.2. Shape memory properties 
An additional unique attribute of superelastic devices is that they can be deployed 
using the shape memory effect. This character is due to their ability to revert to a pre-
deformed  shape  on  heating.  While  superelasticity  is  the  result  of  a  stress-induced 
phase transformation, shape memory is the result of the thermal phase transformation. 
In fact, when the superelastic NiTi is cooled to below a critical temperature, which is 
called  the  transition  temperature  and  is  dependant  on  the  alloy  composition  and 
processing history, it also changes its crystal structure. If no force is applied, this 
phase change is not accompanied by a shape change. The material can be plastically 
deformed in the ‘low temperature’ state and can be restored by heating above the 
transition temperature (Stoeckel e al. 2004). 
 
Self expanding Nitinol stents manufactured with a diameter larger than that of the 
target vessel. The transition temperature is set at 30°C (below body temperature); 
where  it  is  called  martensitic  state  which  is  the  phase  state  below  transition 
temperature. The stent can be easily crimped at or below room temperature and placed 
in the delivery system. The device is received by the physician preloaded in a catheter 
and  in  its  martensitic  state.  It  will  stay  compressed  while  positioning  to  the 
deployment site until temperature is raised to above 30°C. At the desired location it 
will be released from the catheter and warm up to body temperature. It recovers its 
‘pre-programmed’  shape  and  expands  until  it  hits  the  vessel  wall.  Now,  at  body 
temperature  the  stent  is  superelastic.  All  the  self  expanding  stents,  therefore,  are 
constrained in the delivery systems to prevent premature deployment. 
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Advantages  over  current  balloon  expandable  stents  include  a  greater  resistance  to 
crushing in exposed vessels (such as the femoral or carotid arteries), explain lower 
bending stresses when situated in tortuous paths, more flexible delivery systems and 
the elimination of recoil. 
 
2.4.1.3. Dynamic interferences 
Self-expanding stents take advantages of another important feature of super-elasticity; 
which is called dynamic interference. Following balloon expansion, the balloon is 
deflated, causing the stent to spring back towards its smaller, undeformed shape. This 
spring back or loosening is an undesirable feature. In order to fill a 5 mm lumen, the 
stent might have to be  expanded to 6 mm so that it springs back to 5 mm. This 
potentially  damages  the  vessel  and  leads  to  restenosis.  In  contrast,  the  NiTi  stent 
expands directly to its pre-programmed diameter with no recoil (Stoeckel, 2004).  
 
The delivery of a stent made from super-elastic Nitinol is illustrated in Figure 2.7. The 
stent is delivered through the loading curve to point A. Upon release form the delivery 
system inside the vessel, it expands following the unloading path of the stress/strain 
curve, at point B it reaches the diameter of the vessel lumen, positioning itself against 
the vessel wall with a low outward force (Chronic outward force, COF). This force 
remains nearly constant even if the vessel increases in diameter. If the vessel contracts 
through  spasm  or  is  compressed  from  outside,  the  stent  resists  deformation  by  a 
higher force (Radial resistive force; RRF). This hysteresis stress of the NiTi allows for 
the  design  of  self-expanding  stents  that  exert  only  low  outward  force  but  resist 
deformation with a much higher force. After deployment, the NiTi continues to gently 
push outwards the vessel wall, helping to prevent undesirable changes in position   35 
despite movements in the vessel. After deformation is completed, it is deployed by 
releasing from the catheter until the lumen is filled and expansion stopped (point B). 
The gentle pressure against the vessel wall is controlled by the unloading arrows, but 
effort to reclose the vessel is restricted by the stiffness indicated by the unloading 
arrows. 
 
2.5. Problems with bare metal stents 
Stents decrease restenosis by providing the largest initial expansion diameter and by 
preventing  the  early  recoil  which  occurred  with  angioplasty  and  late  negative 
remodelling of the treated vessel (Kuntz et al. 1993; Kuntz et al. 1992). Despite the 
wide  use  of  intracoronary  stents,  biocompatibility  still  remains  limited by  in-stent 
restenosis (ISR) which occurs in 15 to 30% of patients. The lesions or cases in which 
stenting is of unproven benefit include: small vessels (<3 mm lumen), long lesions, 
left main coronary artery disease and bifurcation lesions. Lesions and cases for which 
stenting  is  beneficial  include;  native  coronary  artery  lesions  in  vessels  ≥  3mm  in 
lumen,  chronic  total  occlusions,  restenotic  lesions,  acute  MI  and  treatment  of 
threatened artery closure.  
 
Histological studies following coronary stenting have shown ISR can be attributed 
primarily to neointimal hyperplasia. Neointimal proliferation occurs principally, but 
not exclusively, at the site of the primary lesion within the first six months after stent 
implantation. The bulk of  ISR  consists of extracellular matrix, proteoglycans, and 
collagen, with only 11% cells. Stents-induced arterial injury and lipid core penetration 
that  occurs  during  stent  deployment  leads  to  increased  acute  and  chronic 
inflammation of the vessel wall (Farb et al. 1999). This in turn leads to the elaboration   36 
of cytokines and growth factors that induce multiple signalling pathways and activate 
the migration and proliferation of smooth muscle cells (Kornowski et al. 1998; Suzuki 
et  al.  2001).  Extra  cellular  matrix  (ECM)  is  deposited  by  activated  fibroblasts 
resulting in luminal narrowing, resulting in the deposition of platelets and fibrin at the 
site  of  injury,  forming  thrombus  and  causing  leukocyte  migration  (Fattori  &  Piva 
2003a).  
 
In addition to ISR, bare metal stents (BMS) also have associated with them the risk of 
acute and subacute thrombosis within the first month following stenting (Bertrand et 
al. 2000). Several factors increase the risk of stent thrombosis, including the damage 
of the vessel wall during delivery of the stent, the resistance of the body to having a 
foreign material within the vascular system, which can release metal ions; that is, 
chromium  and  molybdenum  leached  from  stainless  steel  reacts  with  hydrogen 
peroxide  and  superoxide  anions  producing  free  radicals  and  further  inflammation 
(Koster  et  al.  2000).  Vascular  trauma  and/or  the  presence  of  artificial  prostheses 
within  the  vascular  system  incite  a  series  of  complex  reaction  mechanisms.  An 
aggressive  physiological  response  is  elicited  by  the  body  in  order  to  restore 
‘normality’  throughout  the  entire  vascular  system  and  regain  what  is  commonly 
referred to as haemostasis. 
 
In  the  clinical  setting,  neointimal  formation  and  in-stent  restenosis  are  related  to 
patient-specific  factors  such  as  genetic  predisposition  or  diabetes  mellitus  (Sobel 
2001),  to  lesion-specific  factors  such  as  vessel  calibre  (Mintz  et  al.  1996),  lesion 
length or plaque burden (Prati et al. 1999) and to procedure-specific factors such as 
the extent of vessel damage, residual dissections (Kornowski et al. 1998), number of   37 
stents, minimal stent diameter or minimal stent area. Patient-specific factors can not 
be  influenced  to  any  extent.  Attempts  to  modulate  lesion-specific  factors  by 
pharmacological therapy have not been successful so far. Procedure-specific factors 
may  be  favourably  affected  by  the  stent  implantation  technique  and  stent 
characteristics.  This  has  resulted  in  a  huge  variety  of  stents,  differing  in  design, 
material, surface, radioactivity and coatings (Gunn & Cumberland 1999). 
 
Stent design varies in the geometry (number of intersections and interstrut area), in 
the strut configuration and the surface metal-to-artery tissue ratio. These are the major 
determinants  of  stent  profile,  flexibility,  radial  strength  and  (elastic)  expansion 
characteristics.  The  elastic  modulus-  or  stiffness-  of  the  material  affects  stent 
expansion properties as late as eight weeks after deployment (Hofma et al. 1998). 
Reduction of strut–strut intersections can reduce the vascular injury, thrombosis and 
neointimal  hyperplasia  (Rogers  &  Edelman  1995).  Surface  characteristics  can  be 
modulated  by  (electromechanical)  polishing,  ion  implantation  or  coating.  Surface 
characteristics include chemistry, charge, and texture (Edelman et al. 2001) modulate 
cellular vessel response (plasma proteins, inflammatory and proliferative mediators, 
platelet and leukocyte activation). Suitable stent materials are metals, metal-alloys or 
polymers.  Stent  coatings  can  dramatically  reduce  protein  deposition  and  platelet 
adhesion in experimental settings (Regar et al. 2001).  
 
2. 6. Bare metal stent coatings 
Whilst there is considerable literature on the effects of coating stents much of this is 
flawed by poor experimental design as comparative uncoated stents are not included 
in trials. Coatings are various and can be classified in different categories. A variety   38 
of biologically inert coatings have been investigated to render the stent surface less 
thrombogenic. 
 
2.6.1. Metallic stents and surface treatments 
In addition to the choice of material, metallic coatings and surface treatments have 
been  investigated  for  their  ability  to  add  functionality  and  improve  the 
haemocompatibility of stents. De Scheerder et al. have evaluated the effect of metal 
surface  treatment,  using  electrochemical  polishing  on  stent  thrombogenicity  and 
neointimal  hyperplasia  in  both  a  rat  arteriovenous  model  and  a  porcine  coronary 
model  (De  Scheerder  et  al.  2000).  Electrochemical  polishing  decreased  early 
thrombus formation (7 days) and reduced neointimal hyperplasia by 40% (6 week 
follow-up)  after  stent  implantation  when  compared  to  un-polished  stents.  The 
pathophysiological  mechanism  that  most  likely  explains  the  decrease  of  thrombus 
formation  is  that  electrochemical  polishing  results  in  a  decreased  surface  area, 
resulting in less platelet adhesion and fibrinogen binding. In addition, both polished 
and  un-polished  NiTi  stents  displayed  significantly  less  thrombus  formation  in 
comparison to stainless steel stents. This may be because of the unique stress-strain 
relationship of the alloy that allows uniform stent expansion at low pressure. So, the 
thermoelastic Nitinol stent induced less acute arterial injury during deployment than 
the balloon expandable stainless steel and therefore is associated with less thrombus 
formation (Carter et al. 1998; Sheth et al. 1996). 
 
2.6.2. Inorganic/Ceramic coating materials 
Gold is biocompatible and more radio-opaque than stainless steel.  Initial in vitro and 
animal studies demonstrated improved patency resulting in reduced rates of thrombus   39 
formation,  neointimal  hyperplasia  and  improved  re-endothelialisation  (Vom  et  al. 
2002).  These  results  were  not  reproduced  in  subsequent  clinical  trials  and 
significantly increased angiographic restenosis and less favourable one year event free 
survival was reported. A comparison of gold coated versus uncoated stainless steel 
NIR™ stents (Medinol,  Inc.), concluded that gold coating triggers  an  exaggerated 
vascular response resulting in increased risk of restenosis, possibly by gold allergy 
(Svedman et al. 2005) but no increased risk of acute thrombosis (Park et al. 2002b).  
Gold-plated stent restenosis has been found to be diffusing that involves the overall 
stent length indicating a great proliferative neointimal response (Danzi et al. 2002). 
Some  randomized  studies  showed  that  gold-coated  stents  are  associated  with  an 
increased neointimal proliferation. 
  
Silicon carbide is an inert semiconductor. In part the thrombogenicity of bare metal 
stent (BMS) is due to electron transfer between blood and the stent. Silicon carbide 
reduces  this  electron  transfer  resulting  in  reduced  thrombogenicity  and  improved 
biocompatibility. It has been demonstrated to reduce platelet and leukocyte activation 
in vitro compared to stainless steel and tantalum stents. Initial clinical trials have not 
demonstrated any benefit over uncoated stents (Unverdorben et al. 2003). 
 
Titanium nitric oxide (TiNOX) does not produce the reduction-oxidation reactions, 
hydrolysis  or  metal-organic  ion  complex  formation  demonstrated  by  the  nickel 
component  of  stainless  steel  (Kandzari  et  al.  2002).    Porcine  studies  compared 
TiNOX-1 (ceramic) or TiNOX-2 (metallic) with uncoated stainless steel stents. Initial 
findings  demonstrated  reduced  neointimal  formation  and  platelet  adhesion 
(Windecker et al. 2001b). A reduced neointimal hyperplasia up to 50% at 6 week   40 
follow-up (Windecker et al. 2001a) has been observed. It has not yet been used in 
clinical trials. 
 
Diamond–like carbon is one of the most commonly used coatings; it has improved 
biocompatibility in vitro (Gutensohn et al. 2000). Porcine studies have demonstrated 
reduced thrombogenicity and reduced NIH but clinical trials have demonstrated no 
significant benefits (Airoldi et al. 2004). 
 
2.6.3. Synthetic and biological polymeric coatings 
Phosphorylcholine  is  a  naturally  occurring  neutrally  charged  phospholipid,  a 
component of the plasma membrane. It causes less platelet activation than stainless 
steel. Stents coated with phosphorylcholine have been shown to be non-inflammatory 
and non-thrombogenic in vitro and in vivo for six months or longer (Lewis et al. 
2002). Phosphorylcholine also provides a basis for a drug eluting coating. Porcine 
studies demonstrated no significant benefits for NIH (Whelan et al. 2000) although 
clinical trials have shown good tolerance and low levels of restenosis (Galli et al. 
2000;Galli et al. 2001). 
 
The most widely used materials for resorbable stents or stent coatings are the aliphatic 
polyesters  including  poly-L-lactic  acid,  polyglycolic  acid,  poly-DL-lactic  acid  and 
poly-ε -caprolactone. A porcine model using poly-L-lactic acid demonstrated minimal 
inflammatory and thrombotic response with good initial radial strength. Clinical trials 
with this and other polymer-based stents to date have yielded highly variable results. 
The  major  disadvantage  with  bioabsorbable  stents  are  the  induced  marked 
inflammatory  response  during  degradation  (Vaina  &  Serruys  2006).  Two  new   41 
bioabsorbable  coatings  including  one  with  bioabsorbable  oil  (consists  of  a  very 
lipophilic, omega-3 fatty acid blend that is applied after the stent has been crimped on 
the balloon). The other is with hydroxyappatite which is a bioactive porous material 
that is normally found in the bones and the matrix of teeth (Vaina, S. & Serruys,  
2006).  
 
2.6.4. Immobilized drug coatings 
Heparin  -  The  molecular  target  of  heparin  is  antithrombin  III  (ATIII)  (Xiao,Z., 
Théroux,  P.  1998).  Once  activated  by  heparin,  ATIII  inactivates  thrombin  and/or 
activated factor X (Xa) resulting in its anticoagulant activity. Low molecular weight 
heparins  (LMWH),  for  example  enoxaparin,  are  produced  by  degradation  of 
unfractionated  heparin  and  consist  of  smaller  polysaccharide  chains.  LMWH  are 
unable to simultaneously bind ATIII and factor Xa and preferentially bind to factor 
Xa  (Kidane  et  al.  2004).  In  vitro  studies  demonstrate  delayed  onset  of  thrombus 
formation. Heparin coated stents were well tolerated in clinical trials but demonstrate 
no significant benefit (Semiz et al. 2003; Vrolix et al. 2000; Wohrle et al. 2001). 
 
The heparin-modified stent grafts displayed superior blood compatibility compared to 
the unmodified stent grafts and it was further improved by the addition of Abciximab 
(Christensen et al. 2001; Christensen et al. 2005). 
 
Although  a  heparin-coated  stents  (Wiktor  GX  HepaMed)  are  effective  in  the 
prevention of late stent restenosis in a porcine coronary (Ahn et al. 1999), heparin-
coated  Dacron-  covered  stent-grafts  was  not  promising  with  regard  to  neointimal 
thickening and related stenosis in the iliac arteries in sheep (Schurmann et al. 1997).   42 
Other  categories  of  stents  that  have  been  studied,  include  autologous  vein  graft 
wrapped stents, polymeric stents and biodegradable stents. An autologous vein can 
feed through the lumen of a stent providing an intact endothelial surface. Porcine 
trials have demonstrated that the procedure is feasible and initial results are promising 
(Stefanadis et al. 1996). However, studies have not proven that the endothelium of 
these vessels remains intact.  This has yet to be tried clinically. 
 
Murphy  et  al  (Murphy  et  al.  1992)  have  demonstrated  the  technical  feasibility  of 
percutaneous  deployment  of  polyethylene  terephthalate  (PET)  polymeric  stents 
(Figure 2.8A) in vivo in the coronary artery, although they ere associated with an 
intense proliferative neointimal response that resulted in complete vessel occlusion. A 
marked inflammatory and neointimal
 response to an array of biodegradable as well as 
nonbiodegradable
 polymeric stents have been observed in the porcine coronary artery 
(van der Giessen et al. 1996).
   
 
The pioneering work on biodegradable stents was carried out by Zidar and coworkers 
at Duke University based on poly-L-lactide (PLLA) (Tamai et al. 2000), followed by 
biodegradable  stents  made  from  poly-L-lactide  by  Colombo  et  al  (Colombo  & 
Karvouni 2000). The  Igaki-Tamai stent which is a high-molecular weight poly-L-
lactic acid stent was the first biodegradable stent implanted in humans (Figure 2.8B). 
six-months follow up results by intravascular ultrasound (IVUS) showed it does not 
stimulate  intimal  hyperplasia  compared  to  stainless  steel  stents  (Palmaz-Shwartz) 
(Colombo  &  Karvouni  2000),  although  it  lacks  a  demonstration  of  complete 
reabsorbing within a few months suggesting the need for a longer-term investigation 
(Tamai et al. 2000). Quick endothelialisation of biodegradable stents is necessary to   43 
eliminates the chance of pieces of the degrading stent breaking off into the lumen. 
This also dictates that the degradation time of the stent be at least longer than the 
endothelialisation time. Two biodegradable stents are being clinically tested: BVS 
(Abbott  Vascular)  and  tyrosine–polycarbonate  (REVA  Medical/Boston  Scientific) 
(Venkatraman et al. 2008). 
  
Table 2.1. Commercially coated stents (Wieneke et al. 2002). 
Stent  Coating  Company 
BiodivYsio  Phosphorylcholine  Biocompatibles Cardiovascular 
Farnham, UK 
Carbostent  Pyrolytic carbon  Sorin Biomedica Saluggia, 
Italy 
Arthos Inert  Ion implantation  
(no coating in the close sense) 
Amg Raesfeld-Erle, Germany 
Tensum III / TENAX 
 Lekton 
Silicon carbide  Biotronik, Berlin, Germany 
NIRoyal  Gold  Boston Scientific SCIMED 
Maple Grove, USA 
LUNAR Stent  Iridium-oxide  InFlow Dynamics AG 
Munchen, Germnay 
Cypher-Stent  Poly(ethyl methacrylate)/ 
n-butylmethacrylate 
Cordis, Warren, USA 
Yukon  Diamond-like carbon  Translumina, Hechingen, 
Germany 
 
 
2.6.5. Drug-eluting stents 
Drug eluting stents (DES) were developed and approved first in 2003, with significant 
initial success (Valgimigli, M. et al. 2005). By adding a drug-eluting coating, the rate 
of  restenosis  has  been  reduced  to  about  5%  or  less.  Longer-term  follow-up  has   44 
highlighted problems with drug-coated stents (McFadden et al. 2004; Virmani et al. 
2004) significantly reducing their usage after 2005.  
 
DES deliver drugs at the site of the lesion, releasing single or multiple doses of a 
bioactive agent resulting in accumulation in tissues adjacent to the device (Fattori & 
Piva 2003b). Initial studies were aimed at the systemic administration of a variety of 
active  agents  to  ameliorate  the  inflammatory  response  to  stenting.  However,  this 
approach provided inadequate cessation of ISR and increased the risk of systemic 
side-effects (Meurice et al. 2001). This lack of success was attributed primarily to 
insufficient  drug  concentrations  at  the  site  of  trauma,  thus  prompting  the  idea  of 
localised drug delivery.  
 
Investigations have culminated in the development of DES, which utilise the stent 
struts as the delivery platform for the localised administration of an array of active 
agents and to provide a vehicle for the release of therapeutic drugs (Table 2.2). The 
advantages of DES include the prolonged deposition of therapeutic agent directly into 
the vessel wall, at high concentrations and at the time of injury. Because of local 
delivery, systemic concentrations are minimised, reducing the risk of remote systemic 
toxicity (Klugherz et al. 2002).     
 
Although  a  multitude  of  drugs  and  delivery  platforms  have  been  studied  for 
application  as  drug/device  combinations  in  DES,  only  two  products,  Cypher  and 
Taxus, have gained Food and Drug Administration (FDA) approval for use in the 
treatment of coronary stenosis at the outset of this project. The use of either Cypher 
(sirolimus-eluting) or Taxus (paclitaxel-eluting) stents is recommended for patients   45 
with symptomatic coronary artery disease, in whom the target artery is less than 3 mm 
in calibre (internal diameter) or the lesion is longer than 15 mm.  
 
Sirolimus (Rapamycin) is a macrocyclic lactone (Figure 2.9A) that has demonstrated 
potent  anti-fungal,  immunosuppressant  and  anti-proliferative  activity  and  was 
approved by the FDA in September 1999. Paclitaxel (Taxol®) (Figure 2.9B) is an 
anti-tumor  drug,  originally  extracted  from  the  bark  of  the  Pacific  yew  Taxus 
brevifolia. The list of DES introduced are elucidate in Table 2.3.  
 
Table 2.2. Overview of drug delivery vehicle (Regar et al. 2001). 
￿  Polyvinyl pyrolidone/cellulose esters 
￿  Polyvinyl pyrolidone/polyurethane 
￿  Polymethylidene maloleate 
￿  Polylactide/glycocoide co-polymers 
￿  Polyethylene glycol co-polymers 
￿  Polyethylene vinyl alcohol 
￿  Polydimethylsiloxane (silicone rubber) 
 
2.6.5.1. Problems of currently commercialised DES 
The clinical success of commercially available DES, such as Cypher and Taxus, has 
been demonstrated (Regar et al. 2002; Tanabe et al. 2003). The development of DES 
for  the  treatment  of  coronary  stenosis  has  undoubtedly  revolutionised  the  area  of 
interventional cardiology. Both Cypher and Taxus have demonstrated excellent results 
with  regards  to  inhibition  of  neointimal  hyperplasia  and  the  associated  ISR  when 
compared to bare metal stents, with a subsequent reduction in the need for target 
vessel revascularisation (TVR) procedures (Oberhoff, M., 2002, Sousa, J. E., 2001). 
In addition, the problem of subacute thrombosis (within the first 30 days) has been   46 
demonstrated  to  be  low  (<1.0%)  and  equivalent  between  Cypher,  Taxus  and  bare 
metal stents (Leon 2007). 
Table 2.3. Drug eluting stents (Vaina & Serruys 2006). 
Name of stent  Stent platform  Coating  Drug  manufacturer  status 
CYPHER  Stainless steel  Durable polymer  Sirolimus  Cordis   CE Mark 
TAXUS  Stainless steel  Durable polymer  Paclitaxel  Boston Scientific  CE Mark 
Endeavor  Cobalt alloy  Durable polymer  Zotarolimus   Medronic   CE Mark 
Zomaxx  Stainless steel-
tantalum 
Durable polymer  Zotarolimus  Abbott Vascular  CE Mark 
Xience  Cobalt 
chromium 
Durable polymer  Everolimus  Guidant 
Corporation 
CE Mark 
Dexamet  Stainless steel  Durable  Dexamethasone   Abbott Vascular  CE Mark 
BVS  biodegradable  Bioabsorbable   Everolimus  BVS, Guidant  - 
Biomatrix  Stainless steel  Bioabsorbable  Biolimus A9  Biosensors   CE Filed 
Nobori  Stainless steel  Bioabsorbable  Biolimus A9  Terumo   - 
Champion  Stainless steel  Bioabsorbable  Everolimus  Guidant 
Corporation 
- 
Infinnium  Stainless steel  Bioabsorbable  Paclitaxel  Sahajanand  CE Mark 
Supralimus  Stainless steel  Bioabsorbable  Sirolimus  Sahajanand  CE Mark 
CoStar  Cobalt 
chromium 
Bioabsorbable  Paclitaxel  Conor Medsystems  CE Mark 
Nanoporous 
stent 
Stainless steel  Alumina/aluminium 
oxide/Al2O3 
Tacrolimus   Jomed  - 
Yukon DES 
microorous 
stent 
Stainless steel  Aluminium oxide  Sirolimus  Translumina  CE Mark 
Janus   Stainless steel  -  Tacrolimus  Sorin  CE Mark 
 
However,  this  success  has  been  overshadowed  to  some  extent  by  recent  concerns 
regarding late stage thrombosis (LST) (Ong, et al. 2005). They can potentially result 
in thrombosis once the stent platform has ceased eluting drugs or localized tissue 
concentration is insufficient. The Cypher and Taxus DES result in delayed arterial 
healing  when  compared  with  BMS  of  similar  implant  duration  (McFadden  et  al.,  
2004). This results obtained in the study by Joner et al (Joner et al. 2006) who were 
the first group to examine systematically the effects of DES the on human coronary 
pathology. The delay in arterial healing characterized by persistent fibrin deposition   47 
and delayed re-endothelialization when compared with sites of BMS implantation. 
The cause of DES LST is multi-factorial with delayed healing in combination with 
other clinical and procedural risk factors playing a role.  
 
Further  investigations  into  the  biological  mechanisms  and  clinical  implications  of 
DES  and  coronary  thrombosis  have  recently  been  carried  out  by  Lüscher  et  al. 
(Luscher et al. 2007). The report identified several factors which contribute to an 
increased  risk  of  LST,  including  the  procedure  itself  (stent  malapposition  and/or 
under-expansion,  the  number  of  implanted  stents,  stent  length,  persistent  slow 
coronary blood flow and dissections), patient and lesion characteristics, stent design 
and premature cessation of anti-platelet drugs. It is apparent from these studies that 
LST  is  the  result  of  numerous  mechanisms,  with  significant  emphasis  on  the 
discontinuation of dual anti-platelet therapy. It has been shown that DES delay arterial 
healing and endothelialisation of stent struts as a result of the active agents employed 
and as such, once anti-platelet therapy has ceased, the stent is susceptible to a foreign 
body  response  (Venkatraman  &  Boey  2007).  In  particular,  it  appears  that  the 
polymers  currently  used  to  coat  stents  increase  the  risk  of  contact  activation  and 
hypersensitivity  reactions,  which  may  result  in  localised  inflammation  and 
lymphocyte infiltration. 
 
The techniques which facilitate endothelialisation include physical methods such as 
pore  creation  (Deepa  &  Venkatraman  2009)  and  lithography  to  create  nanosized 
surface features, which have been shown to enhance endothelialisation rates in vitro. 
Chemical modification has also been introduced to attach ligands and thus directly 
influence  ECs  (Venkatraman  et  al.  2008).  However,  the  effectiveness  of  these   48 
modifications  to  accelerate  endothelialisation  rates  in  vivo  remains  to  be 
demonstrated.  Finally,  new  stent  platforms,  such  as  endothelial  progenitor  cell 
capturing stents may provide in the near future a more “physiological” answer to stent 
implantation,  reducing  vascular  injury  and  accelerating  vessel  healing  with 
consequent  improvements  in  clinical  outcome.  Another  technique  is  to  anchor  an 
antibody  that  captures  floating  endothelial  progenitor  cells  (EPs)  from  the 
bloodstream.  In  clinical  trials,  the  Genous  stent  -which  is  not  drug-eluting-  was 
reported to have fared as well as the paclitaxel-eluting stent (Genous stent) ( 2009). 
The  concern  that  it  is  successful  in  a  subsection  of  patients  with  a  high  level  of 
floating EPs, needs to be addressed. 
 
The concerns raised with regards to the current coatings employed for stent coating, 
highlights  the  requirement  for  biocompatible,  long-term  non-thrombogenic/anti-
thrombogenic coatings, with long-term adhesive stability without the occurrence of 
polymer delamination or cracking, which also promote endothelialisation.  
 
2.7. Possible role of regenerative medicine and nanotechnology for 
cardiovascular implants 
This  endothelial  monolayer  that  lines  the  normal  blood  vessel  serves  as  a  bio-
regulator  of  cardiovascular  physiology.  The  vascular  endothelium  is  versatile  and 
multifunctional  with  many  synthetic  and  metabolic  properties.  These  include  the 
regulation of thrombus and platelet activation, adhesion and aggregation (Autio et al. 
1989) as well as modulation of vascular tone and blood flow (Furchgott & Zawadzki 
1980). It also controls SMC migration and proliferation (Casscells 1992). EC secrete 
and express numerous growth factors, extracellular matrix products, anti-thrombotic   49 
and  pro-coagulant  factors.  ECs  are  intimately  involved  in  maintaining  a  non-
thrombogenic blood-tissue interface. Re-endothelialized segments of artery are often 
associated with less neointimal thickening the absence of intact EC lining therefore 
predisposes  cardiovascular  implants;  including  bypass  graft  and  stents;  to  platelet 
deposition, thrombus and implant failure. As a result, investigators have developed 
methods to promote the endothelialisation of vascular grafts prior to implantation by 
transplantation of ECs in vitro, a process called EC seeding. The cellular engineering 
approach called  ‘seeding’ involves lining the lumen of the  graft in vitro with EC 
(Herring et al. 1978; Zilla et al. 1987).  
 
 Recent advances in science and technology, especially progressive development in 
nanoscience  and  nanotechnology,  offer  novel  nano-structured  materials  with 
enhanced  characteristics  which  make  them  the  the  material  of  choice  for  various 
applications. The enhanced characteristics include: greater strength, higher resistance 
to  permeability  and  higher  heat  stability  (Wahab  et  al.  2008;  Zeng  et  al.  2009). 
Nanotechnology is concerned with manipulation at the molecular or atomic level to 
provide useful applications (Ghalanbor, et al. 2005; Kubik et al. 2005). The main 
unifying theme is the control of matter on a scale smaller than 1 micrometer, normally 
between 0.1-100 nanometers, as well as the fabrication of devices on this same length 
scale (Figure 2.10). For comparison, the typical carbon-carbon bond length, and the 
spacing between these atoms in a molecule, is in the range 0.12-0.15 nm, and a DNA 
double-helix has a diameter around 2 nm. The smallest cellular life forms; the bacteria 
of the genus Mycoplasma; are around 200 nm in length. Materials reduced to the 
nanoscale can show very  different properties compared to  what they  exhibit on a 
macroscale, enabling unique applications (Kubik et al. 2005). For instance, opaque   50 
substances  may  become  transparent  (copper);  inert  materials  become  catalysts 
(platinum); stable materials turn combustible (aluminum); solids turn into liquids at 
room temperature (gold); and insulators become conductors (silicon). A material such 
as gold, which is chemically inert at normal scales, can serve as a potent chemical 
catalyst at nanoscales. Much of the fascination with nanotechnology stems from these 
unique quantum and surface phenomena that matter exhibits at the nanoscale. 
 
The  difficulties  involved  in  fulfilling  the  numerous  ideal  characteristics  using 
traditional synthetic materials have lead biomaterials research towards the fields of 
nanotechnology  and  tissue  engineering.  Nanotechnology  is  concerned  with  the 
incorporation  of  man-made  molecules  into  traditional  materials  to  express  novel 
advantageous properties such as anti-thrombogenecity and biostability (Habal 1984). 
 
Hybrid  inorganic–organic  composites  are  an  emerging  class  of  new  materials  that 
hold  significant  promise.  Materials  are  being  designed  with  the  good  physical 
properties and the excellent choice of functional group chemical reactivity associated 
with organic chemistry. Such models start with an established polymer system model 
and an assignment of dimensionality to the nanofiller. The most promising nanofillers 
and  their  dimensionality  include  clay  layered  silicates,  single  and  multi-walled 
nanotubes,  carbon  nanofibers  and  polyhedral  oligomeric  silsesquioxane  (POSS)-
nanostructured chemicals (Phillips et al. 2004). 
 
2.8. Nanocomposite 
The term "nanocomposite" was first coined by Roy and Komarneni in the early 1980s 
(Komarneni 1992) signifying a major paradigm shift in the understanding of the sol-  51 
gel process (Hoffman, et al. 1984). This involved using the solution sol-gel process to 
create maximally heterogeneous rather than homogenous materials. Nanocomposites 
should be clearly differentiated from “nanocrystalline “and "nanophased" materials, 
which  refer  to  single  phases  in  the  nanometer  range.  Nanocomposites  refers  to 
composites of more than one independent solid phase where at least one dimension is 
in the nano-meter range with all solid phases in the 1-20 nm range. These solid phases 
may  be  amorphous,  semi-crystalline/crystalline  or  combinations  thereof.  They  can 
also be inorganic or organic or both (Komarneni 1992). 
 
Due  to  their  nano-scale  sizes,  nanocomposites  can  serve  as  bridges  between 
molecules in the polymer. This nature allows them to exhibit different properties from 
conventional  microcomposites  (Alivisatos  1996).  Examples  of  this  in  nature  are 
shells,  bones,  and  teeth.  Composite  shells  or  nacre  are  composed  of  alternating 
calcium carbonate (CaCO3) and nanoscale aragonite asperities (Zaremba et al. 1996) 
and, in so being, are 3000 times stronger than monolithic CaCO3 crystals (Gao et al. 
2003).  Man  has  since  endeavored  to  synthesize  nanocomposites,  and  it  has  been 
found  that  these  synthetic  nanocomposites  have  immense  potential  because  they 
possess  increased  conductivity,  mechanical  strength,  optical  activity,  and  catalytic 
activity (Merkel et al. 2002b). Their behaviour is governed by the method of nano-
reinforcement, the nano-interface, the synthetic process utilized, its microstructural 
effects, and the interaction between the polymeric and reinforcing component (Lee & 
Lichtenhan 1998). 
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2.8.1. Structure of nanocomposites 
Conventionally  when  the  components  of  a  composite  are  mixed,  phase  separation 
occurs resulting in the formation of microcomposites. In nanocomposites however, 
the nanofillers are able to intercalate between the layers of the matrix (intercalated 
type) or be even  further dispersed uniformly within the matrix to form exfoliated 
nanocomposites thus maximizing the surface area for component interaction. While 
intercalated  nanocomposites  have  regular  interlayers,  exfoliated  ones  have  larger 
interlayers (Figure 2.11). 
 
2.8.2. Polyhedral oligomeric silsesquioxane nanocomposites 
Polyhedral oligomeric silsesquioxanes (POSS) have an inorganic silicon oxygen core 
that  is  thermally  and  chemically  robust.  The  term  silsesquioxane  refers  to  all 
structures  with  the  stoichometric  formula  RSiO1.5
.  This  central  core  is  externally 
bonded with organic groups. These substituents can be totally hydrocarbon in nature, 
or they can embody a range of polar structures and functional groups, able to provide 
compatibility of the nanostructure with man-made polymers or biological systems. So, 
each  POSS  nanostructure  can  be  manufactured  to  contain  a  chemically  precise 
number of reactive  groups that impart specific functionality to them. The average 
diameter of a POSS molecule is 1.5 nm. Thus POSS can be used as a monofunctional 
or  graftable  monomer,  a  dysfunctional  comonomer,  a  surface  modifier,  or  a 
polyfunctional crosslinker for polymers (Figure 2.12).  
 
In complete contrast to siloxane, silsesquioxanes (SQS) exist as ladder- or cage-type 
nano-structures (Tran et al. 2001), as illustrated in Figure 2.13. Scott, in 1946, first 
isolated  oligomeric  organosilsesquioxanes,  (CH3SiO1.5)n  along  with  other  volatile   53 
compounds  through  thermolysis  of  the  polymeric  products  obtained  from 
methyltrichlorosilane and dimethylchlorosilane co-hydrolysis (Li et al. 2001a).  
 
Ladder-like polysilsesquioxanes include poly (phenyl silsesquioxane) (Li et al. 2000a; 
Li et al. 2000b), poly(methyl silsesquioxane) (Maciel, Sullivan, & Sindorf 1981) and 
poly (hydridosilsesquioxane) (Frye & Collins 1970). Having an outstanding thermal 
stability,  oxidative  resistance  even  at  temperatures  of  more  than  500°C,  good 
insulating properties and gas permeabilities, these ladder-like silsesquioxane polymers 
have  a  variety  of  applications  in  areas  such  as  electronics  and  optical  devices, 
semiconductor devices,  optical fiber coatings, gas separation membranes and drug 
delivery (Li et al. 2001b).  
 
In 1995, Lichtenhan and co-workers (Lichtenhan et al. 1998) developed and patented 
a  closed-cage  SQS,  POSS  or  molecular  silica  (Lichtenhan  1995).  POSS  with  the 
formula of (RSiO1.5)n where n= 8,10,12 are compounds that embody a truly hybrid 
(inorganic–organic) architecture(Li et al. 2001c). One or more of theses R can be 
replaced by a reactive functional group to form homosilsesquioxanes (Suresh et al. 
2004), or can be formed into dendrimers or used as nanobridges (Dijkstra et al. 2002; 
Moreau et al. 2003b; Wada et al. 2005). A typical POSS molecule with the silica-like 
core (0.53 nm in diameter), externally covered by eight organic corner group with the 
general sizes of from 1 to 3 nm in diameter, can be thought of as the smallest possible 
particles of silica. In this way, POSS can be incorporated into linear or thermosetting 
polymers thereby improving their thermal and oxidation resistance and reducing their 
flammability.  In  addition,  they  can  be  used  in  biomedical  applications  such  as 
scaffolds for drug delivery, imaging reagents (Chiacchio et al. 2005).   54 
 
POSS are increasingly being used to synthesise hybrid nanocomposites due to their 
chemical  versatility  over  silica,  silicones  or  other  nanofillers  such  as  carbon 
nanotubes and nanoclays (Joshi & Butola 2004). Depending on the number of side 
groups, they may exist as pendant cages, be part of a polymeric backbone, or be 
cross-linked. Researchers have since shown that these nanocomposite cubes may be 
incorporated as building blocks (Sanchez et al. 2001a)
 of controllable shapes (Moreau 
et al. 2003a) into other polymers to form hybrid materials (Choi et al. 2001; Wada et 
al. 2005) with improved miscibility and elasticity (Haddad et al. 1999; Sanchez et al. 
2001b). This is achieved as monodispersions in polymers such as epoxide, acrylate, 
norborne, styrene, acetoxystyrene (Xu et al. 2002b) and polyurethanes. 
 
The  nanoscale  size  of  the  POSS  molecules,  as  well  as  the  degree  of  control  and 
opportunity  to  tune  the  interactions  through  substituents  on  the  POSS  cage, 
differentiate these materials from conventional additives (Misra et al. 2007). They can 
be easily functionalized with a wide variety of organic groups such as – NH2, –SH, –
OH and –COOH and can be incorporated into polymer systems via polymerization, 
grafting, blending, and so improving polymer properties. In hybrid nanocomposites, 
the judicious choice of functional moieties may change the dispersion behaviour of 
POSS  molecules  in  the  polymer  matrix,  enhance  the  processing  parameters,  and 
impart desired physical and thermomechanical properties of the final hybrid materials. 
Different POSS molecules have been successfully incorporated into many kinds of 
polymers,  such  as  styryls,  acrylics,  liquid  crystalline  polyesters,  siloxanes,  and 
polyamides (Fu et al. 2000) via polymerization, grafting, blending. 
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POSS’s composition is truly a hybrid. It is not just a mixture of an inorganic particle 
with a polymer, rather POSS represents a physical union of two dissimilar material 
types into a single molecular package that has characteristics imparted to it from each 
of the two dissimilar materials. That is the reason for the fact that POSS enhances the 
physical properties of polymers to a degree that is not possible via the blending of 
polymers with silsesquioxane resin or inorganic particles.  
  
Physical properties in materials begin to manifest themselves from structures formed 
at the 1 nm to 10 nm level. Therefore, it is highly relevant to ensure that the nano-
reinforcing  agents  are  fully  dispersable,  and  compatible  at  this  length  scale. 
Otherwise, physical properties cannot be fully controlled.  
 
2.8.2.1. POSS polymers-copolymers 
In general, there are three ways that POSS building blocks can be incorporated into 
materials. Method I is as an alloying agent, where POSS is blended into a material 
using high shear mixing/blending With method II, POSS can be polymerizable into a 
material  using  standard  copolymerization  or  reactive  grafting  techniques.  With 
method III, POSS can be utilized as a surface modifier. 
 
When working with amorphous materials such as polystyrene, POSS is alloyed into 
the amorphous phase. But when working with semi-crystalline or other multiphase or 
multi-compositioned  plastics  or  biological  systems,  depending  on  the  types  of  R-
groups, POSS cages have relative affinity for the amorphous region in a polymer or 
for the crystalline region. 
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Previous studies have shown that the resultant polymers are hybrid organic–inorganic 
nanostructured  composites  with  dramatically  improved  bulk  properties,  including 
decreased  dielectric  constant  (Leu  et  al.  2003),  decreased  oxygen  permeability 
(Isayeva & Kennedy 2004), increased flammability retardation, increased mechanical 
strength (Gao et al. 2001; Kim et al. 2003; Laine 2005), increased thermal stability 
(Liu et al. 2005; Neumann et al. 2002; Zheng et al. 2001) and increased chemical 
resistance (Laine 2005) and increased glass transition temperature (Kuo et al. 2006; 
Lee & Lichtenhan 1999; Oaten & Choudhury 2005; Patel et al. 2006). 
 
A  special  field  is  represented  by  POSS-modified  polyurethanes  because  these 
polymers encompass a huge number of specialized applications. Some papers have 
appeared  in  recent  years  describing  synthesis,  morphological  characterization,  and 
deformation  behaviour  of  POSS-modified  thermoplastic  PU  elastomers  (Fu  et  al. 
2000; Hsiao et al. 2000b; Madbouly et al. 2007; Nanda et al. 2006). 
 
It  is  well  known  that  the  properties  of  polyurethane  are  primarily  related  to  the 
formation  of  a  microphase  separation  from  the  thermodynamic  incompatibility 
(immiscibility)  of  solid  like  hard  segments  and  rubbery  soft  segments.  The  hard 
segments usually involve interchain interactions by means of van der Waals forces 
and  hydrogen  bonding,  which  determine  the  macroscopic  properties.    Being 
constituted  with  two  thermodynamically  incompatible  soft  and  hard  blocks, 
segmented  PU  are  characterized  with  a  unique  combination  of  mechanical  and 
thermal properties. Variation of the chemical nature of one of the segments or both is 
a  powerful  tool  for  the  control  of  the  structural  and  properties  of  these  polymer   57 
materials. Such characteristics of the segmented PU can be helpful in the creation of 
nanostructured organic–inorganic hybrid materials (Kickelbick 2003). 
 
POSS  could  also  be  incorporated  into  PU  by  various  methods  to  improve  the 
performance of the latter. For example, Liu et al used octaaminophenyl POSS as a 
cross linking agent for PU pre-polymer to prepare PU hybrid networks, and these 
displayed  increased  glass-transition  temperature,  storage  modulus,  and  thermal 
stability (Liu et al. 2006). Neumann et al reported a new type of POSS macromer with 
eight  reactive  isocyanate  groups  for  the  synthesis  of  hybrid  organic-inorganic 
urethane nanomaterials, and this showed thermal stability up to 190 °C (Neumann, D. 
et al. 2002). Synthesis of amphiphilic telechelic oligourethanes with terminal POSS 
groups through reaction of monoisocyanate substituted POSS and oligo(oxyethylene 
diol)  and  investigation  of  the  structure  of  such  polymers  in  solution  have  been 
reported  recently.  Interestingly,  chemical  reaction  of  monoisocyanate  substituted 
POSS  fragments  with  polyamidoamine  of  a  dendritic  nature  (polyamidoamine 
PAMAM dendrimers) leads to the formation of several organo-inorganic core–shell 
type nano-hybrids. Application of dihydroxy-containing POSS with isocyanate pre-
polymers can yield linear segmented PU with POSS fragments as a side group of the 
hard segments. By analogy with this method diamino-POSS has been used to prepare 
nanostructured PU–POSS hybrid aqueous dispersions. As demonstrated, reaction of 
the silanol groups of an open cage POSS with isocyanate moieties gave segmented 
PU with POSS incorporated in the polymer main chain as a part of the hard segment. 
Cross-linked  PU  could  also  be  synthesized  through  the  reaction  of  octafunctional 
POSS with either isocyanate  or amine groups (Bliznyuk et al. 2008). All these studies 
demonstrated that incorporation of POSS had a dramatic effect on the structure and   58 
physical properties of segmented polyurethane. Recently Nanda et al. (Nanda et al. 
2006)  synthesized  well  dispersed  polyurethane/POSS  hybrid  materials  utilizing  a 
solution  polymerization  process.  Ordered  morphologies  with  homogenously 
distributed  POSS  domains  (100–150  nm)  were  observed.  The  authors  reported 
significant  increases  in  physical  properties,  including  tensile  strength,  storage 
modulus, complex viscosity, surface hydrophobicity, and glass transition temperature. 
 
POSS molecules are believed that reduce the viscosity during processing. It is true 
that plasticizers can also be used to reduce viscosity, but modulus and Tg are also 
reduced as a result. This is not the case for POSS incorporation. Increase in glass 
transition temperatures are common and result for the incorporation of POSS directly 
into the polymer backbone. Depending upon how the POSS is incorporated (random 
or blocky), one or more glass transitions may be observed. Increase in glass transition 
has been attributed to chain motion reduction. Based on the study by Professors Laine 
and Feher, it has been  proved that  when  a number of  cell targeting receptors are 
placed  on  a  POSS  very  specific  cell  location  and  binding  can  be  achieved.  In 
summary, POSS bridges a gap between monomers and fillers in terms of size and in 
terms of reinforcement characteristics. Variation of the R-group on POSS can afford 
either plasticization or reinforcement. 
 
The framework of POSS, constituted by Si-O and Si-C bonds, is similar to silicone, 
which is a favored option in biomaterials and first introduced into breast surgery in 
the 1960s due to its inert nature and low inflammatory response. Its biocompatibility 
can be ascribed to the foci of silicon-rich areas with decreased surface free energy 
(Silver et al. 1999). Unlike carbon nanotubes (Cui et al. 2005) POSS moieties are   59 
non-toxic and cytocompatible (Kim et al. 2007). Additionally, it has been confirmed 
that  POSS  cages,  as  nanoscale  building  blocks,  can  be  incorporated  into  other 
polymers  with  improved  mechanical  and  viscoelastic  properties.  Thus,  materials 
scientists are motivated to extend POSS-based polymeric nanocomposites to tissue 
engineering and biomedical applications. Cationic POSS (e.g. ammonium-POSS) has 
been  given  more  and  more  attention  because  it  can  form  a  complex  with  anionic 
molecules with great potential application in DNA/gene delivery, drug delivery, and 
DNA/protein detection. 
 
2.9. Coating stent metals 
Various approaches have been previously used to include polymers in stents including 
dipping (McGillicuddy et al. 2006a; Sharkawi et al. 2005), spraying (Sharkawi, et al. 
2005), solution casting and chemical vapour deposition (Hanefeld et al. 2006; Lahann 
et al. 1999). However, these methods have significant disadvantages. With casting, 
dipping  and  chemical  vapour  deposition,  the  final  surface  morphology  is  smooth 
(Hanefeld et al. 2006a; Lahann et al. 1999a; McGillicuddy et al. 2006b; Sharkawi et 
al. 2005a), resulting in a platform that does not promote endothelial progenitor cells 
(EPC) growth and migration. In addition, solvent-based coating techniques have some 
disadvantages, such as bridging, pooling and lack of uniformity or inability to apply 
different  thicknesses  with  precise  process  control,  in  particular  when  coating 
thicknesses of <0.5 mm are to be prepared (Lahann et al. 1999b; Loeffler et al. 1999; 
Okner et al. 2007). Chemical vapour deposition is unfavourable as it requires high 
temperature and pressure environments and complex equipment (Okner et al. 2007a). 
Considering these disadvantages, a new approach is needed to apply a thin polymeric 
film on the metallic stent surface with a high degree of precision. Spray-coating is   60 
usually  reserved  for  devices  and  surfaces  where  a  consistent  coating  thickness  is 
especially important. Stents are commonly spray-coated to minimize pooling and drip 
spots that could occur with a dip process. Therefore, alternatives were sought to coat 
stent  material,  namely  electrohydrodynamic  spraying  and  ultrasonic  atomization 
spraying, the experimental details of these were given here. 
 
2.9.1. Electrohydrodynamic spray deposition 
Electrohydrodynamic  spraying  (EHDA)  is  a  process  in  which  an  electric  force  is 
generated at the surface of the liquid by applying a potential difference of the order of 
kilovolts between the needle, which perfuses the liquid, and the collection electrode, 
which gathers the product droplets of a jet that forms due to the electric field (Pareta 
et al. 2005; Zhang & Edirisinghe 2006; Zhang et al. 2006). In this way, a polymer 
solution  undergoes  deformation  to  a  meniscus  at  the  outlet  of  a  capillary  and/or 
elongates to a jet which subsequently  breaks up into droplets. Compared to other 
spraying techniques of liquids, electrohydrodynamic processing has some significant 
advantages, e.g. relatively easy generation and avoiding coalescence of droplets due 
to electric charge of the same polarity in the droplets, and achievement of a narrow 
size distribution of droplets in the stable cone-jet mode (Watanabe et al. 2003). 
 
2.9.1.1. Modes of electrohydrodynamic spray deposition 
EHDA  occurs  in  many  modes  (Jaworek  &  Krupa  1999b)  considering  different 
influencing  properties  such  as  the  physical  properties  of  the  liquid  (e.g.  surface 
tension, density, conductivity and viscosity) and processing parameters (e.g. flow rate 
and electric field strength, which is determined by the applied voltage and the distance 
between the needle and the collection point) (Edirisinghe & Jayasinghe 2004) (Figure   61 
2.14). The modes of electrohydrodynamic processing has been characterised by two 
criteria: 
 
1. The geometrical form of the liquid at the outlet of the capillary. 
2. The nature of the jet behaviour in its disintegration into droplets. 
 
Based on these two criteria, the spraying modes can be divided into two groups. The 
first group comprises the modes in which only fragments of liquid are ejected from 
the capillary without a continuous jet; that is, the dripping, micro-dripping, spindle, 
multi-spindle, and ramified-meniscus modes. The second group consists of the modes, 
in which the liquid characteristically issues from the capillary in the form of a long 
continuous jet which disintegrates into droplets after travelling for some time and 
distance,  usually  a  few  mm  from  the  outlet  of  the  capillary.  Stable  cone-jet, 
procession, oscillating, multi-jet and ramified-jet modes are included in the second 
group (Jaworek & Krupa 1999b). The meniscus and the jet in the second group can be 
stable, variable, or rotate spirally around the capillary axis, or whip irregularly. 
 
2.9.1.1.1. Dripping mode 
The dripping mode of electrospray is commonly obtained at lower applied voltage. It 
is similar to dripping when no voltage is applied to the capillary. The dripping mode 
in the electrohydrodynamic processing is very similar to the dripping observed for 
electrically  neutral  conditions.  The  drops  take  the  shape  of  regular  spheres  at  the 
capillary exit and detach from the capillary as the gravity force and the electric force 
overcome the surface tension force. After the drop detachment, the meniscus contracts 
back to form a hemispherical-like meniscus. With increasingly applied voltages, the   62 
meniscus elongates due to electrohydrodynamic forces, which cause the droplets to 
grow smaller as they detach from the meniscus. This is attributed to two different 
reasons: one is the reduction in the surface tension of the liquid because of the electric 
charges  on  the  surface  create  an  electrostatic  pressure  opposite  to  the  capillary 
pressure; the other is the attraction of liquid towards the plate due to the action of the 
electric field and the charges located at the end of the hanging droplet (Cloupeau & 
Prunet-Foch 1990). For further increase of the voltage the drop can for some time, be 
connected with the capillary by a thread, which next breaks of as the drop falls down.  
 
2.9.1.1.2 Micro-dripping mode 
 When the applied voltage is increased further than the value it has in the dripping 
mode, the electric force close to the capillary exit becomes sufficiently high to keep a 
stable hemispherical or ellipsoidal meniscus. The micro-dripping mode differs from 
the dripping mode as the meniscus does not contract back after droplet detachment. 
The droplet production frequency is usually two orders of magnitude higher than that 
of the dripping mode and it ranges from a few droplets up to a few thousand droplets 
per second. A small droplet -much smaller than the capillary diameter- is formed at 
the tip of the meniscus, where the electric field is much stronger. The droplet gets 
detached  from  the  meniscus  and  does  not  undergo  further  disruption.  The  micro-
dripping mode is usually observed at < 4 kV. The size of the droplets can range from 
a few tens up to about a hundred of micrometer in diameter. 
 
2.9.1.1.3. Spindle mode 
The spindle mode is generated at high flow rate with sufficiently high electric field 
where the liquid can elongate in the direction of the electric field, taking the shape of   63 
a thick jet which detaches as a vast spindle-like fragment. Spindle mode differs from 
dripping and micro-dripping modes because it is generated at higher voltages and 
such high voltages detache a fragment of liquid before a continuous jet is formed. 
Second, there is no regular droplet is ejected from the meniscus but only elongated 
fragments of liquid. Third, after its detachment the spindle can disrupt into several 
smaller  droplets  of  different  sizes,  ranging  from  300-1000  µm,  depending  on  the 
electric field stength. The meniscus contracts to its initial shape, and a new jet starts to 
be formed. Finally, the characteristic time that liquid is provided to the capillary is 
nearly equal to or shorter than the jet formation time. Increase in the applied voltage 
causes the single jet to become multiple jets. 
 
2.9.1.1.4. Unstable cone-jet mode 
A  traditional  mode  which  lies  between  the  spindle/multi-spindle  mode  and  stable 
cone-jet mode (described later in this section) can be observed under the condition of 
certain flow rates and applied voltages. It is an intermittent mode, namely unstable (or 
intermittent) cone-jet mode. In this mode, the liquid escapes the capillary in the form 
of a skewed cone and smoothly changes into a thin jet at the tip, which is similar to 
the configuration of the cone-jet mode. However, both the cone and the jet rotate 
regularly  round  the  capillary  axis,  taking  the  shape  of  a  fragment  of  a  spiral. 
Compared with the spindle mode, the unstable cone-jet mode has a thinner jet of 
diameter smaller than 100 µm, of which the end part winds round the mother spiral. 
The jet disintegrates into droplets due to repulsive electrostatic forces and possibly 
centrifugal forces too. 
 
   64 
2.9.1.1.5. Cone-jet mode  
In the cone-jet mode the liquid issues from the capillary in the form of a regular, axi-
symmetric cone with a thin jet at its apex, stretching along the capillary axis and 
breaking up into fine droplets.  
 
The shape of the liquid cone is a result of the balance of liquid pressure, liquid surface 
tension, gravity, electric stress in the liquid surface, liquid inertia, and liquid viscosity 
(Hartman R.P.A et al. 1999). The applied electric field accelerates the surface charge 
toward the cone apex. 
 
A  thin  jet  of  diameter  ranging  from  a  few  micrometers  up  to  a  few  tens  of 
micrometers is formed at the tip of the cone and the jet remains stable to the length of 
a few mm from the capillary exit because of the weak lateral electric field. The space 
charge  in  the  cone-jet  mode  is  much  more  stable  than  in  other  spraying  modes 
because the droplets are smaller and of lower mobility. The space charge reduces the 
electric  field  near  the  end  part  of  the  jet,  so  the  jet  undergoes  instabilities  at  the 
bottom end. As the result, the jet breaks up into a number of primary or main droplets 
and a number of secondary droplets and satellites (K.Tang & A.Gomez 1994c). There 
are two types of instability, namely varicose and kink. In the varicose instability case, 
the axis of the jet is not deflected and the jet disintegrates into equal droplets. In the 
kink instability case, the end of the jet moves irregularly and breaks up into a series of 
droplets due to electrical and inertial forces. Unlike unstable cone-jet mode, the cone 
is  axi-symmetrical  and  both  the  cone  and  the  jet  at  its  initial  fragment  remain 
(Jaworek & Krupa 1999a). Secondly, the cone to jet transition zone is very smooth in 
stable cone-jet mode.   65 
2.9.1.1.6. Multi-jet mode 
On further increase of applied voltage or liquid flow rate, the cone-jet mode changes 
to the multi-jet mode. When the applied voltage increases in the cone-jet mode, the 
cone depth and the jet diameter becomes smaller until a critical level at which the 
Taylor  cone  becomes  skewed,  leading  to  a  single  jet  at  the  rim.  This  situation  is 
unstable and two jets at opposite sides relative to the axis, or three gets symmetrically 
distributed on the rim of the capillary, are formed. The diameter of the jets is smaller 
than a few tens of micrometers. The jet disintegrates due to kink instabilities, into 
small droplets, forming a fine mist around the capillary axis. As has been observed, 2-
8 such jets are ejected from capillary. The number of emission points increases to a 
certain number with the increase in voltage or flow rate, and each jet is formed faster 
and becomes thinner due to increasing shear stresses.     
 
The  reason  for  the  formation  of  multi-jet  mode  from  stable  cone-jet  mode  is  the 
limited velocity of the jet formation as compared to the liquid velocity at the outlet of 
the capillary, resulting from the flow rate. The diameter of the jets also increases with 
the increase in flow rate. As a result, an excess volume of liquid that can not be 
removed by electrical forces accumulates at the outlet of the capillary. The multi-jet 
mode  disappears  then,  changing  to  ramified  meniscus  mode.  In  this  mode,  the 
meniscus becomes perfectly flat with only short cones at the emission points. 
 
2.9.1.1.7. Corona discharge 
When the electric field between the capillary and ground electrode becomes greater 
than the electrical breakdown threshold of the interfacial surface tension of liquid-  66 
surrounding air interface, corona discharge occurs and in this situation none of the 
regular modes can be observed (Cloupeau & Prunet-Foch 1989).  
 
2.9.1.2. Mechanism of stable cone-jet mode 
The  stable  cone-jet  mode  is  most  desirable  as  it  generates  near  mono-dispersed 
droplets (Edirisinghe & Jayasinghe 2004) at a relatively reasonable frequency and the 
size from sub µm to several tens of µm can be obtained. By such a method, a very 
precisely controlled thickness of polymer can be applied to a selected surface of a 
stent without it interfering in the deployment of the stent. As discussed in section 
1.8.1.1.5, this process can be classified into two stages: 1) liquid acceleration and 
cone forming; and 2) the break-up of jet into droplets. 
 
The  liquid  acceleration  and  the  shape  of  the  liquid  cone  process  result  from  the 
balance of several forces involved; these are liquid pressure, liquid surface tension, 
gravity and electric strengths in the liquid surface. The conical shape is sometimes 
refered to as a ‘Taylor cone’ form when the outward stress due to an applied electric 
field  balances  the  inward  stress  due  to  the  liquid  surface  tension.  Hartman  has 
presented a cone-shape model in which forces that have to be taken into account are 
illustrated (Figure 2.15) (Hartman et al. 1999). 
 
2.9.1.2.  The  effect  of  the  physical  properties  of  the  solution  over 
electrohydrodynamic processing in stable cone-jet mode 
The predominant property which can control droplet size and morphology of the film 
produced  is  the  concentration  of  the  polymer  in  the  solution  which  governs  its 
viscosity,  surface  tension  and  electrical  conductivity,  and  these  are  key  EHDA   67 
properties (Jayasinghe & Edirisinghe 2004b;Zhang & Edirisinghe 2006) (A.M.Gañán-
Calvo eta l. 1997;Hartman R.P.A et al. 1999). Each of these properties is discussed 
briefly. 
 
2.9.1.2.1. DC electrical conductivity 
Among  the  properties  of  liquids,  conductivity  is  the  most  important  property  for 
electrospraying in the cone jet mode. Liquids with low conductivity (insulators), such 
as olive oil, can not be processed in the cone-jet mode, as there is not enough charge 
build-up in the liquid. In such cases, electrospraying of liquids in cone-jet mode can 
be  achieved  by  artificially  increasing  their  conductivities  with  additives  like  salt 
(J.M.López-Herrera  et  al.  2003).  For  liquids  with  very  high  conductivity,  the 
electrohydrodynamic  processing  would  ,  again,  not  occur,  unless  the  flow  rate  is 
lowered. The value of liquid conductivity influences the morphology of the liquid 
issued in a stable cone jet mode. As conductivity increases, the filament width, length, 
flow rate for cone jet mode and droplet size all decrease (A.M.Gañán-Calvo et al. 
1997). 
 
Relative permittivity or the dielectric constant is a measure of the polarisability of a 
material in an electric field. The polarization reduces the magnitude of the electric 
field  inside  the  liquid.  Relative  permittivity  along  with  vacuum  permittivity  and 
conductivity determines the electrical relaxation time, te=βε0/K. Electrical relaxation 
time is the time required to smooth a perturbation in the electric charge, where β is the 
relative  permittivity,  and  ε0  and  K  are  the  vacuum  permittivity  and  electrical 
conductivity, respectively (A.M.Gañán-Calvo et al. 1997). 
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2.9.1.2.2. Surface tension 
Electrohydrodynamic spraying occurs when the electric forces overcome the surface 
tension forces of the liquid. The major role of surface tension in drop formation is to 
control the size, or volume and shape of the drop. The onset voltage for a stable cone-
jet mode increases with the liquid surface tension, and this also results in greater 
probability of electrical  discharge occurring due to surrounding air.  It is easier to 
establish a stable cone-jet with sufficient electrical conductivity and moderate surface 
tension (K.Tang & A.Gomez 1994b; Tang & Gomez 1995). Tang and Gomez (1995) 
used CO2 and SF6 (gases with higher electrical break-down threshold) instead of air as 
a surrounding fluid to obtain cone-jet mode for deionised water with conductivity 
1.02 × 10 
-6 Scm
-1. 
 
2.9.1.2.3. Liquid viscosity 
For liquid with viscosity below 100 mPa s, the droplet size in the cone-jet mode has 
been found to be directly proportional to the viscosity (Hartman R.P.A. et al. 2000). 
The droplet size of the glycerol in the cone-jet mode has been found to double when 
the viscosity is increased from 1225 mPa s to 1325 mPa s (Jayasinghe & Edirisinghe 
2002). However, higher viscosities help to produce the stable cone-jet mode as the 
electrical stresses acting on the liquid-air interface can easily be dssipated into liquid 
bulk when the viscosity is sufficiently high (J.M.López-Herrera et al. 2003). 
 
2.9.1.2.4. Density 
The density of the liquid plays an important role in determining the jet diameter in the 
cone jet mode. When the viscosity and conductivity of the liquid are large enough, the 
electrical charge is efficiently transmitted across the jet section by viscous forces.   69 
However, the viscous forces depends on the density of the liquid (A.M.Gañán-Calvo 
et al. 1997). 
 
2.9.1.3. Droplet production in stable cone-jet mode 
The  stable  cone-jet  mode  is  the  most  studied  and  understood  mode  due  to  its 
capability  to  produce  near  mono-dispersed  droplets  over  a  wide  size  range  (sub-
micron  to  hundreds  of  micron).  The  droplet  size  produced  in  the  cone  jet  mode 
depends on a few parameters. 
 
1-  Effect  of  flow  rate  on  cone  jet  mode:  the  size  distribution  produced  in 
electrohydrodynamic spraying in the cone-jet mode depends on the diameter of the 
jet, and on the break-up of this jet into droplets. Every liquid has a minimum flow 
rate, below which a stable cone-jet mode can not exist. At this minimum flow rate the 
jet breaks up due to axi-symmetric instabilities.  
 
2- Effect of applied voltage on cone jet mode: the electric field between the capillary 
and  the  ground  electrode  is  an  important  parameter  in  controlling  the  process  of 
electrohydrodynamic spraying. This is determined by the applied voltage and other 
factors  such  as  the  configuration  of  the  ground  electrode  and  the  inter-electrode 
spacing.  The  spraying  of  the  liquid  takes  place  mainly  due  to  electrical  forces 
produced by this field, therefore a higher applied voltage leads to a stronger spraying 
effect on the liquid. Within a well defined voltage range, the meniscus of the liquid 
becomes conical and stationary. Below this voltage range, the spray always operates 
in  pulsatiling  mode  (A.M.Gañán-Calvo  et  al.  1997).  With  a  given  inter  electrode 
spacing,  different  modes  of  spraying  can  be  observed  if  the  voltage  is  gradually   70 
increased from lower values to higher values. Applied voltage is a key variable in 
establishing the cone-jet mode and the cone-jet mode can prevail within a range of 
applied voltages of higher values (K.Tang & A.Gomez 1994a). Within this range of 
applied voltage of cone-jet mode, droplet size reduces with the increase of applied 
voltage from the lower value of range to higher values. As the droplet size decreases 
with the applied voltage and increases with the flow rate, it is necessary to select the 
highest possible value of applied voltage and the lowest possible value of flow rate to 
achieve  the  minimum  droplet  size  (Jayasinghe  &  Edirisinghe  2004a).  For  highly 
conducting and viscous liquids, the sizes of the droplets electrosprayed from the cone-
jet mode are found to be relatively insensitive to applied voltages (Ku & Kim 2002). 
 
The flow of liquids in a high voltage electric field has received much attention in the 
last two decades because of the phenomenen of jetting and droplet generation, which 
have numerous applications in agriculture, bioengineering, environmental engineering 
and materials science (Fenn et al. 1989; Zhang et al 2006). The technique has been 
applied  to  emulsion  production,  mass  spectroscopy  (Whitehouse  et  al.  1985), 
processing of nano-biomaterials (Huang et al. 2004), microincapsulations, formation 
of powders, thin-film formation (Jaworek & Krupa 1999c) and ceramic electrostatic 
atomization printing (Jayasinghe et al. 2002). EHDA has some significant advantages, 
for example it is relatively easy to generate droplets and avoid coalescence of droplets 
due to electric charge of the same polarity in the droplets, and to achieve a narrow 
size distribution of droplets via the cone-jet mode (Pareta et al. 2005).  
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2.9.2. Ultrasonic atomization spraying 
The first application of ultrasonic waves to the generating of sprays was proposed by 
Wood and Loomis in the beginning of 20
th century (Wood & Loomis 1927). The 
principle is based on employing high frequency sound waves, beyond the range of 
human hearing. Ultrasonic atomizer nozzles convert low viscosity liquids into ultra 
fine  sprays.  The  radiating-wave  frequencies  most  commonly  used  in  ultrasonic 
cleaning, 18-120 kHz, lie just above the human audible frequency range. 
 
An  ultrasonic  power  supply  (generator)  converts  DC  voltage  to  high  frequency 
electrical energy. Ultrasonic nozzles operate by converting a high frequency electrical 
signal,  fed  into  two  electrodes  sandwiched  between  two  piezoelectric  transducers. 
Disc-shaped  ceramic  piezoelectric  transducers  convert  electrical  energy  from  the 
power  generator into mechanical vibrations at the same  frequency.  The vibrations 
from the transducer are intensified by the titanium probe (horn), creating pressure 
waves in the liquid, ultrasonically vibrating at the nozzle’s atomizing tip.   
 
Ultrasonic  atomizers  work  at  many  different  frequencies  and  are  very  good  at 
converting various liquids into fine particles. Without the use of air pressure, liquids 
enter either the rear or side of the atomizing converter, where they are pumped to the 
vibrating surface. Liquid emerging onto the atomizing surface is broken into a spray 
by the ultrasonic energy concentrated there (Figure 2.16). The vibrating surface has 
many possible shapes and styles for different coating and process applications (Figure 
2.17). 
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2.9.2.1. Advantages of ultrasonic atomization spraying 
The process of ultrasonic atomization spraying has some specific characteristics that 
give it advantage over  other traditional mechanical methods, like pressure or  gas-
assisted  systems,  to  generate  sprays  of  very  small  droplets.  The  factors  that 
distinguish  pressureless,  ultrasonic  atomizing  nozzles  from  other  spray  nozzles 
include: 
 
1. In particular, the resulting droplet produced has very narrow size distribution, and 
the droplet diameter is essentially controlled by the ultrasonic frequency (Lang 1962; 
Lozano et al. 2003). Median drop sizes range from 18-68 microns. 
 
In an ultrasonically produced spray, drop size is governed by the frequency at which 
the  nozzle  vibrates,  and  by  the  surface  tension  and  density  of  the  liquid  being 
atomized. Frequency of the specific type of nozzle is the predominant factor.  These 
droplets  are  larger  with  low  frequency  probes  and  smaller  with  higher  frequency 
probes.  
 
For  uniform  particle  size  distribution,  ultrasonic  atomizers  have  to  be  adjusted  in 
order to hit the “sweet spot” so that the liquid being processed is efficiently converted 
to spheres for the application. Resulting droplet size distributions are very narrow and 
the  mean  diameter  is  essentially  only  controlled  by  the  excitation  frequency. 
Generation of droplets in the micron range requires MHz waves, with voltages around 
30 V, which translates into power requirements on the order of 10 W.  
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2. An important feature is ultra-low flow rate, soft and low-velocity spray, typically 
on the order of 7.6-12.7 cm per second. Other common spraying techniques, which 
use pressure in order to generate a spray, generally produce drops with velocities well 
over  100  times  that  generated  by  ultrasonic  atomization  spraying.  This  velocity 
differential means that pressure sprays generate the order of 10,000 as much kinetic 
energy as do ultrasonically atomized sprays. This striking contrast in spray energy has 
important, practical implications: 
 
2.1.  In  coating  applications,  the  unpressurized,  low-velocity  spray  significantly 
reduces the amount of overspray since the drops tend to settle on the substrate, rather 
than bouncing off it. This translates into substantial material savings and reduction in 
emissions into the environment. 
 
2.2. The spray can be controlled and shaped precisely by entraining the slow-moving 
spray in an ancillary air stream. Spray patterns from as small as 0.177 cm wide to as 
much as 30.5-60.1 cm wide can be generated.  
 
2.3. This ultrasonic nozzle design provides an easily controllable atomized spray that 
cannot clog because of the large liquid feed orifice and the self-cleaning ultrasonic 
vibration. 
 
For these reasons, the use of ultrasonic atomizing devices is becoming increasingly 
popular for a number of applications, for example in domestic humidifiers or medical 
nebulisers (Albertini et al. 2005). It is usually recommended for use in applications 
where flow rates are very low and narrow spray patterns are needed.   74 
 
Ultrasonic atomization spraying as a possible spray coating on a moving surface has 
been previously studied. It was found that the percentage area of the covered surface 
increased with an increase in the height of the ultrasound atomiser from the surface 
and the vibrational amplitude of the atomiser, while the liquid film thickness on the 
coated surface decreased with an increase in the height of the ultrasound atomiser, 
vibrational amplitude of the atomiser and the linear velocity of the moving surface. 
Also, it was observed that the percentage area as well as the liquid film thickness 
increased with an increase in the liquid flow rate irrespective of changes in other 
parameters.  The  increase  in  the  viscosity  of  the  spraying  liquid  reduced  the  area 
covered by the spray for surface coating, while it increased the coating film thickness 
(Gaikwads et al. 2005). 
 
Ultrasonic  atomization  spraying  has  also  been  used  for  the  production of  protein-
loaded biodegradable microspheres. It does not produce degradation of the polymer 
matrix  and  the  particle  characteristics  can  be  modified  by  adjusting  formulation 
parameters and spraying conditions (Felder et al. 2003). Dirix et al (1993) reported 
the  preparation  of  protein  loaded  biodegradable  microspheres  using  an  ultrasonic 
nozzle, collecting the particles in the non-solvent bath to remove the organic solvent 
and  to  harden  the  embryonic  microsphere.  Bovine  serum  albumin  loaded 
microspheres with a spherical shape and smooth surface structure were successfully 
prepared  from  poly(lactide-co-glycolide)  using  an  ultrasonic  nozzle.  Process  and 
formulation  parameters  were  investigated  with  respect  to  their  influence  on 
microsphere  characteristics,  such  as  particle  size,  loading  capacity,  and  release 
properties. In conclusion, ultrasonic atomization spraying represents a versatile and   75 
reliable technique for the production of protein loaded biodegradable microspheres 
without  inducing  degradation  of  the  polymer  matrix  (Bittner  &  Kissel  1999).  
Ultrasonic atomization spraying was evaluated as a new approach for the preparation 
of ionically cross-linked controlled-release chitosan microparticles (Beatrice, Nadia, 
& Lorenzo 2005). 
 
With the best matching of polymer characteristics (Pavanetto et al. 1993), liquid and 
the  solute  molar  fraction  (Yasuda  et  al.  2005)  and  process  of  spray  drying  and 
coacervation (Blanco-Prieto et al. 2004), ultrasonic driven atomizers can provide a 
mist-like spray with a particularly narrow droplet size distribution and very low spray 
velocity. Other studies include microencapsulation (Yeo & Park 2004), fabrication of 
porous carbon nanotube (Su et al. 2008), delivery of drug for lung inhalation (Zhang 
et al. 2008). Ultrasonic atomization spraying was used to produce a thin continuous 
polymer  coating  (Pan  et  al.  2007b;  Pan  et  al.  2006)  and  also  polymeric  coating 
incorporating monoclonal antibody for stents (Wang et al. 2009)). 
 
The  introduction  of  foreign  material  into  a  living  organism,  creates  an  interface 
between the material and tissue. This means that the surface free energy, morphology 
(roughness,  porosity),  electrical  properties,  hydrophilicity,  the  presence  of  ionic 
groups  and  surface  contamination  of  a  polymer,  will  all  affect  tissue-polymer 
interaction (Gosolewski 1989).   
 
The  introduction  of  a  foreign  material  into  a  living  organism  creates  an  interface 
between the material and tissue. Many different types of nonporous materials are used 
in  the  vascular  system  including  natural  rubber  latex,  neoprene  rubber,   76 
poly(tetrafluoroethylene)  (PTFE),  poly(ethylene  terephtalate)  (Dacron),    silicone 
rubber and polyurethanes. All foreign substances when exposed to the blood show 
some degree of thrombosis at the vascular interface (SHARP & TAYLOR 1971). So, 
the antithrombogenic properties of these biomaterials are still not good enough for the 
demanding applications such as cardiovascular implants and devices (Aiping & Tian 
2006c) and require the introduction of anticoagulants. 
 
Stainless steel and NiTi alloy was used in this thesis as the material of choice for 
balloon expandable and self-expanding stents. NiTi was used because of its several 
advantages,  including  optimal  radiopacity,  superelasticity  and  shape  memory 
characteristics. According to the concerns raised with regards to the current coatings 
employed for stent coating, a novel POSS incorporated poly(carbonate-urea)urethane 
nanocomposite was introduced for stent materials coating. Hybrid inorganic–organic 
nanocomposites hold significant promise because of the enhanced characteristics of 
the  materials  in  nano-scale.  In  order  to  obtain  materials  with  improved  blood 
compatibility for a short and long term blood reaction a better understanding of the 
complex parameters of the interactions between blood and the biomaterial is required. 
The  chemical  and  physical  characteristics  of  the  biomaterial's  surface  which  are 
responsible  for  the  biological  reactions  at  the  interface  are  certainly  of  great 
importance.  Surface  characteristics  of  the  nanocomposite  were  measured 
comprehensively in this study. Electrohydrodynamic spray deposition and ultrasonic 
atomization spraying were investigated in this thesis as coating techniques. Processing 
parameters of the two techniques were optimised.    
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Figure 2.1. Balloon angioplasty. (A) a guide wire with a deflated balloon is passed 
through the catheter in the narrowed artery; (B) the balloon is then inflated to push the 
plaque against the artery wall; (C) the balloon is then removed  
(http://www.orlandocvi.com/procedures_catheter.html) 
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Figure 2.2. Coronary artery bypass grafting 
(http://www.bostonscientific.com/templatedata/imports/HTML/lifebeatonline/winter2006/learning.sht
ml). 
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Figure 2.3. Stenting procedure. After removal of the balloon the stent is left in place to 
keep the artery open  (http://www.britannica.com/EBchecked/topic-
art/40908/95218/Balloon-angioplasty-and-stent-insertion-In-a-coronary-artery-where). 
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Figure 2.4. (A) Palmaz stent made from stainless steel; and (B) Symphony stent made 
from Nitinol. 
 
 
 
 
 
 
 
 
 
 
Figure 2.5. Schematic stress-strain diagram for Nitinol and stainless steel (Stoeckel, 
Pelton, & Duerig 2004).
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Figure 2.6. . Stress-strain curves comparing with biomaterials. 
 
 
Figure 2.7. Delivery pattern of a super-elastic stent. A stent is manufactured in the 
open configuration (state B), and deformed to a close position (Satate A). 
           Keys:   RRF: Radial resistive force 
           COF: Chronic outward force 
           State A: Stent scaffold 
           State B: Post-deployment    82 
 
 
   
Figure 2.8. (A) Photograph of self-expanding biostable polymeric polyethylene 
terephthalate (PET) stent; (B) the Igaki-Tamai stent is a premounted, balloon 
expandable PLLA stent that also has the ability of self-expansion  (Tamai, Igaki, Kyo, 
Kosuga, Kawashima, Matsui, Komori, Tsuji, Motohara, & Uehata 2000). 
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Figure 2.9. (A) Chemical structure of rapamycin; (B) chemical structure of paclitaxel. 
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Figure 2.10. Critical length scale for different materials (Lichtenhan & Hibrid Plastics 
2003) 
 
 
Figure 2.11. Types of synthesized nanocomposites.    84 
 
 
Figure 2.12. Three-dimensional structure of polyhedral oligomeric silsesquioxane molecule. 
 
 
 
 
 
 
Figure 2.13. Different structures of silsesquioxanes. (A) ladder structure; (B) Partial 
cage structure; (C) cage structure. 
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                       A) Dripping mode                          B) Micro-dripping mode 
 
                                             
                          
                             C) Spindle mode                            D) Multi-spindle mode 
                                                                  
                            
                             E) Cone-jet mode                          F) Multi-jet mode   
                                      
Figure 2.14. Different modes observed in electrohydrodynamic spray deposition.   86 
 
 
 
 
 
Figure 2.15. Forces acting on a Taylor cone (Hartman et al. 1999).  
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Figure 2.16. Schematic diagram of the ultrasonic atomizer: (1) electrical connection to 
the broadband ultrasonic generator connection of oscillator; (2) connection for 
nitrogen; (3) connection for liquid solution; (4) protecting cap; (5) Titanium 
amplifying section; (6) Piezoceramic element; (7) Nozzle; (8) Atomizing surface; (9) 
atomizer jet. 
 
 
 
Figure 2.17. Different nozzle design for ultrasonic atomization spraying.   88 
CHAPTER 3. Materials & Methods 
 
This chapter describes the various experimental techniques used to characterize the 
nanocomposite  polymer.  It  also  describes  the  different  techniques  employed  for 
coating  of  NiTi  and  stainless  steel  alloy  material  with  nanocomposite.  It  also 
discusses the specific techniques used for surface treatment of the alloy to enhance the 
integrity between the alloy and the nanocomposite for long time. 
  
3.1. NiTi superelastic alloy 
Mechanical tests were conducted on a strip of NiTi alloy that was 5.7 mm in width 
and 0.5 mm in thickness. The nearly equiatomic NiTi alloy (55.8 wt % Ni) strips used 
in this study were provided by Memry Corp., Bethel, USA. The material had been 
rolled  and  subsequently  annealed  to  restore  its  superelastic  properties.  An  Instron 
static test machine, equipped with 2000 ±20 kN load cell, was used to apply a tensile 
load to the specimen with a constant corss head rate of 20
 mm/s. The gauge length 
was set at 143 mm. A schematic view of the set up is shown in Figure 3.1. A preload 
of 100 N was applied to remove any slack from the system. The test was conducted in 
two steps: 1) the specimen was loaded and unloaded to characterize the superelastic 
behaviour; and 2) the same specimen was then loaded to failure to determine the 
tensile strength and the failure characteristic of the material. 
 
3.2. Synthesis of POSS-PCU nanocomposite 
The  simplified  reaction  scheme  for  the  POSS-PCU  synthesis  process  is  shown  in 
Figure  3.2.  72g  of  dry  polycarbonate  polyol  (2000Mw)  and  2g  of  cyclohexane   89 
chlorohydrine-polyhedral  oligomeric  silsesquioxane  (POSS)  (Hybrid  Plastics, 
Hattiesburg) were placed in a 250ml reaction flask equipped with a mechanical stirrer 
and nitrogen inlet. The mixture was heated to 135°C to dissolve the POSS cage into 
the  polyol  and  then  cooled  to  70°C.  Flake  4,4’-methylenebis(phenyl  isocyanate) 
(MDI), were added to the polyol blend and then reacted, under nitrogen, at 75-85 °C 
for 90 minutes to form a pre-polymer. 156g of N,N’-dimethylacetamide (DMAC) was 
added slowly to the pre-polymer to form a solution and the solution was cooled to 
40°C.  Chain  extension of  the  pre-polymer  was  carried  out  by  the  slow  drop-wise 
addition of a mixture of 2g of ethylenediamine and 0.05g of diethylamine in 80g 
dimethylacetamide  to  the  pre-polymer  solution.  In  this  manner,  a  solution  of 
polycarbonate  urea-urethane  (PCU)-  with  the  hard  segments  being  molecularly 
modified by nanostructured molecules-polyhedral oligomeric silsesquioxanes (POSS-
PCU  nanocomposite)  with  2  wt%  cyclohexane  chlorohydrin-silsesquioxane-  was 
synthesised. Similarly, by increasing the ratio of POSS to ethylenediamine, 2 wt%, 4 
wt% and 8 wt% POSS-PCU nanocomposites were obtained. 
 
Liu et al. have shown that when the concentration of Octa(propylglycidyl ether) POSS 
is 10 %wt or more, the concentration of POSS moiety on the surface was no longer 
increased(Liu,  Ni,  &  Zheng  2006).  Therefore,  nanocomposites  with  the  POSS 
concentration  less  than  8  wt%  were  investigatede  in  this  study.    The  amount  of 
ethylenediamine decreased accordingly with increasing the POSS amount, therefore, 
the  stiffness  of  the  nanocomposite  reserved  even  at  higher  POSS  concentrations. 
Hereafter,  these  nanocomposites  are  referred  to  as  POSS-PCU2,  POSS-PCU4  and 
POSS-PCU8. For comparison, a pure PCU was also synthesised. All the chemicals,   90 
reagents, glassware and associated relevant equipments were purchased from Sigma-
Aldrich Ltd. (Dorset, UK). 
 
3.3. Characterization of physical properties of POSS-PCU solution 
Measurements were carried out to determine the physical properties governing the 
electrohydrodynamic processing behaviour of the solutions for the research discussed 
in  chapter  5.  Each  instrument  was  calibrated  before  use  and  cleaned  and  dried 
thoroughly  taking  measurements  on  different  samples.  A  20  wt%  POSS-PCU2 
solution was dissolved in extra DMAC and was left overnight at room temperature 
making sure the polymer had completely dissolved. By varying the dilution of this 
polymer solution, several concentrations were obtained for electrospraying. DMAC 
was characterized in the same way as the POSS-PCU solutions. All measurements 
were carried out at ambient temperature. All experiments were repeated five times 
and the average was reported in this thesis. 
 
3.3.1. Density 
The  density  of  the  samples  was  measured  using  a  standard  25  ml  density  bottle 
(VWR, Lutterworth, UK). Calibration was carried out by measuring the density of  
de-ionised water and ethanol. The weight of the density bottle was set to zero and then 
the net weight of the solution was measured and density of that solution was reported 
by dividing the net weight by the specific volume of the density bottle.  
 
3.3.2. DC electrical conductivity 
DC electrical conductivity was measured using a HI-8733 conductivity meter (Hanna 
Instrument Ltd., Bedfordshire, UK). The conductivity probe was calibrated using the   91 
ethanol  with  known  conductivity  value.  The  meter  is  always  used  at  ambient 
temperature. Before each measurement the probe was rinsed with de-ionised water 
and  dried.  About  50  ml  of  solution  was  required  for  this  probe.  The  probe  was 
agitated to remove any bubbles on the probe. The measuring range of this meter is 0.0 
to 199.9/ 0 to 1999 µS/cm and 0.0 to 19.99/0 to 199.9 mS/cm. 
 
3.3.3. Viscosity 
Viscosity  was  determined  using  a  ViscoEasy-L  concentric  cylinder  rotational 
viscometer (Schott, Camlab Ltd., Cambridge, UK) working at 100 rpm at ambient 
temperature  
 
3.3.4. Surface tension 
Surface  tension  was  measured  using  a  Kruss  Tensiometer  K9  (Kruss  GmbH, 
Germany). Wilhelmy’s plate method was used. The ring and plate were lowered till 
the surface of the liquid and pulled on the liquid surface without breaking the surface. 
The value increased first and suddenly dropped to zero when the ring was separated 
from the liquid completely. The maximum value calculated from this procedure is the 
surface tension. The average of five consecutive values is reported as the final result. 
The plate was cleaned and dried after each test to minimize the error. The instrument 
was calibrated with de-ionised water and ethanol.  
 
3.4. Characterization of POSS-PCU films 
For the research in chapter 4, nanocomposite solutions (POSS-PCU2, POSS-PCU4, 
and POSS-PCU8) and PCU as the control were weighed onto a glass plate/petri dish.   92 
The solvent from the polymer solutions was then allowed to evaporate in an oven 
overnight at 60°C prior to further characterization.  
 
3.4.1. Gel permeation chromatography 
The molecular weight distribution of the polymers was measured by gel permeation 
chromatography (GPC) at RAPRA Technology, Shrewsbury, UK. A single solution 
of each sample was prepared by adding 15 mL of eluent to 30 mg of sample and 
warming at 80°C, with shaking, for 30 minutes and then filtered through a 0.45  m 
PTFE membrane into autosampler vials. Gel permeation chromatographic analysis 
was  carried  out  at  80  °C  on  a  PL-GPC  120  (Polymer  Laboratories)  liquid 
chromatography  system  equipped  with  a  PL-AS-MT  autosampler,  PLGel  guard 
column  (Polymer  Labs),  two  mixed  bed-B  columns  ;  30  cm  and  10 m;  and  a 
differential  refractometer.  DMAC  (with  0.01M  lithium  bromide)  was  used  as  an 
eluent at a flow rate of 1 mL/min. Poly(methyl methacrylate) standards were used to 
calibrate  the  GPC  system.  The  results  are  expressed  as  the  "PMMA  equivalent" 
molecular  weights  and  it  should  be  appreciated  that  there  could  be  a  significant 
difference between these PMMA equivalents and the true molecular weights. The data 
was collected and analysed using Polymer Laboratories ‘Cirrus’ software. Test were 
done in duplicate. 
 
3.4.2. Stress–strain analyses 
A  tensometer  (Instron  5565,  UK)  equipped  with  a  500  N  load  cell  was  used  to 
determine  the  mechanical  properties  at  room  temperature.  Dumbbell  shaped  test 
specimens  were  cut  from  the  nanocomposite  films  for  stress-strain  testing,  in 
accordance with DIN 53504 (DIN 53504, 1994). Thickness of the dumbbell shape   93 
samples  was  measured  using  a  digital  micrometer  (IP54  RS).  The  initial  clamp 
distance was 20 mm. The applied stretching speed was 100 mm/min. Five replicates 
were tested for each thickness. 
 
3.4.3. Differential scanning calorimetry 
The POSS-PCU nanocomposites were studied using differential scanning calorimetry 
(DSC)  in  order  to  determine  the  glass  transition  temperature  (Tg)  and  melting 
temperature  (Tm).  Calorimetric  measurements  were  performed  on  a  heat-flux 
differential scanning calorimeter (DSC-60 Shimadzu Ltd., Japan), in a dry nitrogen 
atmosphere achieved with the help of a liquid nitrogen cooling unit. Samples about 10 
mg  in  weight  were  used  for  Tm measurements  and  about  20  mg  was  used  for  Tg 
measurement to improve the quality of the results and to obtain the sharp peaks. The 
DSC was calibrated using an indium standard. The thermal cycle applied for glass 
transition  temperature  was  heating  from  -100°C  to  50°C  at  a  heating  rate  of  20 
°C/min, while melting temperatures were measured by reheating from 50 to 300 °C at 
10 °C/min. The glass transition Tg was calculated as inflection in the Cp change. In 
order to achieve consistency, measurements were repeated three times. 
 
3.4.4. Rheological measurements 
All rheological measurements were carried out using a rheometer (CVO 100, Bohlin 
Instruments Ltd, UK), at shear rates ranging from 0 to 200 s
-1. The temperature was 
maintained at 25±1
°C using a control bath (Bohlin Peltier system). The experiments 
were carried out on as-prepared polymer solution using cone-plate geometry (upper 
plate diameter 40 mm) with 150  m gap. The rheometer was computer-driven using a 
software package (Bohlin software CVO 100).   94 
3.4.5. Scanning electron microscopy 
Surface morphology of the films was examined using a JEOL JSM63101F scanning 
electron  microscope  (SEM)  (JEOL  Ltd.,  UK).  For  this  observation,  samples  were 
placed on aluminium stubs and the surfaces to be examined were gold coated using an 
Edwards  5150B  sputter  coater  prior  to  microscopy.  SEM  was  carried  out  at  an 
accelerating voltage of 10 kV. Samples were viewed under low magnification and 
images  were  captured  at  ×200  magnification.  For  the  research  in  chapter  6,  the 
morphology of the interface and the thickness of the surface layer formed on the NiTi 
samples were determined by SEM using a sample size of 10 mm. 
 
3.4.6. Zeta-potential  
The  ζ-potential  determinations  were  done  with  the  adjustable  gap  cell  unit  of  the 
SurPass  Electrokinetic  Device  (Anton  Paar,  Graz,  Austria).  Two  rectangular 
specimens (10 × 20 mm) were cut from the polymer foils and glued by double sided 
adhesive  tape  on  the  sample  holder  blocks.  The  two  sample  holder  blocks  were 
mounted into the gap cell to achieve an initial slit width of approximately 0.1 mm. 
The  final  slit  width  was  fine-adjusted  by  measuring  the  flow  rate  during  of  the 
electrolyte in the range between 100 and 150 ml/min. The electrolyte was a 10
-3 M 
aqueous  KCl  solution.  The  change  of  the  pH–value  was  done  by  the  automatic 
titration  routine,  using  0.1  M  HCl  for  titration,  beginning  at  pH  10  (adjusted  by 
addition of NaOH). Surface potentials were calculated by software of SurPass based 
on Helmholtz-Smoluchovsky equation shown below.   
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In which  ζ is the zeta potential; dU/dp is the slope of the streaming potential versus 
pressure;  η  is  the  viscosity  of  the  electrolyte;  ε  is  the  dielectric  constant  of  the 
electrolyte; ε0 is the vacuum permittivity; L is the length of the streaming channel; A 
is the cross section of the streaming channel; and R is the AC resistance inside the 
measuring cell. 
 
3.4.7. Contact-angle  
To prepare the samples for contact angle measurements, POSS-PU films about 50 µm 
thick were cast-coated on well-cleaned glass slide substrates and oven-dried at 60 °C 
overnight.  Dynamic  contact  angles  were  measured  at  ambient  humidity  and 
temperature on a Drop Shape Analyser (DSA 10 MK2, Krüss, Hamburg, Germany). 
Water, diiodomethane, ethylene glycol and formamide were used as probe liquids. 
The polymer films were fixed horizontally and immersed in a chamber containing 
probe  liquid.  A  motorised  syringe  was  used  to  increase  or  decrease  the  bubble 
volume. Surface energy was calculated by measuring the contact angle between the 
sample surface and test liquid, which will be discussed in the results. Contact angle 
hysteresis was calculated by measuring advancing and receding contact angles using 
the tilting plate technique.  
 
In the tilting plate method a contact angle sample is slowly tilted until the sessile drop 
on it begins to move in the downhill direction. At that time, the downhill contact 
angle  is  the  advancing  angle  and  the  uphill  angle  the  receding  contact  angle. 
Measurement has been done immediately before actual motion takes place, because 
once  motion  starts,  the  system  is  no  longer  in  thermodynamic  equilibrium.  Six 
different measurements were done and averaged for each sample.     96 
3.4.8.  Attenuated  total  internal  reflection  Fourier  transform  infrared 
spectroscopy  
To analyze the surface composition of the nanocomposites using an Attenuated total 
internal  reflection  Fourier  transform  infrared  spectroscopy  analyser  (ATR-FTIR) 
(Advance 2000, Perkins-Elmer Ltd., US), the surfaces of the polymeric films were 
exposed to infra-red radiation of 4200–600cm
-1 wavelengths at an incident angle of 
301°  and  at  room  temperature  (25  °C).  A  total  of  16  scans  were  performed  per 
sample. The analysis was repeated five times and the results averaged. The surfaces of 
each specimen were analyzed using a 2-mm germanium (Ge) crystal with a 458 angle 
maintaining constant contact pressure between the crystal and the specimens.  
 
3.4.9. Atomic force microscopy 
The structure of POSS-PCU films on glass substrate was studied with an atomic force 
microscopic (AFM) using a Digital Instruments NanoScope (Digital Instrument Inc., 
USA)  in  the  tapping  mode.  A  silicon  probe  with  125  µm  long  silicon  cantilever, 
nominal force constant of 40 N/m and resonant frequency of 275 kHz was used for 
tapping mode surface topography studies. 
 
3.5.  In  vitro  assessment  of  the  resistance  of  POSS-PCU 
nanocomposites to oxidative and hydrolytic stress  
The  resistance  of  the  POSS-PCU  nanocomposite  to  chemical  degradation  was 
investigated  by  incubating  the  specimens  in  a  variety  of  chemically 
aggressive/biological solutions at 37°C. These accelerated in vitro tests have shown 
good correlation with human and animal model results.  
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3.5.1. Plasma protein fractions 
The procedure for plasma fractionation with polyethylene glycol (PEG) was adopted 
from the method described by Hao et al. (Hao 1979). Citrated human plasma (200 
mL) derived from fresh frozen human plasma obtained from the Blood Transfusion 
Department at Royal Free Hospital, London, UK was placed in a beaker in a cold 
room  (4°C).  Polyethyleneglycol  (PEG,  MW=3350,  Sigma  Chemical  Ltd.,  Dorset, 
UK) was added slowly, while stirring, to the plasma in the amount 10 g/100 mL. After 
60 min of stirring, the 10% PEG precipitated, designated fraction I, was removed by 
centrifugation at 2000 rpm for 30 min. An additional 10 g of PEG was then added to 
the supernatant liquid to reconstitute a 10% mixture, followed by centrifugation to 
obtain  fraction  II  (10–20%  PEG  precipitate).  The  process  of  mixing  and 
centrifugation  was  then  repeated  to  obtain  four  plasma  protein  fractions  with  the 
corresponding plasma fractions. The precipitates were reconstituted to the original 
volume of plasma (200 mL) with PBS.  The distribution of plasma proteins in plasma 
fractions I-IV is illustrated in Table 3.1.  
 
3.5.2. Hydrolysis with lysosomal enzymes  
A solution of cholesterol esterase (CE) was prepared by dissolution of CE powder 
(Sigma Chemical Ltd., Dorset, UK) in a pH 7.0, 0.05 Μ phosphate-buffered solution 
(PBS) at a concentration of 1 U mL
−1, which was then sterile filtered using a 0.22 µm 
filter. The standard 1 U is characterizeed by its ability to hydrolyse 1  mΜ min
−1 
phosphatidylcholine at pH 8.0 at 37°C. The other hydrolytic solution is phospholipase 
A2 solution (porcine pancreatic phospholipase, PLA, Sigma Chemical Ltd., Dorset, 
UK), which was prepared in buffer solutions (50 mΜ Tris, pH 8.0, containing 6.8 mΜ 
CaCl2) at a concentration of 0.18 U mL
−1.    98 
Table 3.1. Distribution of selected plasma proteins in the PEG fraction (Hao 1979). 
Fraction  wt%(mg/dL)   
Plasma Proteins        I                  II                    III                IV 
Amount 
(mg/dL) 
Albumin 
IgG 
Transferrin 
α2-Macroglobulin 
Fibrinogen 
Ig (+) 
Haptoglobin 
a-Lipoprotein 
C-3 component 
a1-Acid glycoprotein 
Ceruloplasmin 
Plasminogen 
β-Lipoprotein 
Prothrombin 
C-1 esterase inhibitor 
 6 (206)         4 (138)           86 (2958)       100 
 88 (651)       15 (111)         1 (7)               1 
 6 (13)           22 (49)           58(129)          99 
 35 (66)         65 (123)          —                 — 
 88 (158)         —                  —                 — 
 34 (53)         58 (91)           20 (31)           — 
 2 (2)             40 (43)           56 (61)           86 
 15 (10)         25 (16)           50 (32)           50 
 93 (52)         7 (4)               —                   — 
 —                  —                 100 ± 54         — 
 14 (3)           23 (5)             73 (16)           100 
 69 (11)         19 (3)              —                  89 
 100 (16)         —                  —                  — 
 25 (2)           50 (4)              25 (2)             — 
 —                   —                 100 (4)          100 
3440 
740 
223 
189 
179 
157 
108 
64 
56 
54 
22 
16 
16 
8 
4 
 
3.5.3. Oxidation and peroxidation 
As described by Zhao (Zhao 1993) an oxidising systems can be made by combining 
hydrogen  peroxide  (Fluka  Chemicals,  Buchs,  Germany),  cobalt  chloride  (Sigma 
Chemical Ltd., Dorset, UK) and t-butyl peroxide (Sigma Chemical Ltd., Dorset, UK). 
Therefore, solutions were made of (i) 1.63 M of hydrogen peroxide (H2O2) and 0.1M 
CoCl2 .6H2O (H2O2/ CoCl2) to induce formation of hydroxyl radicals, (ii) 1.63 M t-
butyl hyrdoperoxide and 0.1M CoCl2.6 H2O (t-but/CoCl2) to induce peroxidation i.e. 
generation of alkyl and hydroxyl radicals.  
 
3.5.4. Control 
Both modified and non-modified NiTi was incubated in distilled water under the same 
conditions to act as a negative control (Phua 1987; Salacinski et al. 2002b).    99 
All the degradative solutions contained 10mg streptomycin, 10000U penicillin per 
millilitre to minimise bacterial and fungal infections, which could affect the outcome 
of the results. For the research in chapter 4, five POSS-PCU2 films were incubated in 
each solution at 37°C for 70 days on a shaker platform, and solutions were replaced 
weekly. After completion of the experiments, the samples were rinsed in distilled 
water, dried in air prior to GPC and tensile testing. For the research in chapter 6, five 
POSS-PCU2-coated NiTi strips incubated in the solutions. After completion of the 
experiments,  the  samples  were  rinsed  in  distilled  water  and  dried  in  air  prior  to 
microscopy and peel strength assessment.  
 
3.6. Endothelialisation of POSS-PCU: An in vitro study 
3.6.1. Extraction of human endothelial cells 
Endothelial cells were obtained from human umbilical cord veins  (HUVECs) by an 
adaptation of the method of Jaffe (Jaffe et al. 1973). A sterile technique was utilized 
in  all  manipulations  of  the  cord.  Human  umbilical  cords  were  obtained  from  the 
labour ward of the Royal Free Hospital, Hampstead. The cord was severed from the 
placenta soon after birth, and stored in a sterile container filled with 40 ml of Media 
199 (Invitrogen Ltd, Paisley, UK). The cord was inspected, and all areas with clamp 
marks were cut off. The umbilical vein was cannulated with a blunt 14 gauge needle, 
2 cm long, and the needle was secured by clamping the cord over the needle with an 
umbilical cord tie. The vein was perfused with 100 ml of PBS to wash out the blood 
and allowed to drain. 25 ml of warm filtered collagenase A2 (Sigma-Aldrich Ltd, 
Dorset, UK) solution (12.5 mg in 25 ml media) was then infused into the umbilical 
vein  from  the  other  end  through  another  clamped  syringe.  The  umbilical  cord, 
suspended  by  its  ends,  was  placed  in  the  incubator  at  37°C  for  10  min.  After   100 
incubation,  the  cord  was  massaged  gently  prior  to  collecting  the  collagenase 
suspension  containing  the  endothelial  cells  by  perfusion  with  30  ml  of  PBS.  The 
effluent was collected in a sterile 50 ml conical centrifuge tube containing 10 ml of 
complete medium obtained from the stock made up of 157 ml Medium 199, 40 ml 
foetal  bovine  serum,  3.4  ml  of  200mM  L-glutamine  solution  and  1% 
penicillin/streptomycin (Invitrogen Ltd, Paisley, UK) to neutralize the collagenase. 
The  cells  were  sedimented  at  250  g  for  10  minutes,  and  the  cell  button  was 
resuspended in 5 ml of warm  complete culture medium. The cell suspension was 
added into 5 cm
3 flasks and was incubated at 37°C under 5% CO2. 24 hours later, the 
flasks were gently washed with 4 ml PBS to remove red blood cells and fed with 5 ml 
of complete medium.  
 
3.6.2. Primary endothelial cell culture 
The  HUVECs  in  flasks  were  viewed  daily  under  high  power  transilluminated 
microscopy and the presence of endothelial cells (EC)’s verified by confirmation of 
their  characteristic  cobblestone  morphology.  Once  a  confluent  monolayer  was 
achieved cultures were passaged by removing the cell culture medium, washing with 
4 ml PBS and then adding 3 ml of 10% trypsin solution (Invitrogen, Paisley, UK). 
The flask was then incubated for three minutes prior to gentle tapping in order to 
loosen all the cells. The trypsin was then neutralised by the addition of 5 ml complete 
medium. The cell suspension was spun at 250 g for 10 minutes before discarding the 
supernatant, resuspending the cell pellet in 7 ml complete medium, and placing in a 
75 cm
3 flask. The cells were fed twice a week with a complete change of fresh culture 
medium.  Cultures  were  passaged  every  2-3  days  and  split  in  at  a  ratio  of  1:2. 
Confluent HUVECs from passage 6 was used for the experiments.   101 
3.6.3. Cell viability analysis 
3.6.3.1. Alamar Blue assay 
Alamar Blue (AB, Biosource  Ltd.,  London, UK) is an assay designed to measure 
quantitatively cell metabolism and viability through calorimetric oxidation reduction 
of  resazurin and resarufin indicatore resulting from cell metabolism. The data may be 
collected with either fluorescence-based or absorbance-based instruments. Resazurin 
has a much higher electrochemical potential than the carriers on the cell membrane, 
and on contact with the membrane, it is reduced to resarufin. Resazurin acts as an 
intermediate  electron  acceptor  in  the  electron-transport  chain  between  the  final 
reduction of O2 and cytochrome oxidised by substituting for molecular oxygen as an 
electron acceptor. The rate of bio-reduction is related to the level of redox potential on 
the cell membrane, which in turn characterises the constitutive part of the metabolic 
activity of a given cell type.  
 
AB has certain properties that make this assay attractive. It is soluble in culture media 
in oxidative form as well as in the reduced one, stable in solution and minimally toxic 
to  cells,  and  produces  changes  that  are  easy  to  measure.  AB  allows  a  continuous 
assessment of the metabolism and viability of seeded cells, is simple to perform, and 
does not destroy the cells. So, it is possible to achieve a long term monitoring of cells 
in culture without any negative effects. Some studies on the long-term culture of plant 
cells, fibroblasts, osteoblasts, epithelium cells, lymphocytes and transformed cell lines 
show that the reduction of AB correlates with the viability and proliferative activity of 
cells (Petrenko et al. 2005). Limitations of AB are few. If prolonged incubation times 
are used (> 24 h), reversal of the reduction process occurs via a secondary redox step, 
resulting in a colourless solution, particularly when very high cell concentrations are   102 
used. Microbial contamination would also reduce AB, thus yielding erroneous results, 
but this would affect any other assay of ECs as well.  
 
For the experiment in Chapter 5, POSS-PCU2 nanocomposite has been cast/sprayed 
coated on Melinex film (TAAB, Berkshire, UK) and left overnight in an oven at 60°C 
to evaporate the solvent. In particular, the hybrid materials were cut into disks of 
opportune diameter, to fit inside the 96-well plates (Invitrogen, Paisley, UK). All sets 
of samples were sterilized by autoclaving. Three wells for each sample were plated 
with  2×10
4  cells/well.  HUVECs  were  seeded  and  monitored  for  attachment  to 
nanocomposite polymer surfaces. The AB assay can be adapted providing the 1:10 
ratio of AB reagent volume to medium volume is preserved; that is, 20 l AB reagent 
to 200 l of medium. After a 24 hours incubation, 20  L AB was placed in each well 
and  incubated  for  4  hours.  The  fluorescent  was  measured  using  a  fluorescence 
spectrophotometer (Fluoroskan AscentFL, ThermoLabsystems, Virginia, USA) at 530 
nm excitation and 620 nm emission. The fluorescence signal from each sample was 
isolated  by  subtracting  from  raw  background  fluorescence  signal,  the  background 
control  signal.  Each  absorbance  was  measured  and  displayed  compared  with  the 
control. The experimental process was repeated three times, and the average of the 
results was reported. 
 
3.6.3.2. CellTiter-Blue assay 
The  cell  vitality  and  proliferation  were  also  evaluated  by  CellTiter-Blue  (CTB, 
Promega, Hampshire, UK) assay for the research in chapter 4. The CellTiter-Blue cell 
viability assay (CTB) provides a homogeneous, fluorometric method for estimating 
the number of viable cells. The assay is based on the ability of living cells to convert a   103 
redox  dye  (resazurin)  into  a  fluorescent  end  product  (resorufin).  Nonviable  cells 
rapidly lose metabolic capacity and thus do not generate a fluorescent signal. The 
homogeneous  assay  procedure  involves  adding  the  single  reagent  directly  to  cells 
cultured in serum-supplemented medium. After an incubation step, data are recorded 
using either a plate-reading fluorometer or spectrophotometer.  
 
This  set  of  experiments  was  performed  using  polystyrene  culture  plates  as  the 
standard and POSS-PCU with different concentrations of POSS to elicit the difference 
in  EC  adhesion  between  different  nanocomposites  as  well  as  to  compare  the 
endothelialization  properties  of  silsesquioxane-containing  nanocomposite  to  pure 
PCU.  For  the  research  in  chapter  4,  each  polymer  (PCU  and  POSS-PCU 
nanocomposites) was coated on Melinex film, dried in an oven overnight and then cut 
into  disks  of  opportune  diameter  for  the  96-well  plates.  All  sets  of  samples  were 
sterilized by autoclaving the samples. Cell vitality and proliferation were evaluated 
using  CTB  assay  in  this  set  of  experiment.  The  recommended  quantity  of  CTB 
reagent to use is 1:5 dilution of the original stock of CTB; that is, 20µl of reagent to 
each 100µl of medium in a 96-well format. Three wells per sample were seeded and 
the experiment was repeated three times per sample. After 48 hours incubation, the 
fluorescent  was  measured  using  a  fluorescence  spectrophotometer  at  530  nm 
excitation and 620 nm emission. 
 
Under most experimental conditions, the fluorescent signal from the AB/CTB reagent 
is proportional to the number of viable cells. For individual calibration curves for each 
cell type, known numbers (0.5-2.5 × 10
4) of cells were plated in triplicates in multi-
well  cell  culture  plates.  After  letting  the  cells adhere  to  the  plates  for  24  h,  2:10   104 
dilution of the original stock of CTB (1:10 dilution in the case of AB) was added to 
the medium. The plates were incubated for another 4 h at 37 °C. CTB bioreduction 
was assessed by measuring the fluorescence in the cell culture supernatant using a 
spectrophotometer at 530 nm excitation and 620 nm emission. 
 
3.6.4. Cell confluence morphology 
3.6.4.1. Light microscopy; cellular characterization by immunostaining 
The von Willebrand Factor (vWF) expression specific to mature endothelial cells was 
evaluated in this study. Observations of cytoskeleton and nucleus were carried out to 
check their development on POSS-PCU. 
 
HUVECs were cultured on POSS-PCU2 nanocomposite films for 48 hours. Prior to 
immunolabeling with the vWF antibody, the cells were fixed by incubation with 1% 
paraformaldehyde  at  37  °C  for  20  min  following  two  washes  with  Dulbecco’s 
modified  Eagle  medium  without  red  phenol  (DMEM).  The  cells  were  made 
permeable in the presence of 0.5% Triton X100 followed by 40 min incubation at 
room  temperature  with  500  lL  primary    goat  polyclonal  antibody  anti-von-
Willebrand-factor (Abcam Ltd. Cambridge, UK) diluted to 1/50 in 0.1% Triton X100 
containing 0.5% bovine serum albumin (BSA). Subsequently, the cells were washed 
twice with 1 mL DMEM without red phenol/BSA to remove the excess antibodies. 
These cells were then incubated for 30 min at room temperature with the secondary 
antibody, 500 lL of polyclonal donkey anti-goat-immunoglobulin G conjugated with 
Alexa-Fluor 488 (Invitrogen Ltd, Paisley, UK) diluted to 1/100. After three washes in 
DMEM  without  red  phenol,  the  sample  was  imaged  by  confocal  laser  scanning 
microscopy (Leica DMIRE2 HC Fluo TCS 1-B, Germany), using the 488 nm spectral   105 
line.  The  morphology  of  the  proliferating  ECs  was  also  studied  using  optical 
microscopy.  
  
For immunostaining of the Cytoskeleton and Nucleus, as for vWF immunostaining, 
cells were fixed with 1% paraformaldehyde for 20 min and permeabilized with Triton 
X-100 (0.5%) for 40 min. The cells were then incubated for 30 min at 37 °C with 
propidium iodide labeled with Alexa-Fluor 488 (Invitrogen, UK) diluted to 1/100 in 
Triton X-100 (0.1%) and followed by two rinses with DMEM without phenol red. 
The cells were observed by fluorescence confocal microscopy using the 488nm and 
594nm spectral lines. 
 
3.6.4.2. Electron microscopy 
Seeded polymer films for electron microscopy were washed carefully with PBS and 
the seeded samples were fixed in 4% formaldehayde in PBS for two hours at room 
temperature.  The  samples  were  then  dehydrated  with  ethanol/distilled  water  (10% 
ethanol  increments)  at  41  ºC.  The  discs  were  observed  using  a  scanning  electron 
microscope (Philips SEM Model 501, Netherlands). Before imaging, samples were 
attached to aluminium stubs and coated with gold using an SC500 (EM Scope) sputter 
coater.  
 
The parameters assessed were the presence of cell retraction, loss of filopodia and a 
rounded cell appearance; indicators of impaired cell motility and morphogenesis (Park 
et al. 2002a). 
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3.7. Coating NiTi with POSS-PCU 
3.7.1. Casting 
A casting method was used to prepare polymer films. For cast films, the polymer 
solution was diluted with extra DMAC to reach the final concentration of 15 wt% and 
centrifuged  for  45  minutes.  It  was  then  brushed  onto  the  substrate.  The  polymer 
solution was then allowed to evaporate in oven overnight at 60 °C.  
 
3.7.2. Electrohydrodynamic spray deposition 
In a typical electrohydrodynamic spraying process (Figure 3.3), the equipment used 
consists of a stainless-steel needle with an orifice diameter of 330 µm  held in resin 
and connected to the positive terminal of the high voltage power supply (Glassman 
Europe Ltd., Tadley, UK) capable of applying an electric field between the needle and 
grounded  plate  electrode.  Polymer  solution  was  released  to  the  needle  through  a 
silicone rubber tube by an infusion pump (Harvard, Apparatus Ltd., Edenbridge, UK). 
A jet was ejected from the surface of the charged polymer solution when the applied 
electric  field  strength  overcomes  the  surface  tension.  A  microscope  lens  in 
conjunction with a high-speed camera, which was connected to a computer, was used 
to observe the jet move toward the substrate and capture images. The jet breaks up 
into charged droplets which were collected on the stainless steel substrate located at a 
distance  of  25  mm  from  the  needle  exit  and  fixed  to  a  rotating  plate  (Pareta  & 
Edirisinghe 2006).  
 
Electrohydrodynamic spraying  (EHDA) of POSS-PCU2 solution on a stainless steel 
substrate was investigated over a wide applied voltage-flow rate parametric space and 
in order to study the effect of varying the polymer concentration in the solution and   107 
the electrospraying time studied. Modes of spraying of the polymer solutions were 
established  for  20  wt%,  15  wt%  and  10  wt%  polymer  concentration  solutions.  A 
sample of the 15 wt% polymer solution was subjected to EHDA at 5.8 kV and 4 µl/s 
in the stable cone-jet mode. The films produced with the above mentioned set up were 
collected after 1, 2 and 3 hours, to study the effect of electrospraying time on the film 
thickness. The films were kept overnight in an oven held at 60°C to let the solvent 
present in the film to evaporate.  
 
3.7.3. Ultrasonic atomization spraying 
The POSS-PCU2 nanocomposite coating was applied using an ultrasonic atomising 
spray  (MicroMist™,  Sono-Tek  Co.  Ltd.,  Milton,  NY)  as  shown  in  Figure  3.4.  A 
MicroSpray nozzle is used in the set up of this study with the orifice size of about 0.5 
mm. This orifice size is usually recommended for use in applications where flow rates 
are  very  low  and  narrow  spray  patterns  are  needed  as  required  with  current 
application. 
  
The spray solutions were prepared by dissolving POSS-PCU2 in more DMAC. The 
liquid  ejected  from  the  micro-syringe  was  atomized  and  focused  by  ultrasonic 
atomization spraying equipment, and then the focused liquid beam was sprayed onto 
the surface of NiTi strips. The strip was kept rotating and moving during the spraying 
process to get a homogeneous coating. Adjucement of the nitrogen level and voltage 
applied allowed ultrasonic atomization spraying  of the polymer, provided an even 
spray of polymer. Power is controlled by adjusting the output level on the power 
supply. The heater was used to evaporate the solvent on contact with the sample, 
leaving a polymer layer.   108 
3.7.3.1. Parameter optimisation 
POSS-PCU2 films were prepared by spraying in the arrangement described above 
under  certain  conditions.  The  parameters  varied  were:  polymer  flow  rate,  voltage 
applied,  time  sprayed,  temperature,  distance  from  spray  nozzle,  polymer 
concentration, gas flow rate and drying conditions. These parameters were changed in 
accordance  with  the  Taguchi  method  (Taguchi  1986).  The  Taguchi  method  for 
parameter  optimisation allows  the  effect  of  multiple  parameters  on  a  performance 
characteristic to be assessed in a condensed set of experiments. This will be further 
discussed in chapter 5.  
 
3.8. Surface treatment of NiTi  
Surface  treatment  is  used  to  promote  bond  strength  between  the  POSS-PCU2 
nanocomposite and the surface of NiTi strips. This protocol was done in different 
steps.  
 
3.8.1. Surface roughening 
Rectangular NiTi samples (50 mm × 5 mm) were cut from 0.5 mm thick strips of the 
material.  An  oxide  layer  already  exists  on  the  alloy  surface  as  a  result  of  the 
manufacturing process. Sand blaster at a working distance of 200 mm was used to 
remove  most  of  the  existing  oxide  layer  and  to  produce  a  macroscopically  rough 
surface.  
 
3.8.2. Surface anodization 
Electrochemical reactions are successfully used for degreasing, etching and oxidising 
metal surfaces, where the metal acts as an anode (Ramani, Weinder, & Kumar 1998).   109 
A new electrochemical method, based on the work of Cheng et al. (Cheng, Shi, & 
Man  2005),  was  used  to  produce  a  titanium  oxide  (TiO2)  coating  on  NiTi  that 
involved anodizing the Ti alloy in a methanolic electrolyte. The NiTi sample was 
immersed in an electrolyte prepared by dissolving 10 g of NaNO3 (99.9%) in 1 litre of 
methanol (Sigma-Aldrich Ltd., Dorset, UK). The sample was then galvanostatically 
anodised  at  the  ambient  temperature  (20°C)  using  a  current  density  of  3×10
-2 
mA/mm
2 for 3 hours with a pair of graphite rods as the cathode. The distance between 
anode NiTi and cathode was set at 20 mm for the anodisation process. The anodized 
samples were then left in the oven for 1 hour at 600°C. This step has been called heat 
treatment. The schematic view of the anodisation set up is shown in Figure 3.5. 
 
3.8.3. Silanisation  
3-aminopropyltriethoxysilane (γ-APS) (Sigma-Aldrich Ltd., Dorset, UK) (Figure 3.6) 
was applied to the surface as the coupling agent to chemically improve the adhesion 
between  NiTi  substrate  and  POSS-PCU2  film.  It  has  three  ethoxy  groups  and  an 
amine group as an organofunctional group bound via a propyl group (-CH2-CH2-CH2-
) link to the silicon atom. Prior to immersing in the silane solution, the anodized NiTi 
samples  were  cleaned  by  ultrasonic  vibration  (Kerry  Ultrasonic  machine,  North 
Yorkshire , UK) for 5 min in ethanol and then in acetone. The cleaned metals were 
then immersed in sodium hydroxide (NaOH) alkaline cleaner at 60°C for 15 min to 
make sure there were sufficient OH groups to react with alkoxy functional groups, 
then rinsed with distilled water and dried in air. Solutions of 2 and 5 vol% γ-APS 
were prepared by diluting with ethanol/deionized water (95/5 vol%). The natural pH 
of the γ-APS solution was  ∼8 and the reaction can be catalysed with H
+ or OH
-. 
Acetic acid was used to adjust it to pH~4. These solutions were then activated and   110 
hydrolyzed  either  for  15  min  or  for  60  min  at  the  ambient  temperature  (23°C). 
Concentration, pH and hydrolysis time are believed to have a significant effect on the 
effectiveness of the modification process (Blum et al. 1991; Tesoro & Wu 1991). 
 
The samples were then dipped into the freshly prepared silane solution, allowed to dry 
in air for 15 min and then cured at 110 ºC for 20 minutes to crosslink the silane films. 
Thermal curing is well known to increase the crosslinking of silanes to form siloxane 
film on the NiTi surface. Aminosilane bonds to the oxide layer and also provides a 
reactive amine group for subsequent reaction of isocyanate pre-polymer coat. With 
the formation of chemical bonds between silane molecules and NiTi substrate, Si-O-
Ti bonds are formed. The amine end of the silane molecule can polymerize with the 
isocyanate group of the POSS-PCU2 to form a urea group. The simplified reaction is 
drawn in Figure 3.7. The silanised strips were then primed with pre-polymer. Finally, 
the silanised NiTi strips were coated with polymer and placed in an oven overnight at 
60 ºC to remove any solvent. 
 
3.8.4. Energy dispersive X-ray 
The chemical composition of the coating was obtained using the Energy Dispersive 
X-Ray  (EDX)  analysis  system  (JEOL  Ltd.,  UK)  equipped  with  SEM.  The 
morphology of the interface and the thickness of the surface layer formed on the NiTi 
samples were determined by SEM. Topographic analysis of the modified NiTi surface 
was carried out by a scanning probe microscope operated in atomic force microscopy 
(AFM) contact mode. 
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3.8.5. X-ray photoelectron spectroscopy 
The samples were analyzed by X-ray photoelectron spectroscopy on a VG Scientific 
ESCALAB 5 spectrometer with monochromatic Al Ka (120 W) X-ray radiation. The 
base pressure in the analysis chamber was better than 10
-8 mbar. Survey spectra were 
acquired at 160 eV. High resolution scans were acquired at 40 eV pass energy to 
determine  the  chemical  states  and  concentrations.  The  XPS  depth  profiles  were 
obtained by using a rastered (2 mm
2) 4 keV Argon ions beam. The system boasts a 
Quartz Catalytic Cell capable of pressures up to 6 bar at 400 °C or 1 bar at 1000 
oC.  
 
3.8.6. Peeling test  
An Instron 5565 tensometer equipped with a 500 N load cell was used to measure the 
peel  strength  of  the  POSS-PCU2  coated  NiTi  strips.  The  coated  specimens  were 
loaded in the test machine as shown in Figure 3.8. The approach in this study is based 
on the ASTM D413 standard (ASTM D413 2007), which is used to determine the 
force per unit width required to separate a rubber layer from a flexible substrate such 
as fabric, fibre, wire, or sheet metal. The standard details methods for peeling the strip 
with the unpeeled portion held such as to give α° separation with moving grips. The 
adhesion strength is equal to the mean force recorded during the test. The peeling 
process was initiated manually. The lower machine grip was used to clamp the NiTi 
strip and the upper grip held the polymer film, with an initial distance of 10 mm 
between the grips. The test was conducted with a crosshead displacement rate of 5 
mm/min to a final extension of 40 mm. Tests were conducted on specimens subjected 
to the surface modification and on an unmodified strip, which acted as a control. Both 
electrosprayed  and  cast  samples  with  the  same  thickness  used  for  testing  for 
comparison.  For each type of sample, experimentation was done in triplicate.   112 
3.8.7. Inductively coupled plasma mass spectrometry 
Rectangular (30mm x 5mm) samples were cut from 0.5mm thick NiTi strips. The 
surface  modified  NiTi  strips  were  then  primed  with  pre-polymer  by  ultrasonic 
atomization spraying as discussed in detail in section 3.7.3, and finally coated with 
polymer using the same parameters. Plasma protein fraction I (prepared as discussed 
in section 3.5.1) and Dulbecco’s modified Eagles’ medium (DMEM) was used as the 
release medium to further express the Ni release characteristics of NiTi. The samples 
were then incubated at 37°C in 15mL conical centrifuge tubes were filled with 5mL 
of the plasma protein fraction I / DMEM. One NiTi sample from each group removed 
at 1, 24, 48 and 72 hours. The centrifuge tubes containing plasma fraction I or DMEM 
were  then  sent  to  the  Mass  Spectrometry  Facility,  King’s  College  London  for 
Inductively Coupled Plasma Mass Spectroscopy (ICP-MS) using a PerkinElmer Elan 
DRC+ with an AS93 autosampler. Data was managed using the PerkinElmer Elan 
v3.2 software. The experiments repeated three times and results averaged.  
The Ni release from these samples is compared to the Ni release from unmodified 
NiTi strip and bare NiTi as the control. 
 
3.9. Statistical data analysis 
The data from each experiment obtained was plotted and analysed using GraphPad 
Prism 4 software (GraphPad, San Diego, CA, USA). The data are presented as means 
and standard deviation (n=5). Statistical analysis of tests was carried out using the 
one-way ANOVA test with post-hoc Bonferroni analysis.   
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Figure 3.1. Tensile testing of NiTi strip arrangement using tensometer. 
 
 
 
 
 
 
 
 
 
 
   114 
POSS
OH Cl
POSS
OH Cl
 
                                 +  
 
                                                     + 
 
 
 
 
 
 
 
                                                                                                                                                                                                                                    
                                                                             + 
 
                                                                        
 
 
 
                                                                        
 
  
Figure 3.2. Simplified reaction scheme of nanocomposite synthesis. 
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Figure 3.3. Arrangement of apparatus for electrohydrodynamic spray deposition. 
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Figure 3.4. Arrangement of apparatus for ultrasonic atomization spraying. 
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Figure 3.5. Electrochemical anodisation of NiTi alloy using sodium nitrate in methanol 
solution. 
 
 
 
 
 
 
 
 
 
Figure 3.6. Molecular structure of 3-Aminopropyltriethoxysilane used in this study. NH2 is 
the functional group that chemically reacts with the isocyanate. 
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Figure 3.7.  Reaction stages of organotrialkoxysilane. (A) Hydrolysis; (B) 
Condensation; (C) Hydrogen bonding; (D) Crosslinking. 
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Figure 3.8. Peel test arrangement. Arrows show the moving directions of the grips. 
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CHAPTER 4.  Characterization of Synthesized 
POSS-PCU Nanocomposites 
 
A novel range of poly(carbonate-urea)urethane nanocomposites were synthesised in 
our department with different levels of polyhedral oligomeric silsesquioxane (POSS) 
covalently bonded to poly(carbonate-urea)urethane (PCU) (Salacinski, H. J. 2005). In 
this study, the focus was on the improvement of the surface properties of a polymeric 
thin  film  by  utilizing  the  inherent  characteristic  of  POSS.  A  novel  polyurethane 
system  with  the  hard  segments  being  molecularly  modified  by  nanostructured 
molecules-POSS synthesized and characterized. The bulk properties of POSS-PCU 
nanocomposites  were  characterized  by  differential  scanning  calorimetry,  gel 
permeation  chromatography,  rheometry  and  tensile  property  measurement.  The 
surface properties of POSS-PCU was characterized by attenuated total reflectance- 
Fourier transform infrared spectroscopy, contact angle, atomic force microscopy, ζ-
potential.  This  investigation  forms  the  backbone  of  the  research  reported  out  in 
chapter 5. 
 
4.1. Initial observation 
As  mentioned  in  experimental  details  (chapter  3),  POSS-PCU  nanocomposite  
polymers  with  different  concentrations  of  POSS  were  synthesized.  These  hybrid 
polymers contained 0, 2, 4 and 8 wt% POSS. These nanocomposites were named 
PCU, POSS-PCU2, POSS-PCU4 and POSS-PCU8, respectively. The prepared PCU 
cast films were transparent. The POSS-PCU2 cast films containing 2% POSS are still 
homogeneous and transparent. The products were not homogeneous and clear with   121 
increasing POSS, suggesting that macroscopic phase separation occurred at the scale 
exceeding  the  wavelength  of  visible  light.  POSS-PCU8  cast  films  containing  8% 
POSS  were  opaque.  It  has  been  previously  shown  that  the  POSS  molecules  also 
enhance the micro-phase separation between the hard and soft segments (Hsiao et al. 
2000a). 
   
4.2. Bulk properties of POSS-PCU 
4.2.1. Molecular weight distribution 
GPC analysis revealed thst POSS-PCU possessed a higher number average molecular 
weights with lower polydispersity indices of POSS-PCU as compared to the PCU. 
Figure  4.1  shows  an  overlay  of  the  computed  molecular  weight  distributions  for 
POSS-PCU  nanocomposites.  These  molecular  weight  distribution  plots  are  to  the 
same  area,  the  y-axis  being  a  function  of  weight  fraction.  Mn  increases  with 
increasing  POSS  concentration.  The  Mw/Mn  decreases  with  increasing  POSS 
concentration reaching 2.2 at 8 wt% concentration. POSS-PCU with 4 and 8 wt% 
POSS showed the lowest polydispersity. Chromatogram peak areas are also somewhat 
variable for the different samples. The POSS-PCU4 having the highest chromatogram 
area, PCU has the lowest areas with POSS-PCU8 being high but variable. A summary 
of the results obtained by GPC is given in Table 4.1.  
 
In  a  study  by  Lacono  et  al.  (Lacono  et  al.  2007)  a  higher  POSS  concentration 
produced  high  polydispersity.  The  high  polydispersity  may  be  likely  due  to  the 
decreasing mobility of  growing POSS aryl  ether polymer chains causing  a higher 
incidence of chain length fractionation. 
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Table 4.1. Selected properties of POSS-PCU hybrid nanocomposites compared with control 
PCU based on GPC results. 
 
Sample 
 
Mw 
 
Mn 
 
Polydispersity 
PCU  77600  32300  2.5 
POSS-PCU2  107500  43650  2.5 
POSS-PCU4  91250  46000  2 
POSS-PCU8  102700  47000  2.2 
 
4.2.2. Mechanical behaviour 
The stress–strain curves of POSS-based poly(carbonate-urea)urethanes are shown in 
Figure  4.2.  The  reference  PCU  has  been  used  for  comparison.  The  maximum 
attainable strain of the reference PCU was about 878%. The maximum applied strains 
for POSS-PCU2, POSS-PCU4 and POSS-PCU8 were about 867%, 1044% and 839%, 
respectively. In Figure 4.2, the increase of the POSS concentration generally results in 
a higher modulus and a lower maximum elongation ratio.  
 
The tensile properties of segmented polyurethane depend upon the chemical structure, 
the copolymer composition, and the microphase morphology (Fu et al. 2001). The 
obtained tensile results indicate that all of the POSS-containing hybrid polyurethanes 
behave  like  elastomeric  materials.  The  reasons  for  higher  modulus  and  a  lower 
maximum  elongation  ratio  with  increase  of  the  POSS  concentration  have  been 
described  as  follows  (Fu  et  al.  2000).  First,  the  attachment  of  the  rigid  POSS 
molecules  in  the  hard  segments  probably  enhances  the  stiffness  of  the  modified 
domains at the molecular level. Second, if the POSS molecules can crystallize in the 
hard segments, the modulus may be further increased. Finally, as some hard segments 
containing  POSS  molecules  are  dispersed  in  the  polymer  matrix  at  the  molecular 
level, this can improve the overall modulus of the soft segment dominant matrix. The 
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increased cross-link density could be responsible for the decrease in the elongation at 
break  of  the  materials.  In  a  way,  the  POSS  molecules  can  be  considered  as  a 
compatiblizer between the hard and soft segments, which improves the miscibility 
between the two segments.  
   
In  comparison  of  the  results  obtained  for  cyclohexane  chlorohydrine-POSS-
polyurethane with other studies, the POSS-containing nanocomposites exhibited an 
increased  Young’s  modulus  and  lower  elongation  at  break  with  increasing 
Octa(propylglycidyl ether) POSS content than the control polyurethane networks (Liu 
et al. 2006). This increase has been interpreted on the basis of two factors: i) the nano-
reinforcement of POSS cages on the polymeric matrices, and ii) the increase in cross-
link density of the networks. The nano-reinforcement effect of POSS has also been 
reported by Fu et al. (Hsiao et al. 2000b). Inorganic POSS molecules in their hard 
segments  of  polyurethane  act  as  nano-scale  reinforcing  agents.  The  methylsiloxy 
mono-functionalized POSS molecules appear to form nano-scale crystals in the hard 
segment domains of PU. 
 
Fu  et  al.  (Fu  et  al.  2001)  found  that  a  significant  mechanical  improvement  was 
achieved  by  incorporating  POSS  molecules  in  PU.  They  also  observed  that  the 
maximum  attainable  strain  of  POSS-PU  was  significantly  higher  than  that  of  the 
reference  polyurethane  sample.  They  explained  this  observation  based  on  the 
interpretation  of  the  stress-strain  behaviour  in  typical  segmented  polyurethane 
provided  by  Cella  (Cella  R.J.  1973)  and  Witsiepe  (Witsiepe  W.K.  1973).  The 
hypothesis is that the initial extension may be attributed to the reversible deformation 
of the crystalline (hard) domains (probably 0–50% in POSS-PU-34 containing POSS   124 
34 wt %). At strains of 50–150% in POSS-PU-34, a partly reversible reorientation of 
hard domains probably occurs. At higher strains, the stress is transmitted primarily 
through the amorphous soft segment phase.  
 
4.2.3. Crystallinity 
Thermal analysis has been carried out on POSS-PCU nanocomposites. DSC scans of 
the polyurethanes containing POSS (POSS-PCU) are illustrated in Figure 4.3. DSC 
analysis of samples detected the glass transition of the soft segment and the higher 
temperature melting thermal transition of the hard phase. Values are reported in Table 
4.2.  The  glass  transition  temperature  (Tg)  gives  information  on  the  amorphous 
segment of the nanocomposite while the heat capacity changes (∆Cp) at the Tg is a 
measure  of  the  inter-molecular  interaction  between  these  molecules  during  this 
transition. In the PCU samples, a mean Tg of -29 °C and a mean ∆Cp value of 0.40 
J/gK was observed.  
 
By increasing the POSS fraction in the polymer, the Tg was slightly shifted at lower 
temperatures  (Figure  4.3A)  but  the  difeference  is  not  significant.  DSC  analysis 
showed  only  minimal  changes  in  Tg  for  POSS  nanocomposites  in  comparison  to 
reference  PCU.  It  should  be  noted  that  the  control  PCU  and  the  POSS-PCU 
nanocomposites  displayed  a  glass  transition  in  the  range  of  -29.80  to  -31.79  °C; 
therefore,  the  organic-inorganic  network  is  a  typical  elastomer.  DSC  revealed  a 
plasticizing effect demonstrated by slightly lowered Tg upon increased weight percent 
incorporation of POSS. The Tg of the remaining hard segments was about constant 
despite different POSS concentrations (around 120 
◦C) but it appearsed as a strong 
transition at 8 wt% POSS concentration; which may be related to the phase separation   125 
between the hard and soft segments within the nanocomposite (Figure 4.3B). This can 
describe the cloudy feature of the POSS-PCU8 films. The Tm of the hard segment 
shifted  to  higher  temperatures  in  comparison  to  reference  the  PCU,  with  a  12°C 
increase in the melting transition temperature of the hard segment for POSS-PCU8 
(Table 4.2). The increase in Tm of the hard segment is attributable to the increased 
nano-scale interactions between its constituents thus binding together the POSS-PCU 
nanocomposites.   
 
Table 4.2. DSC melting temperatures and glass transition temperatures of POSS-PCU hybrid 
nanocomposites compared with control PCU. 
 
 
The  plasticizing  effect  demonstrated  by  POSS  was  confirmed  by  lowered  Tg  as 
previously reported (Iacono et al. 2007; et al 2009). The resulting drop in Tg in the 
study by Lacono is due to the incorporation of POSS and caused by a higher fraction 
of lower molecular weight chains observed by increased polydispersity (Lacono et al.  
2007).  This  is  also  consistent  with  the  published  literature  reporting  a  very  small 
effect of cores/filler molecules on Tg in microcomposites. This observation may be 
explained by the fact that nano-cores prevent close packaging of polymer chains due 
to thermal rearranging which in turn results in an increase in dynamic voids within the 
polymer (Merkel et al. 2002a). This extra space allows for earlier segmental mobility 
of the polymer chain and therefore lowering the Tg (Kannan et al. 2006a). 
Sample  Tg (°C)  Tm (°C)  Cp (J/gK) 
PCU  -29.8 ±  0.1  279.7 ± 0.1  0.0121 
POSS-PCU2  -30.4 ± 0.1  281.1 ± 0.1  0.0144 
POSS-PCU4  -30.8 ± 0.1  286.5 ± 0.1  0.0203 
POSS-PCU8  -31.7 ± 0.1  291.7 ± 0.1  0.0285   126 
In  other  POSS-PU  structures,  however,  a  slight  increase  in  Tg  is  observed  with 
increase in POSS concentration (Fu et al.  2000; Xu et al. 2002a; Xu et al. 2004) and 
interpreted as a consequence of cohesive interactions like hydrogen bonding between 
the siloxane cage and polar groups in the macromolecular chain. Fu et al. (Fu et al.  
2000) also observed a slight increase in Tg of the soft segment phase with an increase 
of the POSS concentration, which suggests that some hard segments along with POSS 
molecules may have been dispersed in the soft segment phase. This can be attributed 
to two causes, (i) weakening of hydrogen bonding among the hard segments in the 
microphase  domain  when  the  POSS  molecules  are  incorporated  into  the  hard 
segments, (ii) the POSS molecules act as compatiblizer between the soft and the hard 
segments, which causes an increase of the molecular restraints in the soft segments. 
The melting temperatures of soft segment crystals remain about constant; however, 
the  melting  point  of  the  soft  segment  cannot  be  identified  at  high  POSS 
concentrations.  
 
This  suggests  that  the  incorporation  of  POSS  molecules  has  retarded  the 
crystallizability  of  soft  segments,  which  is  consistent  with  the  notion  that  the 
miscibility between the hard and soft segments is increased by the inclusion of POSS. 
In other words, the incorporation of POSS molecules has weakened the interactions 
between the hard segments, allowing them to be dispersed more readily in the soft 
segment matrix (Fu et al. 2000). In the study by Liu Y. et al. (Liu et al. 2006), the 
hybrid  nanocomposites  showed  an  enhanced  Tg,  which  increased  with  increasing 
POSS content. In POSS-containing hybrid nanocomposites, the increase in the glass 
transition temperature is generally interpreted on the basis of nano-reinforcement of 
the POSS cages in the polymer matrices, which is able to restrict the motions of the   127 
macromolecular chains (Liu et al. 2006). In their case, the Tg enhancement is not only 
ascribed to the nano-reinforcement of the POSS cage but also attributed to additional 
cross-linking between the polyurethane (PU) networks and octa(propylglycidyl ether) 
polyhedral oligomeric silsesquioxane. 
 
4.2.4. Rheological behaviour 
Figure 4.4 shows the apparent viscosity (η) versus the shear rate of the PCU with 0, 2, 
4  and  8  wt%  POSS.  Viscosity  was  somewhat  lower  for  the  POSS-containing 
structures. POSS content has shown the same effect on the rheology of polyurethanes. 
It has been shown that η is somewhat lower for the POSS-containing structures (Turri 
et al. 2005). These results are related to lower molecular weight or to an effect of 
composition on Mark-Houwink parameters in polyurethanes containing POSS (Turri 
et al.  2005). In the study by Zheng et al. (Zhang et al. 2006), pure polyester displayed 
Newtonian flow behaviour, but all the resins with POSS gave shear thinning first, and 
as more the POSS was embedded, the shear thinning behaviour became stronger, and 
the  viscosity  increased.  This  can  be  attributed  to  the  physical  and  chemical 
interactions  between  the  rigid  and  dimensionally-large  POSS  cube  with  polyester 
chains. 
 
4.3. Surface properties of POSS-PCU 
Predictions about the interactions between biomaterial surface and adsorbed proteins 
can  only  be  formulated  by  having  an  exact  knowledge  of  the  structure  of  the 
biomaterial's surface. Interaction between biological environment and foreign body 
material is most likely dominated by surface properties including; chemical structure 
of the surface, electrical properties e.g. kind and content of specific charged or polar   128 
functional  groups,  hydrophilic/hydrophobic  character,  surface  free  energy,  the 
morphology, i.e. the domain structure of a multi-component system such as crystalline 
and  amorphous  domains  and  the  topography,  i.e.  the  surface  roughness,  surface 
contamination of a polymer (Aiping & Tian 2006b; Altankov et al. 2003; Khorasani et 
al. 2006; Khorasani & Mirzadeh 2007; Klee & Hocker 1999; Safinia et al. 2005). 
 
4.3.1. Surface morphology 
Figure 4.5 shows the phase contrast representative AFM images of the POSS–PCU. In 
terms of the volume fraction of POSS and the difference in viscoelastic properties 
between  the  PCU  matrix  and  the  POSS  phases.  The  dark  continuous  regions  are 
assignable to the PCU chains of the organic–inorganic nanocomposite whilst the light 
regions are attributed to POSS domains (Zeng  et al. 2009).  It is seen  that all the 
nanocomposites  exhibited  microphase-separated  morphologies.  For  the 
nanocomposite containing 4 wt% of POSS, the nano-scaled POSS spherical particles 
with the size of 10 nm and POSS agglomerates were homogenously dispersed in the 
continuous PCU matrix. With increasing POSS content, some interconnected POSS 
microdomains  began  to  appear  (Figure  4.5D)  and  the  quantity  of  the  POSS 
microdomains  was  increased  whereas  the  size  of  the  spherical  particles  remained 
almost invariant. 
 
4.3.2. Surface charge 
It is obvious, that the ζ-potential of the pure PCU membrane is in the negative range 
only at strongly basic pH-values. If POSS is incorporated into the PCU polymer, then 
ζ- potentials become less positive with increasing content of POSS (Figure 4.6). The 
values of the points of zero charge (PZC) are listed in Table 4.3, which are estimated   129 
from Figure 4.6. It is obvious that the ζ-potential of the pure PCU films were in the 
negative range if the pH value was basic. Addition of 2% POSS led only to very 
moderate decrease of ζ- potential curves. It is interesting to note that for both polymer 
films the ζ- potential was positive over a wide range up to a pH of 8.5. However, if 
the POSS content was further increased to 4% POSS is caused a remarkable drop of 
the ζ- potential. The further addition of POSS during the copolymerization process 
led  to  materials  that  decreased  the  ζ-  potential  to  more  negative  values.  It  is 
remarkable to note that a POSS content of 8% generated ζ- potentials, which were 
negative over a wide range of pH values (pH > 4.5). These changes in the surface 
potential of materials as a result of the different POSS composition were also well 
reflected when the points of zero charge were considered. It is obvious that large 
changes occurred if the POSS concentration became greater than 2%. Under the pH 
conditions  of  the  body,  the  nanocomposites  containing  4  and  8  wt%  POSS  have 
negative charge while the PCU and POSS-PCU2 are positively charged. 
 
Table 4.3.  Point of zero charge (PZC) as a function of POSS content as derived from ζ- 
potential measurements. 
Sample  PZC ( equal to pH-value at 0 mV) 
PCU  8.8 
POSS-PCU2  8.5 
POSS-PCU4  7.4 
POSS-PCU8  4.5 
 
Electrical properties of solid surfaces, e. g., surface charge or zeta potential may has a 
strong  influence  on  protein  adsorption  and  blood  compatibility  by  affecting 
thrombogenic  events  at  blood-polymer  interface  (Norde  &  Rouwendal  1990).  The 
compatibility of blood with surfaces has been associated chiefly with ionic charges   130 
based on the observation that endothelial wall, the platelets and the plasma proteins 
carry net anionic charges in normal physiological conditions (Bruck 1973; Klee et al.  
1996). Surface charge of the polymer surface interferes with adhesion of cells. Ions 
present on material surfaces may interact with cell receptors to cause cell adhesion 
and growth, and to facilitate cell proliferation, leading to the foreign body reaction 
(Khorasani & Mirzadeh 2007). Blood compatibility data on polymer electrets shows 
that  negatively  charged  surfaces  have  less  of  a  tendency  for  thrombosis  than 
positively charged ones because of electrostatic repulsion between polymer and blood 
components (Aiping & Tian 2006a;Murphy et al. 1970). The natural blood vessel wall 
has a negative ζ potential of -8 to -13 mV (Klee & Hocker 1999).  
 
4.3.3. Hydrophobicity/ hydrophilicity 
Contact angle measurement provides insight into the hydrophobicity as well as the 
surface energy of the film. The hydrophobicity of the POSS-PCU films was tested 
using water drop shape analysis and measured for the corresponding contact angle (θ). 
Surfaces with water contact angle < 90° are considered wetting whereas those with 
water contact angle > 90° are considered non-wetting (Wapner & Hoffman 2000). 
When a liquid drop is placed on a flat and smooth surface, it spreads over the surface 
until  the  mechanical  and  thermodynamic  forces  are  balanced.  The  contact  angles 
increased with increasing POSS content in POSS-PCU nanocomposites (Figure 4.7). 
It is generally agreed that the measurement of contact angle on a given solid surface is 
the  most  practical  way  to  obtain  surface  energies  (Wu  &  Nancollas  1999).  The 
relationship of contact angle and surface energy is governed by Young’s equation 
(Wu 1971). 
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Where θ is the contact angle, γ is the surface free energy, γl is the experimentally 
determined surface energy (surface tension) of the liquid, γs is the surface energy of 
the solid and γsl is the interfacial tension between the tested solid and the probe liquid. 
Among the various possible thermodynamic approaches to determine γs and γsl, the 
equation of state for solid–liquid interfacial tension has been selected for this study 
(Gindl et al. 2001):  
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− − − + =                                                                                   4.2                                                     
 
Where ß is an empirical constant with an average value of 1.057×10
-4 [(m
2 mJ
-1)
2]. In 
combination with the Young equation, the equation of state enables the evaluation of 
the surface free energy of a solid (γs) from a single measurement of contact angle in a 
liquid with a known surface tension (γl). The surface tensions of each probe liquid are 
given in Table 4.4.  
Table 4.4. Surface tensions of four probe liquids. 
Probe fluid  γl (mN/m)  γ
d
l (mN/m)  γ
p
l (mN/m) 
Water  72.8  21.8  51.0 
Diiodomethane  50.8  48.5  2.3 
Ethylene glycol  47.7  29  19 
Formamide  58.2  36  22.2 
 
The  results  of  contact  angle  for  the  POSS-PCU-coated  glass  slides  subjected  to 
measurements with water, diiodomethane, ethylene glycol and formamide as probe 
liquids are shown in Table 4.5. It appears that upon adding POSS to the system the 
contact angle was dramatically increased in the case of all liquids and increased with   132 
increasing POSS content. The highest increase in water repellency was 12.7% for 8 
wt  %  POSS  with  an  average  contact  angle  of  113.7°  (as  compared  to  PCU  with 
average  of  82.9°).  Advancing  contact  angle  results  are  very  reproducible.  Contact 
angle results shown in Table 4.5 indicate that incorporation of even a small amount of 
silsesquioxane strongly enhances the hydrophobicity of the surface.   
 
Calculations for surface tension are reported in Table 4.6. The incorporation of even a 
small amount of POSS molecule strongly enhances the contact angles of the coated 
surface against all liquids. It appears that the total surface energy of polyurethanes is 
in any case reduced by half. The surface free energy decreased from ∼ 35.1 mNm
-1 for 
pure PCU to as low as ∼17.6 mNm
-1 when 8 % POSS was used in the polymer. The 
result is changed very fast in 2% POSS-modified sample, and does not significantly 
improve in the 2–8% POSS range. 
 
In some studies, the surface free energies of the hybrid nanocomposites containing 
various percentages of POSS were calculated according to the geometric mean model 
(Kaelble & Uy 1970) or by the Owens–Wendt method (Owens & Wendt 1969). In 
this study, the calculation is based on the equation of state. Total surface free energy 
of POSS-containing PCU was reduced compared with pure PCU. In particular, it has 
been shown that the polar component is very sensitive to the presence of even a very 
small amount of POSS, suggesting that the inclusion of POSS moiety significantly 
changed the distribution of the polar groups (the urethane moieties) on the surface 
energy of materials; that is the POSS moiety on the surface acts as a screening agent 
to the polar groups of PCU (Koh et al. 2005; Liu et al. 2006). This would mean the 
POSS  nanostructures  screen  the  polar  groups  like  urethanes  or  carboxyls  and  are   133 
preferentially oriented on exposure to air (Turri et al. 2005). This value of surface free 
energy of all POSS-PCU (17.6-21.9 mN/m)  is less than the surface free energy (∼ 
32.5  mN/m)  of  a  glass  slide  treated  with  the  silane  coupling  agent  (3,3,3- 
trifluoropropyl)trimethoxysilane) (Koh et al. 2005). It is approaching reported values 
of  16  mN/m  surface  energy  and  120°  contact  angle  for  Teflon  which  is  a 
biocompatible hydrophobic materials for vascular applications. 
 
Table 4.5. Advancing (θa) and receding (θr) contact angles, and hysteresis of POSS-PCU 
compared with control PCU. Inset: advancing and receding contact angle were measured 
in different probe liquids; (W) water, (D) diiodemethane, (EG) ethylene glycol and 
(F) formamide. (×=not available) 
 
 
 
 
 
 
Table 4.6. Surface tension of POSS-PCU against PCU.  
Sample  γs  (mN/m) 
PCU  35.1 ± 8.1 
POSS-PCU2  21.9 ± 8.3 
POSS-PCU4  17.6 ± 4.6 
POSS-PCU8  17.6 ± 4.7   
 
Increased  hydrophobicity  of  some  hybrid  polymer  surfaces  with  incorporation  of 
POSS  has  also  been  reported  in  other  studies  (Hirao  et  al.  2002;  Li  et  al.  2002; 
Muisener et al. 2003)
;(Koh et al. 2005; Li et al. 2002; Turri et al. 2005; Zeng et al.  
2009)  including  polyurethane-based  nanocomposites  (Zhang  et  al.  2006).  The 
θa   θr    
Sample        
     W                D              EG              F 
 
  W           D            EG             F 
PCU  82.9  28.1  67.6  61.7  ×    14.0  × 
POSS-PCU2  110.1  54.7  88.4  90.6  73.9  12.8  49.3  60.5 
POSS-PCU4  113.2  71.8  93.7  96.9  ×  ×  24.0  × 
POSS-PCU8  113.7  74.5  94.2  96.4  49.9  10.3  31.5  24.2   134 
obtained findings are consistent with previously reported studies showing increased 
surface hydrophobicity for other POSS/polymer systems and POSS molecules with 
fluorinated  alkyl  chains  attached  to  the  POSS  cage  (Misra  et  al.  2007),  PMMA 
blended  with  fluorinated  POSS-terminated  polymers  (Koh  et  al.  2005),  other 
monofunctionalized POSS-containing linear polymer systems (Liu et al. 2006, Mabry 
et al. 2008) or diol-functionalized POSS (Turri & Levi 2005) and octa (propylglycidyl 
ether)-functionalized  POSS  (Liu  et  al.  2006).  The  POSS  moiety  of  the  organic–
inorganic hybrid which contains organosilicon and organofluorine moieties is of low 
free energy (Koh et al. 2005; Li et al. 2002). Surface modification as a function of 
POSS nano-particle concentration was also observed in contact angle studies (Misra 
et al. 2007; Mu et al. 2007). 
 
Advancing/receding  hysteresis  is  influenced  by  many  factors  such  as  the  surface 
roughness, chemical heterogeneity of the surface, presence of low molecular weight 
species,  molecular  orientation,  rearrangements  of  functional  groups,  changes  in 
morphology (Morra et al. 1990; Muller et al. 2001). In a multiphase system advancing 
contact angle is more sensitive to the low surface energy or hydrophobic domains 
whereas  receding  contact  angle  is  more  sensitive  to  the  high  surface  energy  or 
hydrophilic  domains  (Schwartz  &  Garoff  1985;  Turri  &  Levi  2005).  POSS 
modification enhances both advancing angles and hysteresis. Moreover, the surfaces 
show different kinetic wettability behaviour, since the POSS-modified polyurethanes 
show a progressive increase of the hysteresis. The kinetic effects with the wetting 
cycles  are  a  consequence  of  modifications  occurring  at  the  liquid–solid  interface, 
evolving toward a more favourable energetic state. 
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Increase in the water contact angle and decrease in surface energy demonstrate the 
hydrophobic  nature  of  the  POSS-PCU  nanocomposite  surface.  This  has  been 
explained partially by Misra et al. (Misra et al. 2007) using the cumulative effect of 
the  eight  hydrophobic  isobutyl  groups  attached  to  the  corner  silicon  atoms  of  the 
POSS cage. The effect is pronounced because of the higher concentration of POSS 
moieties  on  the  film  surface.  This  study  attributes  the  increased  hysteresis  in  the 
POSS containing systems to the low surface energy characteristic of POSS, which 
promotes  its  migration  towards  the  surface,  explains  the  hysteresis  behaviour 
exhibited by POSS-PCU nanocomposites (Misra et al. 2007). In the study by Liu Y. et 
al.(Liu  et  al.  2006),  X-Ray  photoelectron  spectroscopy  analysis  revealed  that  the 
concentration  of  elemental  Si  on  the  surface  of  the  hybrid  composites  was 
significantly higher than the theoretical values calculated in terms of the feed ratios. 
This observation suggests that an enrichment of Si-containing moiety on the surfaces 
exist (Koh et al. 2005;Wen et al. 1997). This result is important in understanding the 
improvements  in  surface  hydrophobicity  for  the  POSS-modified  polyurethane 
composites.  
 
Increase in the water contact angle and decrease in surface energy demonstrate the 
hydrophobic nature of the POSS-PCU nanocomposite surface which is in favour of 
polymer  blood  compatibility.  This  can  be  attributed  to  the  low  surface  energy 
characteristic of POSS, which promotes its migration towards the surface and explains 
the hysteresis behaviour exhibited by POSS-PCU nanocomposites (Misra et al. 2007). 
The  reason  why  incorporation  of  POSS  decreased  the  surface  free  energy  can 
probably be related to the surface-oriented enrichment of POSS structures bearing 
low-surface-tension substituents (Misra et al. 2007;Turri & Levi 2005).    136 
Based on the previous studies, non-wettable materials have less of a tendency for 
thrombosis (Sharp & Taylor 1971). Biomaterial surfaces with very low polar surface 
energies or high dispersive surface energies favour blood compatibility. The results 
show that the best blood compatibility is obtained for a ratio of the dispersive and 
polar surface tension of nearly 12 (Klee et al. 1996).  
 
Surface energy is one of the most influential factors on protein adsorption. Smaller 
interfacial  energies  between  blood  and  the  polymer  surface  imply  better  blood 
compatibility (Klee & Hocker 1999).  It has been suggested that a hemocompatible 
surface should have a surface energy in the range of 20-25 mN/m (Gogolewski 1989). 
 
The  surface  roughness  as  well  as  the  chemical  heterogeneity  imparted  by  the 
enrichment of POSS nano-particles on the PCU surface is the other factor which may 
increase the hysteresis of the system. These characteristics are studied in the next 
section.  
 
4.3.4. Surface topography 
4.3.4.1. Surface chemical mapping 
ATR-FTIR  analysis  provided  further  evidence  of  POSS  surface  enrichment.  The 
incorporation of POSS into the PCU matrix was confirmed by spectroscopic analysis. 
Figure 4.8 illustrates the typical ATR-FTIR spectrum of reference PCU, and POSS- 
PCU hybrid nanocomposites. The control PCU showed typical wavelengths at 1736 
cm
-1 indicative of the carbonyl segments of carbonate (–NHCO–;C=O), the 1512 cm
-1 
wavelength is indicative of urethane carbonyl groups (–NHCOO–) and bonds in the 
1240–1250  cm
-1  range  show  the  presence  of  the  C–O–C  bonds  of  the  CO–O–C   137 
segments (Kannan et al. 2006b). The broad absorption band with the maximum near 
3300 cm
-1 is typical for stretching vibrations of OH and N–H groups of PU (Bliznyuk 
et al. 2008). For the control PU, the stretching vibrations of the N-H groups occur at 
3300 cm
-1, which together with the carbonyl bands at 1736 cm
-1 are indicative of the 
presence of urethane moieties. 
 
Characteristic absorption bands of POSS are observed at 1080-1130 cm
-1, attributed to 
Si-O-Si stretching vibrations in the silsesquioxane cages (Misra et al. 2007),(Zhang et 
al. 1998). For the POSS-PCU hybrid nanocomposite, not only the characteristic bands 
of PCU, but also the absorption bands at 1109 representative of Si–O–Si stretching 
vibrations (Bliznyuk et al. 2008;Huang et al. 2003) were observed. The presence of 
the  latter  did  not  alter  the  existing  polyurethane  bonds.  The  characteristic  1109 
absorbance  is  observed  in  the  POSS-PCU2,  POSS-PCU4  and  POSS-PCU8 
composites, with strong intensity signals. With increasing POSS concentration, the 
intensity of the peaks will be stronger. The absorbance band at 2250–2275 cm
-1 that is 
characteristic of isocyanate disappears gradually with increasing POSS concentration 
as expcted.  It also shows POSS can self-assemble on the surface of the POSS-PCU 
nanocomposite. This can indicate the POSS moieties acts as a nanocore-crosslinker; 
which helps the completion of the reaction between the diamine and the PCU pre-
polymers. 
 
4.3.4.2. Surface roughness 
Increments in surface hydrophobicity may also be related to the surface roughness 
(Gao  &  McCarthy  2006).  To  check  whether  the  surface  roughness  influenced  the 
contact angles, and, therefore whether it influenced the surface free energies of POSS-  138 
PCU  films,  AFM  was  used  to  observe  the  topographical  images.  Typical  AFM 
topographical images of the pure PCU and hybrid POSS-PCU nanocomposite films 
are shown in Figure 4.9.  
 
AFM phase imaging provides insight into the distribution of nanostructured POSS 
domains based on the differences in localized stiffness and modulus. The average 
roughness (Ra) provides information on the phase separation between the two phases 
in hybrid POSS-PCU. Incorporation of POSS in the PCU matrix leads to dramatic 
modification of the polymer surface, as revealed by tapping mode AFM images of the 
POSS-PCU nanocomposite. While the surface of the reference PCU sample, shown in 
Figure 4.9A, is smooth with no apparent surface features (average roughness, Ra, of 
20  nm),  the  POSS-PCU  blends  exhibit  raised  features  with  increased  surface 
roughness [Fig. 4.11B: POSS-PCU2, Ra=23 nm, Fig. 4.11C: POSS-PCU4, Ra=98 nm, 
Fig.  4.11D:  POSS-PCU8,  Ra=122  nm].  In  POSS-PCU4,  spherical  particles  were 
homogenously dispersed. With increasing POSS content, some interconnected POSS 
micro-domains  appeared.  More  agglomerates  appeared  when  concentration  of  the 
POSS component is up to 8wt% (POSS-PCU8).  
 
Generally, the average roughness (Ra) of POSS-PCU films were very small (about 
100 nm), showing highly intermingled nano-phase separated hybrid materials. It also 
suggests that the studied films had good surface planarity. Smaller Ra and Rq values 
have  been  related  to  improved  adhesion  between  organic  and  inorganic  phases 
(Wahab et al. 2008). Using atomic force microscopy, the degree of surface roughness 
showed  good  correlation  with  increasing  contact  angle.  The  average  sizes  of  the 
surface protrusions were measured as the peak-to-valley ratio. As shown in Figure   139 
4.9, images obtained from AFM revealed significant surface roughening of the POSS-
PCU8 as compared to PCU with an average surface roughness of 0.12 and 0.02 µm, 
respectively. Surface roughnesses with Ra values << 100 nm have been reported to 
have a very limited effect on contact angles (Neumann 1972; Schulze et al. 1989). 
Therefore with the Ra obtained in this study (about 100 nm), it can be concluded that 
surface roughness could be partially the reason for the decreasing surface free energy 
of the hybrid PU. The reason why incorporation of POSS decreased the surface free 
energy can probably be related to the surface-oriented enrichment of POSS structures 
bearing low-surface-tension substituents (Misra et al. 2007;Turri & Levi 2005). The 
same  effect  of  POSS  on  surface  roughness  has  been  observed  in  polyurethane 
containing  3–20% diol functionalized POSS nano-filler (Turri & Levi 2005).  
 
The existence of nanometer-scale surface roughness has been shown to contribute to 
analogous hydrophobic behaviour (Pal et al. 2005;Zhu et al. 2005), both theoretically 
and  experimentally.  It  was  recently  shown  that  POSS  covalently  bound  into 
polyurethanes improves dewetting, due to the increase in the nanometer-scale surface 
roughness  as  well  as  hydrophobic  alkyl  groups  present  in  the  POSS  structures 
(Lacono et al. 2007; Turri & Levi 2005).  Contact angle and surface morphology 
results by AFM confirm that the outermost layer of the blend film is almost covered 
by the POSS moieties (Koh et al. 2005). Smooth surfaces are believed to be more 
antithrombogenic than rough ones. Rough surfaces may have an early thrombogenic 
effect in contact with blood, however, enhances more rapid and firm attachment of the 
fibrin lining and thus endothelialization (Gogolewski 1989).  
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The limited effect of POSS on surface properties between 2-8% is similar to what has 
been indicated in previous report (Liu et al. 2006); Si enrichment on the surfaces of 
the  hybrid  composites  does  not  increase  significantly  when  the  concentration  of 
Octa(propylglycidyl  ether)  POSS  is  10  %wt  or  more,  implying  that  thereafter  the 
concentration of POSS moiety on the surface was no longer increased.   
 
A schematic view of the POSS distribution in bulk and on the surface is shown in 
Figure 4.10. These findings indicate that the incorporation of a small amount of POSS 
of the correct composition allows desired modification of surface properties, such as 
increased surface roughness and surface hydrophobicity and reduced surface energy. 
POSS moieties preferentially segregate towards the film-air surface as a consequence 
of the strong thermodynamic driving force to minimize the surface energy (Misra et 
al.  2007)
,(Koh  et  al.  2005).  POSS  moieties  in  the  polymeric  films  prepared  by 
blending were also shown to be highly populated on the outermost surface of the film 
(Koh et al. 2005). Overall dispersion and domain size of POSS in the polymer matrix 
is a function of various inter- and intra-molecular forces acting between POSS-POSS 
moieties  as  well  as  between  POSS  and  the  polymer  matrix.  Dispersion  and 
compatibility of POSS in the polymer matrix can be controlled by the proper selection 
of organic (R) groups attached to the corner silicon atom (Misra et al. 2007).  
 
4.4. Endothelialisation of hybrid POSS-PCU nanocomposites: An in 
vitro study 
Two techniques have been developed in order  to harvest ECs from veins. Firstly, 
mechanical scraping (Ryan & Maxwell 1986) and secondly enzymatic digestion using 
collagenase or trypsin (Jaffe et al. 1973). Mechanical scraping uses an abrasive action   141 
to  remove  EC  from  the  vascular  wall  which  leads  to  significant  EC  damage,  the 
possibility of contamination with smooth muscle cells and provides a poor harvest of 
EC  (Hoshi  &  Mckeehan  1986;Welch  et  al.  1992).  Enzymatic  digestion  using 
collagenase or trypsin (Jaffe et al. 1973) which has been used in this study to remove 
the endothelium avoids the problem of mechanical damage to the cells and provides 
much improved EC recovery.  
 
4.4.1. Cell viability 
Cell viability is the ability of the cells to survive in the presence of culture media in 
contact  with  the  nanocomposite.  On  the  other  hand,  cell  adhesion  referred  to  the 
number of cells actually adherent to the nanocomposite after the culture media was 
removed and the wells were gently rinsed. In order to differentiate between these two 
parameters, CellTiterBlue (CTB) was added to the cell adhesion assay wells only after 
the original culture medium had been removed and gently rinsed with PBS to ensure 
that only those cells which were adherent, were present. All wells contained CTB to 
begin with and the media was not changed for 24 hours. Fresh media was added after 
24 hours and CTB added after 48 hours to investigate metabolism capacity of the 
cells. 
 
Given the importance of endothelialisation in cardiovascular implants, the ability of 
these nanocomposites to sustain endothelialisation is studied. However, optimising 
the surface concentration of POSS is essential in order to promote endothelialisation 
following implantation as excessive amounts of silica-based molecules could hinder 
endothelialisation due to its high hydrophobicity (Zilla et al. 1991).  
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Since the bioreduction of CTB occurs via, as yet, unidentified cellular metabolites, 
individual calibration curves had to be constructed for HUVECs cell type and for each 
medium. After appropriate calibration, the CTB assay was found to be equivalent to 
established cell proliferation assays (Figure 4.11). The colour change from blue to 
pink was taken as a measure of the overall metabolizing capacity of these cells; an 
indicator  of  their  viability.  If  these  cells  were  physiologically  dysfunctional  then 
accordingly the amount of dye metabolised would have been decreased. 
 
Developing  a  cardiovascular  implant  with  favourable  blood-material  interaction 
would require the ECs to undergo four phases. These cells have to first remain viable 
within  the  culture  medium  exposed  to  POSS-PCU.  Next,  the  ECs  would  have  to 
adhere to the polymer surface, preferably within a short time. These adherent ECs 
would then need to proliferate at a steady rate in order to achieve a confluent EC 
monolayer. This POSS modified PCU has been tested for its cytotoxicity effects on 
HUVECs.  This  study  demonstrated  that  this  supports  the  adherence,  growth  and 
proliferation of HUVECs. Quantitative analysis of HUVECs attachment on POSS–
PCU nanocomposites studied with CellTiterBlue (CTB) showed a significant increase 
in  mean  EC  proliferation  at  48  hours  over  baseline  values.  The  EC  attachment 
increased on POSS-PCU2 films compared with PCU. Upon adding more POSS, there 
was  no  significant  difference  found  between  different  concentrations.  This  study 
showed that there was no significant difference between HUVECs viability on the 
POSS-PCU2 and POSS-PCU4 following measurement with CTB assay at 48 hours of 
cell culture (P > 0.05) as is shown in Figure 4.12. Optical microscopy images of the 
HUVECs on nanocomposites are shown in Figure 4.13. The cells coverage for POSS-
PCU2 and POSS-PCU4 is greater than that of PCU. The morophology of the cells   143 
confirms the proliferation of the cells after 14 days.  For all the samples a spread 
confluent layer of cells was observed after 21 days (Figure 4.13 A-E3).  
 
4.4.2. Immunostaining 
Mature  endothelial  cells  in  culture  have  a  very  distinctive  and  well  described 
cobblestone appearance upon confluence. Typically, they appear as flat, 1-2  m thick, 
cells about 10-20  m in diameter with a central nucleus. ECs also exhibit contact 
inhibition and can be seen growing in patches or clusters in sparsely seeded cultures.  
Immunohistochemistry is one of the most widely used tools for characterising cell 
types by using antibodies specific to the cell of interest. However, one significant 
difficulty  of  this  technique  has  been  the  relative  lack  of  a  dependable  marker  for 
endothelial cells. Two of the most commonly used antibodies are vWF and CD31. 
vWF has been routinely used for endothelial identification in adult cells.  Confocal 
microscopy was also performed in order to observe vWF expression. After seven days 
of culture the HUVECs seeded on the polymer were vWF positive. HUVECs thus 
seem to proliferate, spread, and keep their phenotype on polymer surfaces (Figure 
4.14).  
 
4.5. Biodegradative resistance of POSS-PCU nanocomposite 
4.5.1. Mechanisms of degradation 
When determining the suitability of a particular polymer for use in vivo as an implant 
it  is  vital  that  an  assessment  has  been  made  of  that  polymer’s  susceptibility  to 
biodegradation. This is  because post-implantation interaction between the polymer 
and  adjacent  tissues  may  induce  change  in  its  chemical  and  physical  properties 
(Salacinski et al. 2002). Chemical changes may occur by covalent bond cleavage,   144 
crosslinking  or  molecular  rearrangement.  Physical  changes  include  swelling, 
plasticisation,  crystallisation  or  decrystallisation,  creep  and  stress  cracking.  The 
purpose of assessment is to understand the mechanism of degradation in order to 
devise  strategies  to  protect  the  material  from  such  forces,  thereby  increasing 
longevity. Three modes of chemical degradation predominate in vivo: mineralisation, 
hydrolysis and oxidation.  
 
Polyurethanes (PUs) are known to be susceptible to degradation in vivo (McCarthy et 
al. 1997). In recent years it has become apparent that polyurethanes are particularly 
susceptible  to  hydrolysis  and  oxidation.  Stokes  (Stokes  et  al.  1987)  carried  out 
extensive research into the mechanisms leading to cleavage of the polymer chains by 
studying  the  surface  cracking  of  implanted  polyurethanes.  He  postulated  that  this 
biodegradation  was  due  to  neutrophil-  and  monocyte-derived  macrophage  induced 
oxidation, residual stress, polyether soft-segment chemistry, molecular morphology, 
foreign body giant cells.  Using carbonate groups instead has been shown to improve 
the degradative resistance of PU (Edwards et al. 1998), an effect due to the increased 
hydrogen bonding between all of the segments (Tang et al. 2001).  
 
Polycarbonate urethanes are susceptible to degradation from adherent cells, hydrolysis 
at the carbonate linkages and to oxidation (Labow et al.  2001;Tang et al. 2001). The 
incorporation  of  silicon  in  the  form  of  polydiemthylsiloxane  (PDMS)  either  as  a 
surface-modifying  end  group  or  by  its  interaction  with  the  soft  segment  of  the 
polymer (Werner & Jacobasch 1999, Barbucci et al. 2003; Mirzadeh et al. 1995) is to 
reduce inflammatory response in vivo and enhance hydrolytic and oxidative stability 
of such polymers (Mathur et al. 1997). The reason for this approach is that PDMS has   145 
extreme  resistance  to  hydrolysis  and  oxidation.  However,  the  incompatibility  of 
PDMS integration into PU has led to poor materials which display low biostability 
(Salacinski et al. 2002). Nanofillers substantially increase the mechanical strength of 
the composite. A new POSS nanocage -integrated PCU were designed and used in 
this study. The POSS nanocages are considered to reduce inflammatory reaction in 
vivo  so  it  is  encouraging  that  despite  obvious  oxidative  and  peroxidative 
susceptibility,  the  nanocages  are  resistant  to  hydrolytic  enzymes  and  the  plasma 
protein fractions.  
 
The susceptibility of POSS-PCU2 to instability was assessed in vitro by incubating 
the films in biological/chemical solutions. These solutions include hydrolysis with 
lysosomal enzymes, plasma protein fractions (I-IV), oxidation and peroxidation and 
distilled  water  as  control.  Distilled  water  has  been  chosen  based  on  the  previous 
studies carried out by Phua et al. (Phua 1987) and Salasinski et al. (Salacinski et al. 
2002b). More details of the solutions have been described in the experimental section 
(Chapter 3). The resistance of POSS-PCU to biodegradation forces were measured by 
tensile and molecular weight analysis. Initial observation of POSS-PCU2 incubated in 
the mentioned solutions after 70 days is shown in Figure 4.15. The samples incubated 
in hydrolytic and most specifically oxidative solutions appeared dark compared to 
other samples. That is partially because the MDI is prone to discolouration. It can be 
oxidized and coloured in oxidative environment.  The results of stress-strain analysis 
of nanocomposites are summarized  in Table 4.7. 
 
4.5.2. The effect of serum proteins 
POSS-PCU incubated in serum proteins exhibited no significant difference in tensile 
strength  and  molecular  weight  distribution  compared  to  water  incubated  controls   146 
(Figure 4.17 & 4.18). There were no consistent trends noted in the effect of different 
plasma treatments on tensile strength of POSS-PCU2 films. 
 
Table 4.7. Stress-strain behaviour of nanocomposite. 
Sample  Stress 100%  
strain (MPa) 
Stress 300%  
strain (MPa) 
Stress 500%  
strain (MPa) 
Pre-incubation  5.675  11.657  26.485 
Distilled water  3.711  12.091  23.561 
Cholesterol esterase  5.999  10.952  19.316 
Phospholipase A2  6.251          11.963          23.567       
Hydrogen peroxide  6.170  11.822  23.674 
Tert-butyl peroxide  3.245  6.888  9.688 
Plasma fraction I  6.013  11.264  21.199 
Plasma fraction II  6.069  11.736  23.555 
Plasma fraction III  6.095  11.860  23.695 
Plasma fraction IV  5.631  10.606  20.537 
 
Table 4.8. Selected properties of polymers based on GPC results. 
Sample  Mw  Mn  Polydispersity 
Pre-incubated  110000  42900  2.6 
Distilled Water  113500  45800  2.45 
t-butyl Peroxide  53200  22700  2.35 
Hydrogen Peroxide  12300  48300  2.55 
Cholesterol Esterase  124500  48700  2.4 
Phospholipase A2  123500  51500  2.45 
Plasma Fraction I  105000  43400  2.45 
Plasma Fraction II  120500  50000  2.45 
Plasma Fraction III  106500  44600  2.4 
Plasma Fraction IV  118000  42300  2.4 
 
4.5.3. Hydrolysis 
Hydrolysis  is  the  fracture  of  vulnerable  chemical  bonds  with  water.  In  vitro 
experiments have demonstrated that polyurethanes are a potent activator of monocyte-  147 
derived macrophages (Labow et al. 1999a)and stimulate the formation of foreign body 
giant  cells  (Kao  et  al.  1994)-  two  notable  features  of  the  chronic  inflammatory 
response. It is hypothesised that exposure to hydrolysing enzymes  released following 
lysosomal degranulation during the chronic inflammatory reaction is a mechanism of 
polymer biodegradation. Cholesterol esterase (CE) (Santerre et al. 1994; Santerre et 
al. 1993) and more recently phospholipase A2 (Labow et al. 1997) are the enzymes 
party  in  the  process  of  hydrolytic  degradation.  CE  preferentially  attacks  the  ester 
group of the soft segment of polyurethane (Labow et al. 1999b). CE has also been 
observed to cause release of breakdown products from poly(ether) urethanes when 
used at very high concentration (Salacinski et al. 2002) whereas the specificity of 
phospholipase  A2  is  unknown.  Polyester  polyurethanes;  although  are  the  first 
generation  of  polyurethanes  to  be  investigated  for  biomedical  applications;  are 
considered unsuitable because of their hydrolytic instability (Santerre et al. 1994). 
Polyurethanes are also susceptible to microbial attack through enzymatic action of 
hydrolases such as ureases and esterases (Howard 2002). 
 
In  this  study,  POSS-PCU  appeared  resistant  to  both  PLA  and  CE  as  judged  by 
negligible difference in tensile strength compared to pre-incubated samples (p> 0.05). 
Stress-strain curves performed on the polymers showed no significant difference in 
stress-strain behaviour existed between the control, PLA, CE and plasma fractions-
incubated nanocomposites. This data shows that the soft segment of the polyurethane 
nanocomposite remains intact in spite of accelerated degradation as illustrated by the 
preservation of its elastic modulus in the Table 4.7. Molecular weight distribution in 
the CE and PLA solutions are the same as the samples of water-incubated control   148 
(Table  4.8).  This  result  might  be  partially  because  POSS-PCU  does  not  contain 
hydrolytically-vulnerable ester linkages.  
 
4.5.4. Oxidation 
In vivo, oxidising free radicals are generated during the inflammatory response by the 
respiratory burst of activated neutrophils and it is believed that this process leads to 
oxidation of the polymer (Hooper 2000;Zhao 1993). 
 
Oxidation  of  aliphatic  polymer  chains  usually  involves  four  stages:  initiation  by 
hydrogen  abstraction;  formation  of  hydro-peroxide  by  molecular  oxygen;  chain 
reaction propagation and termination (Salacinski et al. 2002). Free radical formation 
may be prompted by the aqueous ions of certain transition metals such as cobalt and 
molybdenum  (Stokes  et  al.  1990).  Polyurethanes  with  soft  segments  that  are 
oxidatively stable like carbonate have lower rate of biodegradation compared to ether 
which is prone to oxidative degradation. 
 
In  this  study,  POSS-PCU2  films  were  exposed  to  solutions  capable  of  generating 
several  oxidising  free  radical  species  including:  hydroxyl  (OH)  species  from  the 
H2O2/CoCl2 mixture; alkyl (OR) species from the t-butyl peroxide/CoCl2 peroxide 
mixture. The pre-incubated samples generally showed a greater stress and modulus 
compared  to  all  the  conditioned  samples.  There  were  no  significant  differences 
between  the  moduli  of  the  pre-incubated  sample  and  H2O2-incubated  samples  at 
100%,  300%  and  500%  (P  >  0.05).  Compared  to  pre-incubated  samples,  sample 
exposed to t-butyl peroxide/cobalt chloride showed a significant reduction in modulus 
at 100% (p< 0.001) and did not reach 500% strain because the samples fractured. It is   149 
important  to  note  however  that  in  the  case  of  t-butyl-peroxide  incubated 
nanocomposites,  samples  torn  at  strain  more  than  500%  indicating  an  apparent 
decrease in tensile strength of POSS-PCU2 compared to all the other samples. This 
degradation is supported by the GPC results (Figure 4.18).  
 
Although according to tensile results, POSS-PCU2 appeared relatively resistant to the 
H2O2/CoCl2  mixture,  the  results  of  GPC  also  show  that  both  the  ‘biodegradative 
solutions’  cause  some  decrease  in  the  apparent  molecular  weight  distribution 
compared to controls, indicating possible material degradation. However, the most 
substantial  drop  in  molecular  weight  was  for  the  t-butyl  peroxide  solution  in  the 
presence of cobalt chloride.  
 
Clearly, POSS-PCU2 was not invulnerable to metal ion oxidative degradation. Two 
reasons might account for this: firstly, although the aliphatic structure of POSS-PCU2 
contains  a  lower  proportion  of  ether  linkage  in  its  soft  segment  compared  to 
poly(ether) urethanes, some susceptible ether linkages remain. Secondly, carbonate 
bonds may be subject to acid catalysed hydrolysis if the pH is low enough with the 
formation of carbon-dioxide and alcohol. Ward has proposed such a mechanism as the 
main mode of biodegradation of polycarbonate polyurethanes (Ward 1995). However, 
the pH of the H2O2/ t-but peroxide mixture was 5.2±0.4; which does not approach the 
degree of the acidity thought necessary to promote such hydrolysis. Further studies 
are required to elucidate the exact mechanism-whether oxidative or hydrolytic- by 
which poly(carbonate) urethanes lose their chemical integrity.  
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The  biologically  abundant  H2O2  system  (H2O2/cobalt  chloride)  showed  little 
degradation of POSS-PCU2, in contrast to t-butyl peroxide solution (t-butyl/cobalt 
chloride). Based on these differences and the yellowing of the samples in solutions t-
butyl peroxide/cobalt chloride it can be proposed that the t-butyl peroxide systems are 
effective at causing degradation of the POSS nanocages-based polymers. 
 
These results confirms that the POSS-PCU nanocomposite revealed that in spite of 
accelerated  degradation,  all  samples  had  shown  no  significant  difference  in  their 
strength  and  molecular  weight  distribution  properties.  This  is  an  indicator  of  the 
stability  of  the  soft  phase  of  the  POSS-integrated  PCU  to  all  forms  of  in  vitro 
degradation with the exception of t-butyl peroxide solution in the presence of cobalt 
chloride as a catalyst.  Thus, the POSS-PCU2 is biologically resistant after long time 
exposure to simulated biodegradative solutions. 
 
In summary, the structure of a unique PCU system having inorganic POSS molecules 
in their hard segments as nano-scale reinforcing agent has been studied. The POSS-
containing PCU networks displayed enhanced glass transition temperatures, higher  
modulus  and  lower  polydispersity  indices.  The  organic-inorganic  nanocomposites 
displayed a significant enhancement in surface roughness, surface hydrophobicity, as 
well  as  a  reduction  in  surface  free  energy  compared  to  the  control  polyurethane. 
While  microscopy,  spectroscopy,  contact  angle  analyses  all  indicate  dramatic 
modification of surface properties for these nanocomposites, bulk properties are only 
minimally affected by incorporation of POSS in the PCU matrix. These results show 
the preferential orientation of POSS towards the surface. The improvement in surface 
properties was ascribed to the presence of the POSS moiety in the place of the polar   151 
component  of  polyurethane.  HUVECs  viability  on  the  nanocomposites  shows  that 
HUVECs cultured directly onto the nanocomposite exhibited optimal cell viability for 
up to 48 hours. This study showed that POSS-PCU is resistant to plasma proteins and 
hydrolytic enzyme degradation. However, POSS-PCU is vulnerable to some oxidative 
species.  The  addition  of  POSS  nanocore/fillers  to  the  PCU  imparts  a  type  of 
‘shielding’  effect  on  the  soft  phase  of  the  nanocomposite  thereby  preserving  its 
elasticity  and  compliant  properties  via  zones  of  intercalation.  In  addition,  the 
extensions of these nanofillers from the hard phase into the soft phase help cross-link 
and bind together the entire composite as a single elastic unit. This is exemplified by 
the  increase  in  Tm  compared  to  PCU.  These  results  herein  indicate  the  immense 
potential of nanofillers such as POSS in optimising the characteristics necessary in 
biomedical devices. Further work is necessary; to quantify the chemical changes that 
occur with exposure to these species, to relate these in vitro changes to in vivo 
 performance  and  to  consider  how  the  chemical  structure  may  be  augmented  to 
enhance bioresistance further.  
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Figure 4.1. Molecular weight distribution of control PCU and POSS-PCU nanocomposites. 
 
Figure 4.2. Stress–strain curves of POSS-based polyurethane nanocomposites: (A) 
PCU; (B) POSS-PU2; (C) POSS-PU4; (D) POSS-PU8.  153 
 
 
Figure 4.3. Heating DSC scans in nitrogen (10°C/min) overlay of (A) PCU as 
compared to (B) POSS-PCU2; (C) POSS-PCU4 and (D) POSS-PCU8. Inset: negligible 
change of Tg and increase in Tm by addition of POSS.  
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Figure 4.4. The viscosity of control PCU and POSS-PCU nanocomposites as a function of 
shear rate at 25 °C. 
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Figure 4.5. AFM phase contrast micrographs of (A) PCU; (B) POSS-PCU2; (C) 
POSS-PCU4; and (D) POSS-PCU8. 
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Figure 4.6. ζ-potentials of control PCU and POSS-PCU nanocomposites in dependence of pH 
value of electrolyte solution. Inset: surface charge shifts towards negative values by addition 
of POSS. 
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Figure 4.7. Water contact angle images on the surface of: (A) PCU; (B) POSS-PCU2; 
(C) POSS-PCU4; and (D) POSS-PCU8. 
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Figure 4.8. FT-IR spectra of: (A) PCU; (B) POSS-PU2; (C) POSS-PU4; and (D) 
POSS-PU8. 
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Figure 4.9. AFM topography images of (A) PCU; (B) POSS-PCU2; (C) POSS-PCU4 
(D) POSS-PCU8. Inset: increase of surface roughness by addition of POSS. 
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Figure 4.10.  (A) Schematic representation of bulk versus surface distribution of POSS 
nano-particles in POSS-PCU nanocomposite. (B) Preferential segregation of POSS 
moieties towards the film-air surface. POSS behaves like umbrella which make the surface 
hydrophobic. 
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 Figure 4.11. CellTiter Blue standard calibration curve for HUVECs. 
 
 
Figure 4.12. Cell viability test using CellTiter-Blue assay for HUVECs exposed to POSS-
PCU nanocomposites and control PCU for 48 h. 
Keys: 
 ** p< 0.01 significant against PCU. 
 ** p< 0.01  significant against POSS-PCU4 
* p< 0.01  Significantly decreased against POSS-PCU2 and POSS-
PCU4. 
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Figure 4.13. Morphological evolution of ECs seeded on TCP (A1–3); PCU (B1-3); 
POSS-PCU2 (C1-3); POSS-PCU4 (D1-3); and POSS-PCU8 (E1-3) by optical phase 
contrast microscopy. EPCs at 7 days (A-E1), 14 days (A-E2) and 21 days (A-E3). 
TCP were used as a control. Insets: A-E1)typical round shape cells, A-E2 & A-E3) 
differentiation and proliferation of cells. Objective × 20. 
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Figure 4.14. Cytoskeleton visualization (A) and cell phenotype characterization vWF
+ (B) by 
confocal microscopy after 48 hours of culture on POSS-PCU2, objective ×20.  
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Figure 4.15. Initial observation of POSS-PCU2 following 70 days immersion in different 
degradative solutions. 
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Figure 4.16. Ultimate tensile strength of POSS-PCU2 following 70 days immersion in 
different media.  
** p< 0.05 significant against pre-incubated. 
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Figure 4.17. Molecular weight distribution of POSS-PCU2 nanocomposites following 
70 days immersion in different media: (A) hydrolytic solutions; (B) plasma fractions; 
and (C) oxidative/peroxidative solutions. 
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CHAPTER 5.  Coating Stainless Steel and NiTi 
with POSS-PCU 
 
In this chapter the electrohydrodynamic spraying and ultrasonic atomization spraying 
of  POSS-PCU2  nanocomposite  polymer  developed  and  investigated  for  coating 
metallic stent materials. The experimental details of these thechniques were given in 
Chapter 3. The results are compared with data from samples made by simply casting 
the metal with the polymer.    
   
Based on the results in Chapter 4, POSS-PCU2 was chosen for this part of the work. 
In this research, electrohydrodynamic spraying of POSS-PCU2 solution on a stainless 
steel substrate over a wide rang of applied voltage and flow rates was investigated and 
the effect of varying the polymer concentration in the solution and the electrospraying 
time  on  the  coating  has  been  studied.  Ultrasonic  atomization  spraying  was  also  
assessed for coating NiTi with POSS-PCU2. This coating technique was optimised 
using different variables such as nanocomposite concentration, applied voltage and 
flow  rate.    The  structural  features  of  the  POSS-PCU2  films  were  assessed  using 
microscopy. Films were also tensile tested. These results are reported and compared 
with cast-coated films.  
 
5.1. Casting 
POSS-PCU2  films  were  prepared  by  brushing  polymer  solution  on  NiTi/stainless 
steel. By adding different amounts of polymer solution, different films with different 
thicknesses  were  prepared.  Further  structural  characterization  will  be  discussed  in 
comparison with other techniques in the following sections.    168 
5.2. Electrohydrodynamic spraying set up 
The stable cone-jet mode EHDA used to deposit the nanocomposite polymer allowed 
the formation of films on a rotating stainless steel substrate. An electrostatic field is 
created between the positively charged needle and the earthed stainless steel collector.   
A rotating plate was used to ensure even spreading of droplets generated by EHDA 
and a balance between deposition and drying time, which leads to the formation of 
film instantaneously with uniform thickness. The centre of rotation of the plate was 
slightly off-set to the exit of the needle so that all droplets do not collect in the centre 
while rotating (Figure 5.1). 
 
5.2.1. Solution characterization         
The  effect  of  the  polymer  concentration  on  the  properties  relevant  to 
electrohydrodynamic spraying is shown in Table 5.1. As expected, the viscosity of the 
solution  increased  with  increasing  polymer  concentration.  Polymer  concentration 
slightly increases the surface tension of the solutions. High polymer concentrations 
also  result  in  higher  electrical  conductivity.  The  aromatic  rings  in  MDI  are  more 
likely  to  be  responsible  for  the  electrical  conductivity.  The  extra  electrons  of  the 
double bonds which are free to move throughout the structure could account for the 
electrical  conductivity  in  the  solution.  The  first  report  of  metallic  conductivity  in 
doped polymers (Friend et al. 1999) has lead to the development of a number of 
conductive polymers which were based on molecules containing aromatic rings, such 
as poly(p-phenylene) and poly(pyrrole)  (Nicholson 2006). 
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5.2.2. Mode selection map 
Figure  5.2  shows  the  different  spraying  modes  observed  for  15  wt%  polymer 
solutions at different applied voltages. Figure 5.2A shows the dripping mode in which 
drops take the shape of regular spheres, eventually detaching from the capillary due to 
gravity.  Figure  5.2B  exhibits  the  unstable  cone-jet  mode  where  visually  the  cone 
appears  and  disappears  intermittently,  in  contrast,  the  stable  cone-jet  mode  was 
obtained for the solution at 5.6 kV (Figure 5.2C). In the stable cone-jet mode the 
solution exits the capillary in the form of a cone with a jet emanating from the cone 
apex. Figure 5.2D exhibits rim emission mode in which an irregular jet comes out of 
the capillary in random directions. Figure 5.2E represents a jet exiting the needle in 
the precession mode with spiral-like rotating around the capillary. The increase in the 
flow  rate  forms  the  multi-rim  emission  with  several  jets  exiting  (Figure  5.2F). 
Overall, as the polymer concentration is increased, the stable cone-jet mode region 
expands and covers a larger range of flow rates and voltages. 
 
Table 5.1. Physical properties of POSS-PCU2 nanocomposite polymer solution, the values 
are mean of three readings; DMAC: N, N-dimethylacetamide. 
UCL-Nano/ 
DMAC 
Density  
(kg/m
3) 
Viscosity 
 (mPa s)          
Surface 
tension  
(mN/m)         
Electrical 
conductivity (µS/m) 
10%  955  936  33  2.1 
15%  964  2930  36  2.6 
20%  1100  3960  40  3.3 
DMAC  937  1.2  34  0.2 
 
 
The mode of spraying for applied voltage versus flow rate in the range of 1-10 kV and 
1-10 µl/s was investigated to establish the best spraying conditions for the polymer   170 
solutions. Thus, mode selection maps were established for three  concentrations of 
polymer: 10 wt%, 15 wt% and 20 wt% (Figure 5.3). At a fixed flow rate, the spraying 
mode changes at different applied voltages. It shows several electrospraying modes 
such  as,  dripping,  unstable  cone-jet,  stable  cone-jet,  rim  emission,  precession  and 
multi-rim emission. As shown in Figure 5.3A, the 10%wt polymer solution was too 
dilute for film formation and the envelope for stable cone-jet mode spraying was only 
obtained at higher flow rates in a small applied voltage envelope, making process 
control very difficult. The solution containing 20 wt% of polymer had the largest 
stable cone-jet mode region (Figure 5.3B) but a small amount of polymer blocked the 
silicon rubber tube connected to the needle, and this made it difficult to maintain the 
electrospray. Decreasing the polymer concentration to 15%wt avoided blockage and 
spraying conditions of 5.8 kV and 4 µl/s were chosen for 15 wt% solution as these 
resulted in the homogenous film forming conditions (Figure 5.3B).  
 
5.3. Ultrasonic atomization spraying 
This method utilizes vibrations, supplied by a voltage applied through an ultrasonic 
generator, to create capillary waves, with small wave length and high frequency, on 
the  surface  of  a  liquid.  Tehrefore,  there  are  so  many  variables  to  optimise  the 
procedure of atomization. 
 
5.3.1. Parameter optimisation 
Varying  parameters  of  the  atomization  process  permitted  the  modification  of  the 
patterns present on the surface and the thickness. Sprayed films were prepared for 
different parameter values in accordance with the Taguchi method (Taguchi 1986) 
(Table 5.2). Here, the Taguchi method allowed three parameters to be investigated   171 
with  three  levels  of  variability  (polymer  flow  rate,  voltage,  and  time)  and  five 
parameters with two levels of variability (temperature, distance from nozzle, polymer 
concentration, gas flow rate, and drying conditions) in 12 experiments. In contrast, to 
test all contribution of variables, 59 (3
3 +2
5) experiments would be required.  
 
Table 5.2: Taguchi orthogonal array method for parameter testing. 
Sample 
Number 
Polymer 
Flow 
Rate 
(m
3/h) 
Applied 
Voltage 
(V) 
 
Time of 
spraying 
(hour) 
Temp. 
(°C) 
Distance of 
the substrate  
from Nozzle 
(mm) 
Polymer 
Conc. 
(wt%) 
Gas 
Flow 
×10
-4 
(N/m
2) 
Drying 
Condition 
1  10  11  1  37  90  2  4  Oven 
2  10  15  3  57  90  2  3  Room 
3  10  20  2  37  90  5  3  Room 
4  10  11  3  37  70  2  4  Room 
5  15  15  2  57  90  2  3  Oven 
6  15  20  1  37  70  5  4  Oven 
7  15  15  3  57  70  5  4  Room 
8  15  11  1  57  70  5  3  Room 
9  18  20  2  37  90  5  4  Oven 
10  18  11  2  57  70  5  4  Room 
11  18  20  3  57  70  2  3  Oven 
12  18  15  1  37  90  2  3  Oven 
 
5.4. Film characterization 
5.4.1. Surface morphology 
Surface morphologies of the films deposited on stainless steel prepared from the 15% 
polymer  solution  are  shown  in  Figure  5.4,  after  1  hour,  2  hours  and  3  hours  of 
electrospraying. These reveal their very uniform non-porous films were produced by 
this method after 1 hour of electrospraying, while the films prepared after 2 and 3 
hours showed a porous structure. The shorter the electrospraying time, the thinner the   172 
layer thickness and the denser the deposited film (Figures 5.4D-F). Similar results 
have  been  reported  in  other  studies  (Nguyen  &  Djurado  2001).  It  is  known  that 
droplets generated during spraying will have varying spreading times on a substrate 
due to surface tension between the substrate and the spraying medium (Chen et al. 
1996). The surface energy of the metallic substrate is greater than that of the polymer 
solution.  The  accumulation  of  polymer  results  in  reduced  surface  energy  on  the 
deposited  substrate.  When  deposition  time  and  layer  thickness  are  increased,  the 
droplets spread slowly on the surface of the denser preceding layer, which has smaller 
surface energy than stainless steel, leading to the formation of a porous top layer. 
With a deposition time of 3 hours, the top surface is very porous. 
 
The thickness of EHDA films deposited in this work increased parabolically with 
electrospraying time (Figure 5.5). Electrosprayed film thickness was about 50 µm 
after spraying for 2 hours. It can be concluded that as the film thickness increased, the 
stability of the cone-jet mode was affected. This is because the polymer coat acted as 
a dielectric layer in the electric field and this made droplet deposition and thickness 
control difficult (Pareta & Edirisinghe 2006).  
 
The use of a Taguchi orthogonal array allowed for the seven different parameters in 
ultrasonic  atomization  spraying  to  be  altered  and  assessed  with  minimal 
experimentation.  The  results  of  SEM  are  shown  in  Figure  5.6.  The  most  striking 
observation from the SEM images below is the presence of dried polymer residue on 
the surface of samples 3, 6, 7, 8, 9 and 10, all of which are sprayed using a polymer 
concentration of 5 wt%. It is also possible to determine the polymer droplet size, and 
therefore  the  surface  smoothness  from  the  SEM  images.  This  was  achieved  by   173 
averaging the diameter of particles at ×160 magnification for each sample. Droplet 
size was assessed by measuring the diameter of 10 visible droplets from the SEM 
images and taking the average. The results are shown in Table 5.3. 
 
Table5. 3. Droplet sizes of 12 samples sprayed with POSS-PCU2 with different parameters. 
Sample  Droplet size Distribution  
(µm) 
Mean Droplet Size (µm) 
1  62 – 137  99 
2  97 – 165  131 
3  56 – 125  91 
4  46 – 88  67 
5  90 – 145  118 
6  46 – 125  85 
7  115 – 159  137 
8  55 – 157  106 
9  66 – 106  86 
10  71 – 179  125 
11  73 – 228  151 
12  78 – 108  93 
 
It is obvious to see that the droplet size is related to the spraying temperature (Figure 
5.7). This graph clearly shows that a lower spraying temperature leads to a smaller 
droplet diameter. The graph clearly show that lower spraying temperatures lead to a 
reduced  droplet  diameter  (p  value  =  10
-6;  p  value  <  0.001  shows  significant 
difference),  and  therefore,  by  extension,  a  more  irregular  surface  morphology. 
Samples 1, 3, 4, 6, 9 and 12 were all sprayed at 37°C and showed a smaller mean 
droplet diameter, and therefore a less smooth surface when compared with samples 
sprayed at 57°C. An unpaired, 2-tailed T-test showed that this result is statistically 
significant (p value= 10
-6; p value < 0.001). Sample 12 was deemed to have the most 
favourable surface morphology as there was minimal polymer residue and a small   174 
mean  droplet  size.  Parameter  testing  was  performed  to  ascertain  the  optimal 
parameters for spraying stents with POSS-PCU2 by ultrasonic atomization spraying. 
The SEM images show that polymer residue forms when a polymer concentration of 5 
wt% is used. This is most probably due to incomplete spraying. At higher polymer 
concentrations,  the  viscosity  is  higher  and  it  is  therefore  more  difficult  to  create 
capillary waves with high enough amplitude to break up into droplets. This leads to 
‘spitting’  of  larger  drops  which,  when  once  the  solvent  has  evaporated,  result  in 
residue. This residue could break-off if implanted and cause hypersensitivity reactions 
and  thrombus  formation.  A  polymer  concentration  of  2  wt%  seems  to  be  more 
compatible with ultrasonic atomization spraying and spraying with this concentration 
leads to minimal residue formation, and is thus more suitable for use in stent coatings. 
The surface smoothness was assessed by measuring the mean diameter of droplets. A 
smaller mean droplet diameter results in a more uneven surface. This may be because 
at higher temperatures the solvent evaporates quicker, whereas at lower temperatures, 
the slower solvent evaporation allows a degree of cohesion to occur before all of the 
solvent evaporates, reducing the mean droplet diameter. A lower spraying temperature 
therefore leads to a more uneven surface. An uneven surface also aids in ‘trapping’ 
circulating endothelial progenitor cells (Cabanlit et al. 2007b). A more uneven surface 
may therefore aid endothelial healing and reduce the risk of late thrombosis. 
 
5.4.2. Mechanical properties 
The tensile strength of the cast films is shown in Figure 5.8. The results show the 
nanocomposite  polymer  behaves  like  elastomer.  The  tensile  strength  of  the  films 
varied between 40-57 N/mm
2. 
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The stress-strain curves of electrosprayed polymer films within the thickness range of 
30 µm to 100 µm are given in Figure 5.9. The maximum attainable strain was 300%. 
The results demonstrated a thickness dependent stress–strain relationship at the size 
scale of a coronary stent; the typical thickness of a stent is 100 µm (De Beule et al. 
2007). These results agree well with SEM images. As shown in Figure 5.9, tensile 
strength was inversely proportional to the film thickness and this could be due to the 
presence of increased porosity at higher film thicknesses. 
 
The  ultrasonic  prepared  polymer  films  were  prepared  according  to  the  parameters 
shown in Table 5.4. These films were used for further characterization. The times 
were varied to alter the thickness of the polymer coating.  
 
Table 5.4. Set of parameters used for films preparation for tensile testing and ICP/MS. 
  Parameter       Value 
Polymer solution flow rate  18ml/hr 
Applied voltage  15 V 
Time of spraying  0.5,  2,  2.5 ,  3 hours 
Temperature of the chamber  37°C 
Distance of substrate from spray nozzle  9cm 
Polymer solution concentration  2 wt% 
Gas flow rate  0.3 bar 
Drying condition of the sprayed films  Oven (60° C) 
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Tensometry  of  cast  and  ultrasonic  sprayed  samples  of  different  thicknesses  was 
performed and the results are shown in Figure 5.10. The results show that, at 49 and 
68 µm, the maximum tensile stress before breaking for both cast and sprayed samples 
were very similar, with a mean maximum stress of 45±2 MPa for cast samples and 
44±2 MPa for sprayed samples. However, there wasis a more difference between cast 
and sprayed samples at 23 and 31 µm, with a mean maximum stress of 38±3 MPa for 
cast samples and 33±4 MPa for sprayed samples. The mean elongation at break for 
cast POSS-PCU2 samples was 530%, whereas that of sprayed samples was 556%.  
 
5.5. Comparison of endothelialisation of sprayed and cast films 
5.5.1. Cell adhesion and proliferation 
Alamar Blue (AB) is a non-toxic, simple assay which quantifies cell viability, cell 
proliferation  and  cytotoxicity.  This  aqueous  dye  is  stable  in  solution  and  will  not 
affect cell metabolism when added to cell culture media. Cell metabolism results in 
chemical reduction of colourimetric oxidation reduction indicators incorporated into 
the  dye;  resarfurin  and  resazurin.  This  colour  change  may  be  measured  using  a 
colorimetric machine.  
 
The calibration study reveals a linear increase of absorbance with the number of cells 
(Figure 5.11) showing that the amount of dye metabolised by the cells is an indicator 
of the number of cell adherent in this case. The colour change from blue to pink was 
taken  as  a  measure  of  the  overall  metabolizing  capacity  of  these  cells.  After 
appropriate calibration, the AB assay was found to be equivalent to established cell 
proliferation assays. AB cell viability assay showed that sprayed films promoted cell 
adhesion and cell viability. Quantitative analysis of HUVECs attachment on POSS–  177 
PCU2  studied  with  AB  showed  a  significant  increase  in  mean  endothelial  cells 
attachment at 72 hours compared with cast films (Figure 5.12).  
 
5.5.2. Cell morphology 
SEM  images  also  confirmed  the  endothelial  cells  adhered  to  POSS-PCU2  films 
(Figure 5.13). HUVECs were adherent to polymer films at 72 hours. SEM clearly 
visualised the presence of optimal cell – polymer interactions with the formation of 
numerous  filopodia  at  its  surface,  flattened  ECs  and  no  rounded  cells.  Cell 
morphology was consistent with healthy metabolizing cell spread across the films. 
This suggests that these ECs were capable of morphogenesis and had the ability to 
proliferate well.   
 
Cells  were  shown  to  adhere  to  both  cast  and  sprayed  films.  Although  cast  films 
although showed a good percentage of cell coverage after 72 hours, coverage was still 
less than for the sprayed POSS-PCU2 film, which was fully covered by HUVECs. 
Surface area of the POSS-PCU2 films covered by cells appeared to be greater on 
sprayed  samples  compared  to  cast  film.  The  surface  morphology  of  POSS-PCU2 
sprayed films was shown to have a rough undulating surface (Figure 5.13A). AB cell 
viability assay showed that sprayed films promoted cell adhesion and cell viability.  
 
Ultrasonic atomization spraying therefore created a favourable surface roughness, and 
ECs  adhered  well  to  the  nanocomposite  surface.  So,  it  can  be  concluded  that 
ultrasonic  atomization  spraying  provided  a  surface  that  encouraged  endothelial 
progenitor cells growth (EPCs) and migration. Uneven surfaces have been shown to 
promote EPC growth and migration and in the case of vascular stents, an uneven   178 
surface  also  aids  in  ‘trapping’  circulating  EPCs  (Cabanlit  et  al.  2007a).  Cell 
metabolism  increased  between  8  and  72  hours  for  both  those  seeded  onto  tissue 
culture plastic (TCP) or polymer. Based on the results, this coating technique offers 
versatility of architecture and supports endothelial cell adherence and proliferation. So 
spraying  the  POSS-PCU  nanocomposite  provides  a  suitable  technology  for  stent 
coating applications. 
 
In  summary,  electrohydrodynamic  and  ultrasonic  atomization  spraying  approaches 
have been applied to POSS-PCU nanocomposite polymer coating for metallic stents. 
POSS-PCU  can  be  successfully  subjected  to  electrospraying  and  ultrasonic 
atomization spraying. In this research, polymer stent coatings have been formed with 
nearly linear control over the film thickness with electrospray deposition time. This 
has  possible  application  for  stent  design,  especially  in  smaller  stents  including 
coronary and peripheral arterial applications. The tensile strength of the films varies 
as a function of coating thickness and therefore it is of immense importance to be able 
to  control  the  film  thickness  while  forming.  As  a  comparison,  poly(styrene-b-
isobutylene-b-styrene) (SIBS), the polymer used on the Taxus™ stent, has a reported 
tensile strength of 9.4MPa (the tensile strength repoted > 20 MPa in this study) and an 
elongation at break of 592% (elongation at break > 400% in this study) and the stress 
to strain failure of arteries and veins is up to 260% (Antony, Puskas, & Kontopoulou 
2003;  Lee  &  Haut  1992).  POSS-PCU2,  whether  cast  or  sprayed  has  comparable 
mechanical  properties  to  the  SIBS  polymer,  which  is  currently  widely  used  as 
coronary stents and the stress to strain failure is far superior to that of arteries and 
veins. Surface morphology revealed that POSS-PCU coated stents by spraying would   179 
have  a  surface  morphology  that  promotes  EPC  growth  and  therefore  improve  the 
healing process.  
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Figure 5.1. The electrohydrodynamic spraying set up for stainless steel coating. 
The rotating centre is 8 mm away from the jet.  
 
 
 
 
 
 
 
 
   181 
 
Figure 5.2. Electrohydrodynamic spraying modes obtained from 10 wt% polymer 
solution at a flow rate of 8 µl/s; (A) dripping mode at 4 kV; (B) unstable cone-jet 
mode at 5.6 kV; (C) stable cone-jet mode at 6.1 kV; (D) rim emission at 5.8 kV; (E) 
Precession mode at 8.2 kV; and (F) multi rim emission at 9.5 kV. 
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Figure 5.3. Mode Selection map for: (a) 10wt%; (b) 15 wt%; and (c) 20 wt% polymer 
solution (needle diameter: 300  m, distance from the substrate: 250mm). The 
different modes presented are: (A) dripping mode; (B) unstable cone-jet mode; (C) 
stable cone-jet mode; (D) rim emission mode; (E) precession mode; (F) multi-rim 
emission.   183 
 
 
 
Figure 5.4. Morphology of the electrosprayed films after (a, d) 1 hour, (b, e) 2 hours, (c, f) 3 
hours. 
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Figure 5.5. Film thickness as a function of electrospraying time. 
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Figure 5.6. SEM images of polymer films. Each sample is displayed at left) ×160 and right) 
×1250 magnifications (A-F represent sample numbers 1-6 respectively as defined in Table 
5.2). Continued   186 
 
Figure 5.6. SEM images of polymer films. Each sample is displayed at left) ×160 and right) 
×1250 magnifications (G-I represent sample numbers 7-12 respectively as defined in Table 
5.2).   187 
 
 
 
Figure 5.7. Graph showing the relationship between spraying temperature and mean polymer 
droplet diameter. 
 
 
 
Figure 5.8. Tensile strength of cast films. 
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Figure  5.9.  Comparison  of  tensile  stress  between  films  prepared  by  electrohydrodynamic 
spraying with different thicknesses. 
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Figure 5.10.  Comparison of tensile stress between films with different thicknesses. 
Films prepared by: (A) casting; and (B) ultrasonic atomization spraying. 
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Figure 5.11. Alamar Blue standard calibration curve for HUVECs. 
 
 
 
Figure 5.12. Alamar Blue viability assay on HUVECs exposed to POSS-PCU2 
nanocomposite for 8 and 72 h. 
Keys: 
 ** p<0.05 Significant against cast. 
•  p>0.05 Not significant against sprayed. 
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Figure 5.13. Scanning microscopy images of nanocomposite surface prepared by 
ultrasonic atomization (A). HUVECs adhered to nanocomposite after 24 hours on film 
surface prepared by casting (B);  and ultrasonic atomization spraying (C). Inset: 
Images show that the percentage of cell coverage on sprayed film is more than that on the cast 
film.   
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CHAPTER 6.  Surface Modification of NiTi to 
Enhance Bonding of Nanocomposite 
 
This  chapter  presents  an  innovative  approach  to  self-expanding  coronary  stent 
preparation. The aim of this work was to coat NiTi stent alloy with POSS-PCU2 and 
increase the stability of the coating. In prolonged applications in the human body, the 
corrosion of the NiTi alloy can result in the release of deleterious ions which leads to 
unwanted biological reactions. Coating the NiTi surface with POSS-PCU can enhance 
surface resistance, reduce Ni release and therefore improve biocompatibility. Failure 
of the coating in vivo, reduces the efficiency and imparts even more complexity to the 
implant including formation of debris which can induce thrombus formation. 
 
In the Chapter 4, POSS-PCU hybrid nanocomposites with different formulations were 
been characterised in terms of bulk properties and most importantly surface properties 
which affect the blood/tissue interaction in vivo. POSS-PCU2 has been chosen for the 
stent  coating  stents  application.  In  Chapter  5,  electrohydrodynamic  spraying  and 
ultrasonic atomization spraying methods were investigated in order to apply POSS-
PCU  nanocomposite  polymer  to  metallic  stents  (Bakhshi  et  al.  2008).  Both  these 
investigations in the previous chapters involved choosing the material and coating 
technique with ideal characteristics for coating stent technology.  
 
This research describes surface modification to promote bond strength between the 
POSS-PCU2 nanocomposite and the surface of NiTi strips. The aim is to develop 
protocols with the potential for effective bonding of the nanocomposite polymer to   193 
NiTi in the development of stents; including coronary or peripheral stents. In this 
work  the  stability  and  the  integrity  of  the  POSS-PCU2  coating  in  pseudo-
physiological  solutions  is  also  evaluated  to  determine  whether  the  surface 
modification applied retains its effectiveness long-term. Prior to deposition the NiTi 
was surface modified. The peel strength of the deposit was studied before and after 
degradation of the coating. 
 
6.1. NiTi alloy superelastic properties 
Figure 6.1 shows the stress-strain curve obtained for the NiTi strip. In the first loading 
cycle, the specimen was tensioned to a stress of approximately 650 MPa before being 
unloaded. This stress was high enough to induce a full transformation, with a stress-
strain  curve  following  a  nonlinear  loop  that  is  characteristic  of  the  superelastic 
response of Nitinol. This behaviour confirms that the material is fully superelastic at 
room  temperature.  Quantitative  analysis  of  the  stress-strain  curve  shows  that  the 
Young’s modulus of the material varies greatly across its superelastic strain range.  
 
6.2. Surface characterization of NiTi after surface modification 
6.2.1. Assessment of oxide layer thickness 
At the end of the anodisation process, the sample surface appeared dark brown and 
was free of cracks, which is an indication of oxygen efficiency. Figure 6.2 shows the 
cross-sectional  views  of  the  NiTi  strips  before  and  after  anodisation.  After 
anodisation,  the  thickness  of  the  strip  increased  by  20   m  and  this  indicates  the 
formation of a uniform oxide layer (Figure 6.2B). The measurement of the thickness 
of this layer was estimated up to the curvature which leads to the base of the metallic 
strips. These measurements compare well with the 17µm reported by Cheng et al.   194 
(Cheng et al. 2005) who used a similar process and deposition time. However, these 
values are significantly higher than those achieved using other methods of preparing 
oxide layers on NiTi alloys. For example, oxide layers with a thickness of ~0.5µm 
have been prepared using solution-based oxidation with hydrogen peroxide (Hu et al. 
2007). Furthermore, much finer oxide coatings (2 nm) can be prepared  by controlling 
the partial pressure of oxygen in a selective oxidation process, but this requires more 
sophisticated equipment including the use of atmospheric sensors (Pohl et al. 2008).   
 
A current density of 3×10
-2 mA/mm
2 was selected for the anodization process. This 
value  was  selected  based  on  previous  studies  (Cheng  et  al.  2005),  although  the 
thickness of the NiTi strips in this application is much thicker (2mm compared to 
0.5mm). With the anodisation process lasting for three hours, it was anticipated that 
during this procedure the anode potential rises with time and can reach a value of 
1.15V, and these measurements have been used as indicators of coating thickness. It is 
postulated  that  TiO2  is  formed  as  a  result  of  hydrolysis  and  polycondensation  of 
titanium methoxide in the presence of water (Cheng et al. 2005). Even if the surface 
layer is nickel oxide, it still provides a suitable platform for binding of aminosilane, 
since an oxide layer is required for silanisation. Electrolytic methods have been used 
to coat surfaces of NiTi alloys. For example thin tantalum coatings on NiTi alloys 
enhance resistance to corrosion when placed in a 3.5% NaCl solution (El Abedin et al. 
2005).  
 
Figure 6.2C shows the thickness of the modified NiTi strip was reduced by ~5µm 
after heat treatment at 600°C for 1hr; compared with the thickness before heating. 
Hence on heating, densification occurs and the thickness of the coating is reduced.   195 
The  structure  of  these  coatings  (Figure  6.2)  shows  the  existence  of  micro  to 
nanoscaled pores within the coating layer. Some pores are still evident in the post-
heated coating, which means that an optimal heating temperature or time is desired. 
The aging of the oxide layers by heat treatment is also believed to reduce the ion 
dissolution and improve its alloy biocompatibility, which makes the material ideal for 
its application (Wisbey et al. 1991). However, it should be noted that the mechanical 
response of the material is affected by heat treatment. A study of this effect has been 
carried out previously (Liu et al. 2008). It showed that the material’s austenite phase 
formation end temperature, which is critical to superelastic response, increases after 
heat  treatment  and  is  a  function  of  heat  treatment  time  and  temperature.  Careful 
management of the heat treatment process can be used to optimise the mechanical 
response of the material for the requirements of an intravascular device. Simply by 
changing the temperature and duration of the heat treatment, one can optimise the 
procedure to maintain superelastic properties of the NiTi (Liu et al. 2008).  
 
6.2.2. Surface topography  
The  surface  morphology  varies  markedly  between  anodised  and  anodised-heat 
modified strips (Figure 6.3). Anodized samples present micro-scaled topographical 
variations of the surface which consist of valley and mountain like features. Upon 
thermal oxidation which reinforces the initial oxidation process from the anodisation 
procedure, smaller sized nano-scaled peaks develop which make the surface more 
even. This is largely due to coalescence of the oxide layer, which results in a more 
homogenous surface.  
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6.2.3. Surface chemical mapping 
The  oxygen  (O)  peak  in  the  spectrum  obtained  for  anodized  NiTi  confirms  the 
presence of an oxide layer through anodisation (Figure 6.4B). The O peak observed 
has the same order of intensity as the titanium peak; the major alloying element of 
NiTi. The intensity of the Ni peak is less than that of the Ti peak which favours 
biocompatibility since it reduces the risk of nickel release.  
 
As  described  earlier  in  experimental  details  (Chapter  3),  the  silanisation  process 
involves  four  steps;  namely,  hydrolysis,  condensation,  hydrogen  bonding  and 
crosslinking. Control of each step will affect the efficiency of the whole process. To 
optimise the silanisation process, a few parameters were altered such as hydrolysis 
time,  concentration  of  silane  solution  and  pH.  These  parameters  were  changed  in 
accordance  to  the  Taguchi  method  (Taguchi  1986)  as  shown  in  Table  6.1.  The 
Taguchi method for parameter optimisation allows the effect of multiple parameters 
on a performance characteristic to be assessed in a condensed set of experiments. For 
example, in the Table 6.1, the Taguchi method has allowed three parameters with two 
levels  of  variability  (hydrolysis  time,  concentration  of  silane  solution,  pH)  to  be 
assessed in four experiments. In contrast, to test all variables, eight (2
3) would be 
required.  
Table 6.1. Orthogonal Arrays for parameter testing. 
Parameters  Experimental 
Number  Concentration of 
silane solution/ vol% 
pH  Deposition  
time/ min 
1 (A)  2  4  15 
2 (B)  2  8  60 
3 ( C)  5  4  60 
4 (D)  5  8  15 
Key: The amount of Si in Table 6.2 is calculated according to the experiments in Table 6.1.   197 
The  chemical  composition  of  the  NiTi  surface  after  different  silane  modification 
conditions is compared in Table 6.2. The strip under modification (A) is rich in Si 
uniformly in all regions whereas hardly any Si could be detected on all the regions 
selected for the rest of the surface by SEM/EDX.  Energy dispersive X-ray analysis 
(EDX)  analysis  on  the  whole  surface  showed  Si  peaks  of  moderate  intensity 
indicating that a 5% silane solution at pH=4 and 1 hour deposition results in a rather 
uniform silane film. The hydrophobic siloxane layer is usually ten molecular layers 
thick (up to 800 nm), depending on the silane concentration (Sundararajan & van Ooij 
2000; van Ooij et al. 2006). 
 
The  chemistry  of  the  NiTi  surface  after  each  step  of  surface  treatment  has  been 
studied by X-ray Photoelectron Spectroscopy (XPS). In contrast to EDX, XPS has 
much  higher  surface  sensitivity  (probing  depth  in  the  nm  rather  than  mm  range). 
Figure 6.5 shows typical XPS survey spectra of the surfaces of the NiTi strip. The 
analysis  of  all  observed  peak  intensities  in  the  survey  XP  spectra  allows  a 
quantification of the elemental composition of the surface region probed by XPS. The 
surfaces  of  four  samples  were  analysed:  NiTi  alloy  as  received,  NiTi  after 
anodisation, NiTi after heat treatment at 600 °C and NiTi after silanisation. Relative 
atom concentrations (at %) of all elements found are summarized in Table 6.3. 
 
The as-received sample showed a surface dominated by a relatively thick layer of 
carbon  and  oxygen.    There  was  a  clear  preference  for  a  ‘capping’  layer  of  TiO2.  
Nickel was detected at low levels, due to attenuation by the carbon/oxygen/titanium 
over layers. Analysis of the C(1s) and O(1s) high resolution scans suggest a large 
degree of hydrocarbon contamination on the surface together with carbide. Survey   198 
scan revealed that the surface also consisted of N, Na, Cl, Ca and Si. The Si content 
on  the  surface  was  due  to  the  lubricant;  which  disappeared  after  cleaning  and 
anodisation. The presence of C may be attributed to surface contamination by carbon-
containing molecules absorbed from the environment. 
 
Table 6.2. Composition of the Si compositions (in wt.%) measured by EDX for different 
silane modification scenarios. A) 2%, 15min, pH=4; B) 2%, 1hour, pH=8; C) 5%, 1hour, 
pH=4; D) 5%, 15min, pH=8; 
 
 
 
 
 
 
 
 
 
Key: × Si is not detectable because the silane concentration in that area was lower than the 
range detectable by EDX. 
Table 6.3. Surface composition obtained from the quantification of the XPS survey spectra. 
NiTi alloy  
(As received) 
Anodized NiTi    Heated treated  
NiTi at 600°C 
Silanised NiTi   
Element 
At. 
% 
BE 
eV 
At. 
% 
BE 
eV 
At.  
% 
BE 
eV 
At. 
% 
BE 
eV 
O 1s  34.47  530.41  46.62  530.03  48.89  530.01  49.36  530.034 
C l s  54.15  284.912  27.39  285.03  25.44  285.51  28.31  285.34 
N 1s  1.04  399.91  1.01  398.53  0.96  399.51  3.36  400.34 
Si 2s  3.99  152.91  ×  ×  ×  ×  3.98  153.84 
Ti 2p  3.34  458.41  10.24  458.03  12.72  458.51  7.51  458.34 
Ni 2p  1.00  855.41  4.76  855.53  4.84  855.01  6.85  855.34 
Ca 2p      0.86  384.03  0.26  347.01  0.64  346.84 
Na KLL  1.41  495.41  8.22  495.53  5.19  496.51     
Key: × is not detectable. BE: Binding energy 
Spectrum  A  B  C  D 
         
Spectrum 1  1.68  1.33  0.48  × 
Spectrum  2  3.11  ×  0.31  0.68 
Spectrum  3  0.89  ×  0.94  × 
Spectrum  4  0.62  0.58  0.90  0.53 
         
Average  1.57  0.48  0.66  0.30   199 
The dominant elements after anodisation process were O, C, Ti. The anodized sample 
showed a surface more enriched in Ti compared to the NiTi as received. Ni content 
had also increased, but not as much as Ti. Titanium is again in a TiO2 like form, but 
exhibited broadening to low binding energy, possibly due to a lower oxidation state of 
titanium (e.g. Ti(III)). Other elements present on the surface were: N, Ca, Cl and Na.  
The Na content was much higher than in the NiTi as received. This might be because 
of the anodisation has been done in sodium nitrate solution in methanol. Si was not 
detected in the sample after cleaning and anodisation.  
 
The heat treated sample again showed preference for Ti (as TiO2) at the surface.  C, 
N, Na, Ca, Cl and Si were also present. Ni was present as Ni(II), the shape of the 
spectrum was characteristic of NiO. It is worth noting that the heat treatment process 
had affected the Ti content more than Ni. The surface Ti concentration of the heat 
treated sample could be as high as 12.72 at%. These results suggest that the anodized 
sample  was  covered  by  a  titanium  oxide  film.  The  silanised  sample  showed 
preference for Ti (as TiO2) at the surface. No sodium was detected. N (1s) intensity 
was  increased.  High  resolution  scans  of  N(1s)  level  revealed  two  nitrogen  states, 
399.4 and 401.2 eV. The former may be characteristic of NHx-like species, whereas 
the latter is more than likely associated with a surface bond. This is because of the 
NH2 group in 3-aminopropyltriethoxysilane used in the silanisation process. Detection 
of the Si signal also indicates silanisation has occurred.  
 
The  coating  method  had  three  steps  where  the  anodisation  process  involved  the 
formation of an oxide layer which then reacted with 3-aminopropyltriethoxysilane. 
The final step involved the binding of the free isocyanate groups in the polyurethane   200 
nanocomposite with the free amine groups of the 3-aminopropyltriethoxysilane. The 
schematic illustration of these bonding mechanisms between the reagents and NiTi 
strips is shown in Figure 6.6. 
 
6.3. Bonding strength 
The approach employed was based on the ASTM D413 standard, which is used to 
determine the force per unit width required to separate a rubber layer from a flexible 
substrate such as fabric, fibre, wire, or sheet metal ( 2007). The standard describes 
methods for peeling the strip with the unpeeled portion held to give α° separation 
with moving grips. The adhesion strength is equal to the mean force recorded during 
the test.  
 
The  cross  section  of  the  polymer  coatings  deposited  by  EHDA  and  casting  on 
modified NiTi are compared in Figure 6.7. Castings (Figure 6.7A) produced a more 
uniform coating than electrospraying  (Figure 6.7B, C).  In  addition, in the case of 
electrosprayed coatings the thickness could be varied very effectively by adjusting the 
spraying  time.  Peel  strength  data  (Figure  6.8)  confirmed  that  a  significant 
improvement  in  adhesion  could  be  achieved  by  using  the  described  modification 
procedures in experimental details (Chapter3). Analysis of the data showed that above 
an extension of 25 mm the load required to remove the polymer from the modified 
strip for all the samples was, on average, three times greater than that for the control. 
 
There was no significant difference between the bonding strength as a result of the 
different  coating  methods  (Figure  6.8).  Considering  EHDA  deposition,  the  peel 
strength of the 100  m thick polymer coating was slightly greater than that for the 50   201 
 m thick coating. It should be noted that below an extension of 10 mm, all the curves 
of the modified specimens showed a positive slope. In this range the applied load was 
not high enough to break the bond between the polymer and the strip; however, the 
applied extension caused the exposed polymer (i.e. the polymer that was manually 
peeled from the strip) to strain. The initial region of the curve should be ignored and it 
is not significant to the overall peel strength measured. It is possible to apply a coating 
thickness  of  <  10   m,  however  such  specimens  were  difficult  to  handle  for  peel 
strength  testing.  So,  the  specimen  thickness  used  in  this  study  was  increased  to 
facilitate peel strength testing. The proposed surface treatment can be applied to a 
range of strut/wire thickness. Yin Y. et al. (Yin et al. 2009) used the same peel test 
technique for assessment of bond strength of the coating on metal surfaces. 
 
Stainless  steel  is  another  metal  widely  used  in  the  construction  of  commercially 
available coronary stents. To see how surface treatment utilized in this work may 
influence the functionality of stainless steel; the same protocol for surface treatment 
was applied on stainless steel substrates. Upon applied silanisation process, a about 
three times improvement in the bond strength observed compared to the non-treated 
stainless steel. The results show that this surface treatment protocol is still effective 
when stainless steel material is used as the stent for coating. Results are shown in 
Appendix B.  
 
6.4. Coating durability 
The susceptibility of POSS-PCU2 coated-NiTi to instability was assessed in vitro by 
incubating the coated strips that had been modified in biological/chemical solutions, 
as were un-modified samples. These solutions included hydrolysis with lysosomal   202 
enzymes, plasma protein fractions (I-IV), oxidation and peroxidation with distilled 
water as control. More details of the solutions have been described in experimental 
details (Chapter 3).  
 
The surface topography of the aged samples is shown in Figure 6.9. Topographic and 
structural changes due to aging can influence the adhesion properties of the coating, 
leading to coating failures. The nanocomposite polymer coating incubated in distilled  
water characteristically showed a smooth and uniform surface (Figure 6.9A). Also, no 
cracks or failure of the coatings were observed for the polymer coating subjected to 
hydrolysis (Figures 6.9B, C). The coating exposed to plasma fractions still appeared 
uniform, which indicates sufficient interfacial adhesion (Figures 6.9D, E). Pores or 
surface cracking was visible on the surface of the nanocomposite exposed to oxidative 
degradation (Figure 6.9F).  Incubation of the POSS-PCU in oxidative environment 
such as t-butyl peroxide in the presence of cobalt chloride as the catalyst resulted in 
increased surface degradation (crack formation). This effect was more pronounced 
with the H2O2 systems (figure 6.9G). Therefore, the nanocomposite coating incubated 
in oxidative solutions did not exhibit the required resistance to oxidative environment. 
As summary of the results are shown in Table 6.4. 
 
Three modes of chemical degradation predominate in vivo: mineralisation, hydrolysis 
and  oxidation.  In  recent  years  it  has  become  apparent  that  polyurethanes  are 
particularly  susceptible  to  the  latter  two  processes,  both  of  which  lead  to  the 
phenomenon of environmental stress cracking. 
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POSS-PCU  appeared  resistant  to  both  PLA  and  CE  as  judged  by  a  lack  of 
environmental surface cracking (ESC). ESC was observed in POSS-PCU2 exposed to 
the H2O2/CoCl2 mixture, and most particularly to the t-butyl peroxide mixture. Zhao 
et  al  proposed  that  plasma  proteins  were  able  to  act  as  ESC  promoters  in 
poly(ether)urethanes,  although  the  mechanism  of  action  remains  unknown  (Zhao 
1991). Notably, POSS-PCU showed no ESC compared to water incubated controls.  
 
Table 6.4. Effect of aging solution on POSS-PCU2 coating surface. 
Solution  Surface cracks  observed 
in SEM images 
H2O 
Plasma fraction I 
Plasma fraction II 
Plasma fraction III 
Plasma fraction IV 
Phospholipase A2 
cholesterol esterase 
hydrogen peroxide/cobalt chloride 
tert-butyl peroxide/cobalt chloride 
-  
- 
- 
- 
- 
- 
- 
+ 
+ 
 
The H2O2 (Co) solution provides an oxidative reaction comparable to that observed in 
the  functional  activity  of  the  inflammatory  cells  in  response  to some  biomaterials 
(Hooper 2000). However, a solution concentration of 1.63 M H2O2 -which is very 
high compared to that reported by Lee et al. (Lee 2007), which is < 20µmol- was 
used. 
 
Some  biomaterials  influence  the  functional  activity  of  inflammatory  cells,  so  an 
increase in release of hydrogen peroxide by cells is observed (Hooper 2000). In some 
instances, material-mediated inflammatory responses may even cause degradation of 
the  material  itself  (via  oxidative  products  released  by  implant-associated   204 
inflammatory cells) (Tang 1995). In vivo, such degradation is caused or enhanced by 
the  action  of  metabolic  products  such  as  hydrogen  ions,  lysosomal  enzymes  and 
peroxides released from the adherent leukocytes and foreign body giant cells at the 
cell-polymer interface (Zhao 1991). In the study by Lee et al. (Lee 2007) hydrogen 
peroxide generated by activated macrophages and neutrophils, in a lipopolysaccharide  
model of acute inflammation was imaged using peroxalate nanoparticles. Although 
H2O2 (Co) solution provides an oxidative reaction comparable to that observed in the 
respiratory burst of adherent macrophages and foreign-body giant cells (Zhao 1993), 
the concentration used in this work (1.63 M H2O2) was very high compared to that 
reported by Lee et al (Lee 2007), which is < 20µm. 
   
In this study, peel strength analysis showed that, in spite of accelerated degradation, 
the  coating  showed  no  significant  difference  in  adhesion  properties  between  the 
control,  hydrolytic  and  plasma-degraded  nanocomposites  (Figure  6.10).  This  is  an 
indicator of the stability of the surface modification applied and coating durability to 
these  types  of  in  vitro  degradation.  When  compared  to  the  similar  experiments 
performed  on  non-modified  NiTi,  the  modified  NiTi  showed  significantly  greater 
stability in a degradative environment. In fact, the non-modified specimens lost their 
polymer coating completely after a few weeks. The surface modification proposed 
retained its effectiveness to promote coating adhesion to the NiTi. It is important to 
note however that in the case of H2O2 and t-butyl-peroxide-degraded nanocomposites, 
a decrease in peel strength was observed. Therefore, except in aggressive oxidative 
environments, the polymer coating on the modified NiTi stent alloy withstands effects 
of biological environments without any signs of instability or delamination.  
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The  problem  of  delamination  is  particularly  challenging  with  stent  coating 
applications, and requires full consideration of the interface between the coating and 
the underlying substrate. Ruptures and cracks could be problematic by inducing fast 
restenosis and uneven surface structures are a major cause of thrombogenic events 
with stent implants (Unger et al. 2007). Therefore, coatings are expected to minimize 
the risk of bare metal parts getting into direct contact with tissue throughout the stent 
lifetime.  A  few  studies  have  investigated  the  effect  of  mechanical  strain  forces 
encountered during stent deployment. They have examined the integrity of the coating 
on the stent by studying any sign of cracking or delamination of the coating after 
balloon expansion and implantation (Chen et al. 2005; Cho et al. 2008; Hanefeld et al. 
2006c;  Richard  et  al.  2005;  Sternberg  et  al.  2007;  Unger,  Westedt,  Hanefeld, 
Wombacher,  Zimmermann,  Greiner,  Ausborn,  &  Kissel  2007;  Wang  et  al.  2008; 
Westedt et al. 2006; Zhang et al. 2006).  
 
6.5. Corrosion resistance 
As described in detail in Experimental details (Chapter 3), three set of NiTi strips 
were chosen for corrosion resistance studies. The first group was surface modified 
NiTi strip coated with POSS-PCU2 according to the method which was shown to lead 
to a much greater resistance to decay in peel strength compared to untreated NiTi. The 
second group was untreated NiTi strip coated with POSS-PCU2. Bare NiTi strips 
were chosen as the control. The Ni release from all three groups in plasma fraction I 
and  Dulbecco’s  modified  Eagles’  medium  (DMEM)  was  measured  by  Inductively 
Coupled Plasma Mass Spectroscopy (ICP-MS).  
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The Ni release tests (Figure 6.11) clearly showed the effect of coating NiTi samples 
with POSS-PCU2, even after one hour. In both media, Ni release was much greater 
from the bare NiTi samples, reaching 1521ng/mL in the plasma fraction and 1784 
ng/mL in DMEM after 3 days compared to 3.15 ng/mL and 4.16 ng/mL,  respectively, 
for surface treated sprayed NiTi samples (p value = 3 × 10 
-8, p value < 0.001 which 
shows  a  significant  difference).  In  addition,  there  is  also  a  difference  between 
untreated  POSS-PCU2  coated  NiTi  samples  and  surface  treated  samples.  After  3 
hours, the amount of Ni released from untreated sprayed samples was higher than the 
amount released from surface treated samples, 31.27 ng/mL and 13.77 ng/mL released 
from untreated NiTi samples in plasma fraction and DMEM, respectively, compared 
with 3.514 and 4.163 from surface treated samples (p value = 5 ×10 
-6; p value < 
0.001  which  shows  a  significant  difference).  It  is  also  important  to  note  that  the 
POSS-PCU coated samples (both treated and untreated), not only reduced the amount 
of Ni released, but also significantly reduced the rate at which it was released, shown 
by the minimal change in Ni concentration between 1 hour (6.89±1.97 ng/mL) and 72 
hours (13.32±8.70 ng/mL). This is compared to an increase in Ni concentration of 
more than 1300 ng/mL between 1 hour and 72 hours. Based on these results it is clear 
that  coating  with  POSS-PCU2  reduced  the  amount  of  Ni  released  to  a  negligible 
amount. Surface treatment process of the NiTi strips before coating helped this effect 
further. This process increased the strength of the bond between polymer and NiTi 
and thereby increased the corrosion resistance.  This is of great importance as the 
release of Ni from NiTi can result in tissue damage and therefore delay healing and 
increase the risk of thrombus formation (Berger-Gorbet et al. 1996b; Heintz et al. 
2001b). 
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In summary, an approach for depositing the POSS-PCU2 onto NiTi self-expandable 
stent  is  outlined.  This  involves  pre-modification  of  the  metal  alloy  and 
electrohydrodynamic polymer deposition. The effective surface modification protocol 
has  been  deduced.  The  coating  has  the  potential  to  protect  the  materials  surface, 
mitigate corrosion and increase the longevity of the device in vivo. The results of peel 
strength have shown that a three-fold increase in the bond strength of the POSS-PCU2 
to the metal alloy can be readily achieved upon surface modification. Comparative in 
vitro degradation of the coating on modified and non-modified NiTi was carried out 
and demonstrated the ability of the coating to remain integral with the stent after long 
period (70 days) of exposure to biological environments under static conditions. It is 
also indicated how the adhesion strength of the POSS-PCU2 coating changes post-
exposure to physiological solutions comprised of hydrolytic, oxidative, peroxidative 
and biological media. This part of the study shows that the modified NiTi presents far 
greater resistance to decay in peel strength compared to the non-modified NiTi. Ni 
release  profiles  showed  the  dramatic  effect  that  POSS-PCU  had  on  the  corrosion 
resistance  of  NiTi  samples.  It  is  clear  that  coating  with  POSS-PCU  reduced  the 
amount of Ni released to a negligible level. This effect was exaggerated by surface 
treatment of  NiTi before coating. This process  increased the strength of the bond 
between polymer and NiTi and thereby increases the corrosion resistance. This is of 
great  importance  as  the  release  of  Ni  from  NiTi  can  result  in  tissue  damage  and 
therefore delays healing and increases the risk of thrombus formation (Berger-Gorbet 
et al. 1996a; Heintz et al. 2001a).   208 
 
Figure 6.1. Mechanical response of NiTi strip. 
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Figure 6.2. Scanning electron micrographs showing the cross-sections of oxide coating 
on NiTi: (A) before anodisation; (B) after anodisation followed by; (C) heat treatment 
at 600 °C for 1 h. (Z) schematic view of the NiTi strip. H= thickness of the NiTi strip in 
different stages of surface treatment. 
 
 
 
Figure 6.3. Topography of anodized NiTi samples: (A) before heat treatment; (B) after 
heat treatment at 600°C. The scale in left image is in µm and in the right image is in nm. 
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Figure 6.4. Energy dispersive X-ray spectra of the treated NiTi: (A) as supplied before 
treatment; (B) after anodisation; and (C) after silanisation.   211 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5. XPS survey spectra of the surface of NiTi : (A) NiTi alloy as received; 
(B)anodized NiTi; (C) heat treated at 600°C; and (D) Silanised NiTi. Key: cps=counts 
per second. The emission occurs from different orbital with different binding energies for the 
core levels. 
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Figure 6.6. Schematic illustration of the bonding mechanism between activated silane solution 
and NiTi. 
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Figure 6.7. Scanning electron micrographs showing cross-sections of treated, coated 
NiTi strip: (A) casting; (B) electrosprayed; 100  m thick polymer coating; (C) 
electrosprayed, 50  m thick polymer coating. 
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Figure 6.8. Peel strength test results for untreated and treated NiTi strip: (◊) 100  m 
electrosprayed coating on treated NiTi; (×) 50  m electrosprayed coating on treated 
NiTi; (♦) casting on treated NiTi; (●) Untreated NiTi. Inset: greater bond strength 
between polymer and treated NiTi compared to untreated NiTi. 
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Figure 6.9. Typical scanning electron micrographs of post-incubated POSS-PCU2 
nanocomposite polymer coating on NiTi in: (A) distilled water; (B) Cholesterol 
Esterase; (C) Phospholipase A2; (D) Plasma fraction II; (E) Plasma fraction III; (F) 
H2O2 ; and G) t-butyl peroxide after 70 days. Inserts show cross-sections.   216 
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Figure 6.10. Peel strength test of coated NiTi strip following 70 days immersion in 
different media. A) hydrolytic solutions, B) plasma fractions and C) 
oxidative/peroxidative solutions.   217 
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Figure 6.11. Ni release profiles from NiTi strips obtained from mass spectroscopy. Strips 
were incubated in DMEM. Inset: A) negligible Ni release from coated NiTi compared with 
bare NiTi; B) less Ni release from coated treated NiTi compared with coated untreated NiTi. 
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Figure 6.12. Ni release profiles from NiTi strips obtained from mass spectroscopy. Strips 
were incubated in plasma fraction I. Inset: A) negligible Ni release from coated NiTi 
compared with bare NiTi; B) less Ni release from coated treated NiTi compared with coated 
untreated NiTi. 
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CHAPTER 7. Conclusions and Future Work 
 
 
7.1. Conclusions 
The  investigations  carried  out  in  this  research  resulted  in  the  following  major 
conclusions: 
 
•  As  discussed  in  the  literature  review,  the  development  of  the  polymeric 
coatings of stents, including coronary or peripheral stents, is currently limited by the 
problem of thrombosis/restenosis. In this thesis, a suitable material was sought for the 
coating of metallic stent materials and a new nanocomposite based on poly(carbonate-
urea)urethane which incorporated silsesquioxane nanocages was discovered for this 
purpose. 
 
•  The  development  of  an  ideal  stent  coating  involves  identifying  the  right 
polymer and then optimising its coating technique on the metallic stent. The POSS 
addition  to  the  primary  PCU  increased  the  strength  of  the  polymer  with  great 
homogeneity  throughout  the  polymer  as  compared  with  PCU  only.  Contact  angle 
analysis showed that the POSS nanocube linked up to the hard segment of PCU, 
increasing the hydrophobicity characteristics of PCU and reducing the surface energy. 
The surface charge of the polymer shifted towards negative values by the addition of 
POSS during the polymerisation of PCU. Compared to bulk properties, the surface 
properties of PCU differed most upon the addition of POSS. This showed preferential 
orientation of nanocages towards the surface. 
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•  In vitro degradation studies revealed that POSS-PCU was resistant to a broad 
range  of  hydrolytic  enzymes  and  plasma  proteins  whilst  retaining  its  viscoelastic 
properties. GPC, SEM and stress-strain studies demonstrated that POSS nanocores 
shield  the  soft  segment(s)  of  the  polyurethane,  responsible  for  its  elasticity,  from 
different forms of degradation, principally hydrolysis and plasma protein fractions. 
These nanocomposites hence provide an optimal method, by which these polymers 
may be strengthened and improved in biostability whilst maintaining their elasticity, 
making them ideal materials for the development of cardiovascular implant. 
 
•  The biocompatibility of the novel nanocomposite polymer for a coating at the 
vascular interface was assessed for its potential as a substrate that will support the 
appropriate  cellular  activity.  At  a  cellular  level,  cytocompatibility  studies  were 
conducted using endothelial cells. The parameters studied were viability, adhesion 
and  confluence  morphology.  Cells  were  able  to  survive  for  up  to  three  days  in  a 
POSS-PCU medium without any evidence of toxicity. The analysis showed that the 
films of nanocomposite polymer were not toxic but also can be successfully seeded 
with endothelial cells. It also indicated that, once seeded, the endothelial cells remain 
viable  and  proliferate  for  a  period  of  three  days.  These  results  suggest  that  once 
placed in vivo, POSS-PCU coatings would allow endothelialisation without causing 
any adverse effects on the host. 
 
•  On studying the behaviour of POSS-PCU and the cells, the results revealed 
that with increasing concentrations of POSS, the polymer’s potential for cell adhesion 
properties increased compared to PCU alone. Interestingly, there was no significant 
difference  in  cells  adhesion  with  further  increase  of  POSS  (POSS-PCU2  versus   221 
POSS-PCU4).  It  is  postulated  that  this  behaviour  was  attributable  to  its  inherent 
surface  roughness  as  a  result  of  POSS  integration.  This  was  confirmed  on  AFM 
studies  which  showed  that  surface  roughness  was  directly  proportional  to  POSS 
content.  
 
•  Having identified POSS-PCU as a suitable material for a cardiovascular stent 
coating, the optimal coating technique was determined. Using stainless steel and NiTi 
materials, different methods -including electrospraying and dip-coating- were used to 
coat the metals with POSS-PCU.  In addition, the optimum experimental parameters 
necessary to create an even coating were determined. Materiasls made using a variety 
of parameter conditions were subjected to stress-strain testing and SEM to optimise a 
consistent  and  reproducible  procedure.  It  was  also  found  that  ultrasonic  spraying 
produced  a  surface  morphology  with  potential  for  endothelial  cells  adhesion 
compared to the casting technique. This finding is in favour of endothelialisation of 
the stents following implantation. So it is anticipated that adhesion and proliferation 
of a layer of endothelial cells on coating would help prevent problems such as the 
development of intimal hyperplasia.  
 
•  A  new  surface  modification  technique  to  enhance  the  bonding  between 
nanocomposite  polymer  and  NiTi  was  developed.  This  involved  a  surface 
modification to promote bond strength between the POSS-PCU nanocomposite and 
the surface of NiTi. The surface modification introduced enhances the potential of the 
coating to protect the materials surface, mitigate corrosion and increase the longevity 
of the device in vivo. This is of great importance as the release of Ni from NiTi can 
increase the risk of thrombus formation.   222 
 
•  These combined results suggest that the nanocomposite is suitable for further 
development in the production of a coronary stents coating. 
 
7.2. Future work 
With the culmination of this work, the early stages of developing a coating of stent 
with POSS-PCU is completed. Considering the investigations carried out in this thesis 
and the results obtained, the following recommendations for further work are made. 
 
￿  In-vitro degradation in pseudo-physiological solutions, coating adhesion and 
corrosion resistance was already investigated in the present work. A future study for 
evaluation  of  the  coating  integrity  with  the  stent  over  the  lifespan  of  the  device 
involves the coating durability after accelerated durability testing. This study would 
estimate  the  durability  of  POSS-PCU  on  Nitinol  and  stainless  steel  stents  under 
pulsating  flow  conditions  and  physiologic  loading  simulating  blood  pressure 
conditions in the human body. 
 
￿  The investigation of coating durability after expansion to the largest labelled 
diameter  is  also  suggested  to  simulate  stent  deployment.  6%  deformation  of  the 
NiTi/25% deformation of the stainless steel stent should be done by mounting the 
stent on a balloon. The following experiments are suggested to study the stent after 
deployment: 
 
o  Surface topography by AFM on deformed and un-deformed samples.   223 
o  Surface morphology, smoothness of the surface before and after dilation 
should  be  investigated  by  SEM  to  track  the  signs  of  delamination  or 
destruction after expansion. 
o  Structural changes after expansion should be observed by XPS for metal 
compounds on the surface and cracks on the surface. 
 
￿  The two main coating techniques used, i.e. electrohydrodynamic spraying and 
ultrasonic atomization spraying should be compared upon deployment to see which 
will be less influenced by expansion. 
  
￿  Coating  thickness  on  stent  should  be  investigated  by  variable  angle 
spectroscopic ellipsometry or by AFM. Some studies applied a scratch system to the 
coating equipped with surface profiler which can read the thickness. 
 
￿  Some  characteristics  of  the  nanocomposite  should  be  investigated  after 
sterilization.  Sterilization  techniques  include  using  ethylene  oxide,  radiation, 
chemicals and heat. The following experiments should be done after sterilisation: 
 
-  Molecular weight of the polymer by GPC. 
-  Mechanical properties by tensometer. 
-  Degree of crystallinity before and after sterilization by DSC or wide angle X-
ray diffraction. 
-  Contact angle measurement. 
   224 
The  characteristics  of  the  coatings  need  to  be  investigated  before  and  after 
sterilization.  In  this  case,  the  coated  stent  should  be  mounted  on  a  balloon  and 
sterilized with ethylene oxide. The sterilized coated stent should be examined by SEM 
and compared with pre-sterilization coated stent.  
 
￿  One clear limitation of this study was the fact that EC adhesion was studied 
under  static  conditions,  and  the  possible  influence  of  pulsating  flow  was  not 
recognized.  A  next  step  is  the  evaluation  of  the  EC  attachment  on  coated-stent 
exposed to the circulated flow of ECs in an in vitro flow circuit model during further 
experiments. 
 
￿  The  assessment  of  vascular  smooth  muscle  cells  adhesion,  apoptosis  and 
growth should also be done by SEM and fluorescent microscopy. 
 
￿  It is also suggested to investigate the potential for the development of a device 
with the aim of achieving in-situ endothelialisation once implanted. Human peripheral 
blood  contains  both  circulating  endothelial  cells  and  endothelial  progenitor  cells. 
Further investigations are being carried out to improve and optimize the endothelial 
progenitor cells extraction and growth methods, employing magnetic beads to isolate 
CD34
+ or CD133
+ cells. Circulating endothelial cells are being isolated from human 
peripheral  blood  and  characterized  by  fluorescent-activated  cell  sorting  and 
immunohistochemistry.  The  next  step  should  be  to  seed  the  isolated  cells  on  the 
nanocomposite following extracted from human blood and to investigate endothelial-
like properties on the nanocomposite after 14 days of culture. 
   225 
￿  Haemocompatibility of the coated stent in a closed-loop system under whole 
blood flow is recommended. Hydrophobicity and smoothness, negative charges of the 
surface investigated in this study are complementary tests to discuss the results for 
thrombogenicity.  TCP  and  unloaded  stent  can  be  used  as  negative  and  positive 
control,  respectively.  The  set  of  experiments  for  haemocompatibility  assessment 
should include: 
 
-  Thromboelastography. 
-  Platelet adhesion and spreading by immunofluorescent microscope. 
-  Activated partial thromboplastin time (APTT). 
-  Fibrinogen adsorption test by ELISA. 
-  Anticoagulant activity of the surface using factor Xa chromogenic assay. 
 
￿  Comparison  of  POSS-PCU  in  terms  of  haemocompatibility/biological 
properties with commercially available polymers for coatings is recommended. Stents 
should be compared with different coatings like poly(ethylene-co-vinylacetate) and 
polybutylmethacrylate  (PEVA/PBMA),  or  poly(styrene-b-isobutylene-b-styrene) 
(SIBS); which are the polymers used in the construction of commercially available 
DES. 
 
￿  Although  the  in  vitro  experiments  on  POSS-PCU 
 with  different  POSS  concentrations  presented  here  are  promising,  further  in  vivo 
investigations, from a broad experimental study based on a sheep model, would need 
to be performed before concluding on its overall biocompatibility and for its potential   226 
use  in  the  stents  coatings  setting.  The  result  for  up  to  7-month  implantation  is 
recommended. 
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